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1. Abstract
As the obesity epidemic continues unabated further investigation of novel weight loss 
approaches is warranted. Low carbohydrate diets (LCDs) provide one possible dietary 
strategy for weight loss. This thesis addresses continuing concerns regarding this weight 
loss approach by comphrensively investigating LCDs.
The effects of a LCD, with and without exercise, on CVD risk factors was investigated in a 
6 month randomised study. Fifty-six overweight or obese men were instructed to follow a 
LCD whilst either increasing or maintaining baseline activity levels (Chapter 3). Results 
demonstrated LCDs to be a safe and effective weight loss strategy with no significant 
additive effects of exercise seen.
Low levels of compliance to exercise instructions were evident therefore subjects were re­
grouped according to reported exercise levels (Chapter 4). An additive effect on the 
reduction of weight, body fat mass, diastolic blood pressure, glycaemic response and C- 
reactive protein (CRP) was seen in subjects who reported increasing activity levels.
In order to elucidate the nature and extent of the rapid initial weight loss associated with 
LCDs a second study investigated the early changes in weight and body composition 
(Chapter 5). Overweight or obese women (n=17) followed a LCD for 8 weeks with rapid 
initial weight loss observed and body fat reduced from the outset.
Finally, a systematic review with a meta-analysis was conducted to assess the current 
evidence investigating the efficacy and CVD risk of reduced carbohydrate diets with 
exercise as a weight loss intervention (Chapter 6). No significant added effect of exercise 
on weight loss or CVD risk reduction was seen.
This evidence demonstrates that LCDs are an effective means of reducing adiposity and 
inducing positive effects across numerous CVD risk factors. Regular but modest amounts 
of exercise may induce additional positive effects on weight and CVD risk. Therefore a 
whole lifestyle approach incorporating a LCD with exercise is an efficacious alternative to 
more conventional weight loss strategies.
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2. Introduction
This investigation of LCDs arose due to the need for further information on effective 
weight loss strategies to assist with the increasing prevalence of obesity. In the UK, 43% 
of men and 33% of women are overweight with an additional 22% of men and 23% of 
women being obese (Department of Health, 2004a). Public health messages highlight the 
need for effective weight management but the obesity epidemic controls to spiral out of 
control. Nevertheless, perhaps with increased public awareness of the health implications of 
being overweight, an ever increasing number of people are attempting to lose weight 
(Serdula, 1999). Unfortunately many individuals are unsuccessful in losing weight using 
traditional and evidence based weight loss strategies, (hypocaloric, low fat diets). Safe and 
effective alternative weight loss approaches are therefore needed to enable individuals to 
select the dietary pattern best suited to them and thus increase the likelihood of weight loss 
success whilst reducing their risk of associated co-morbidities.
Reduction of dietary carbohydrates offers one possible strategy for weight management. 
Although first reported in 1863 as the ‘Banting Diet’ (Hamilton and Greenway, 2004), 
LCDs hit centre stage in the 1990’s with a blaze of publicity surrounding a ‘new’ weight 
loss book published by Dr Robert Atkins, (Atkins, 2003) (20 years after its first 
publication). Atkins, an American cardiologist, flew in the face of the evidence base around 
carbohydrate metabolism suggesting that his dietary plan had a ‘metabolic advantage’ over 
traditional low fat weight loss approaches and that reduction of dietary carbohydrate was all 
that was needed for both weight loss and maintenance. Atkins theory was that obesity is 
caused by a diet rich in carbohydrate which leads to metabolic disturbances such as insulin 
resistance. This hyperinsulinemia can be corrected by following a LCD which allows one 
to lose more weight than an isocaloric low fat diet due to its ‘metabolic advantage’. His 
approach had immediate appeal to the lay public as a simple solution to obesity, and the 
message ‘cut out carbohydrate and eat as much protein and fat as you like’ was 
understandably immensely appealing. The Atkins New Diet Revolution was the best selling 
diet book in history (Lenzer, 2003), with Atkins books having sold over 45 million copies 
over 40 years (Astrup et a i, 2004). The portrayal of LCDs by the media as a ‘quick fix’ 
with ‘amazing results’ spurred public interest in this novel dietary plan which allows only 
20g of carbohydrate per day, forbidding bread, all other starches, fruit, many vegetables, 
beans and pulses during the initial stages. Although some of the claims made by Atkins 
were evidence-based, others were unsubstantiated and the scientific community was
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outraged by the blatant misuse of science for commercial gain. The controversy 
surrounding this diet continued unabated and many learned and professional bodies such as 
the American Dietetic Association, the British Dietetic Association, the British Heart 
Foundation (BHF) and the National Heart Foundation of Australia released statements 
condemning LCDs as unhealthy.
Although lagging behind public interest in LCDs, in 2003 a systematic review of the 
efficacy and safety of LCDs was published by Bravata and colleagues. The authors 
concluded that there was, ‘insufficient evidence to make recommendations for or against 
the use of LCDs’ (Bravata et al., 2003, p i837). This review was swiftly followed by the 
publication of several large randomised controlled trials investigating the effects of a LCD 
compared to a more conventional energy restricted low fat diet (Brehm et a l, 2003; Foster 
et a l, 2003; Samaha et a l, 2003). Significantly greater weight losses were reported in all 3 
of these studies after a LCD was followed for 6 months as compared to a low fat diet in 
overweight or obese women (Brehm et a l, 2003) obese men and women (Foster et a l, 
2003) and severely obese men and women with a high prevalence of diabetes and the 
metabolic syndrome (Samaha et a l, 2003). In addition no adverse effects on CVD risk 
were reported in those following a LCD with more substantial improvement across some 
CVD risk factors compared to subjects following a low fat diet. Whilst this data provided 
much needed information on the efficacy and health consequences of LCDs, there was a 
lack of information surrounding the effects of LCDs on initial body composition changes, 
emerging CVD risk factors (e.g. cytokines) and the effects of LCDs with and without 
exercise. Further understanding of these aspects is crucial to establish the implications of 
LCDs within a whole lifestyle approach to weight management and health.
LCDs continue to be viewed with caution due to fears they will lead to a high saturated fat 
intake (Council on Foods and Nutrition, 1973; Crowe, 2005), increased insulin resistance 
(Schwenke, 2005), renal abnormalities (St Jeor et al, 2001), increased bone loss due to 
high protein intakes (Barzel and Massey, 1998) and production of ketone bodies, (Carter et 
al, 2006) and an impairment to exercise (Bilsborough and Crowe, 2003).
This thesis contains a series of linked studies that aimed to address some of the gaps in the 
evidence base. The first study was an intervention to investigate the effect of a LCD, with 
and without exercise in achieving weight and body fat loss in obese men. Although 
substantial weight loss can be achieved through exercise (Ross et a l, 2000) many studies
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have reported little or no additive effects of exercise when combined with food restriction 
(Catenacci and Wyatt, 2007). Exercise has diverse beneficial effects and can improve both 
physical and psychological health (Fentem, 1994). Regular physical activity can impact on 
CVD risk by reducing adiposity, insulin resistance, hypertension, inflammation and 
improving lipid profile (British Nutrition Foundation (BNF) Report, 2005; Thompson et al, 
2005). The review by Bravata et al (2003) was unable to evaluate the effect of LCDs with 
and without exercise due to insufficient information available. Therefore the study reported 
in Chapter 3 and 4, set out to clarify if exercise alongside a LCD has additive effects on 
weight loss and CVD risk factors thus providing information to allow health professionals 
to make recommendations on the safety and health implications of a weight loss approach 
combining a LCD with exercise. As new risk factors are emerging as important indicators 
of CVD risk (BNF Report, 2005) changes in novel, as well as conventional, CVD risk 
factors were examined in order to comprehensively examine the impact of LCD, with and 
without exercise, on CVD risk.
Following on from this study in men. Chapter 5 examines the effect of a LCD in women. 
This study, published last year in the International Journal of Body Composition Research 
(Hiscutt et a l, 2007) developed from the need to examine in more detail the exact timing 
and extent of body composition change in the initial period of commencing a LCD. As the 
health risks associated with obesity are due to increased adiposity, understanding the nature 
of this early weight loss induced by LCDs, and specifically the contribution of fat and 
water losses, allows further elucidation of their health consequences.
Finally, in Chapter 6 a critical review of the efficacy of reduced carbohydrate diets with 
exercise as a weight loss intervention and the implications of this weight loss approach on 
CVD risk factors is presented. This is the most up to date synthesis of the evidence 
available as of January 2008 and assesses if it is now possible to evaluate the added effect, 
if any, of exercise with a LCD. This chapter uses a meta-analysis to combine published 
work with the results from Chapters 3 and 4.
The overall objective of this thesis was to rigorously investigate the potential of LCDs to 
treat obesity. This will provide individuals with a comprehensive evidence base of the 
effects of a LCD, with and without exercise, from which to base their decision as to 
whether adopting a low carbohydrate lifestyle approach to weight loss is one which will 
suit them.
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3. A randomised trial investigating the effects of a low carbohydrate weight loss 
regimen, with and without the additive effects of exercise, on cardiovascular risk 
factors in overweight and obese men
3.1 Introduction
3.1.1 Cardiovascular disease
3.1.1.1 Definition
CVD is the term used to classify a group of disorders affecting the heart and blood vessels 
and includes coronary heart disease (CHD), cerebrovascular disease and peripheral vascular 
disease (BNF, 2005).
3.1.1.2 Prevalence
CVD is responsible for 16.6 million deaths worldwide (WHO, 2003) and is the most 
common cause of death in the United Kingdom (UK). Although CVD mortality rates are 
falling, morbidity associated with CVD is increasing (Department of Health, 2003). Of the
16.6 million deaths globally, 7.2 million are due to ischaemic heart disease, 5.5 million due 
to CVD with hypertension and other heart conditions causing the remaining 3.9 million.
3.1.1.3 Pathogenesis
The processes of atherosclerosis and thrombosis involved in the development of CVD 
occur irrespective of which blood vessels are affected (coronary, cerebral or peripheral).
Atherosclerosis is thought to be initiated in the ‘setting of an unfavourable serum lipid 
profile’ (Crowther, 2005, p436) due to the normal homeostatic processes of the 
endothelium being disrupted by injury. This results in increased adhesiveness and 
permeability of the endothelium which also develops procoagulant properties (Ross, 1999). 
Modified low density lipoprotein (LDL) particles which have left the circulation are a 
major cause of injury to the endothelium. These oxidised LDL particles are taken up by the 
macrophages in the arterial wall, causing foam cells to develop and accumulate. As the 
inflammatory process continues there is an increase in the migration of monocytes across 
the arterial wall which then engulf further lipid leading to the development of the 
atherosclerotic plaque. Continued migration and proliferation of smooth muscle cells of the 
arterial wall results in formation of fibrous tissue and finally an atherosclerotic plaque with
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a lipid core (BNF, 2005). Thinning of the artery lumen results and the fibrous cap may 
rupture leading to thrombosis.
Thrombosis begins when damage to the endothelium occurs, such as at the site of an 
atherosclerotic plaque. The pathway leading to thrombosis is activated by proteins (e.g. 
Collagen and von Willebrand factor (vWF) and causes a cascade of reactions which 
ultimately result in clot formation (BNF, 2005).
3.1.1.4 CVD risk factors
CVD risk is affected by both modifiable and non-modifiable risk factors which are 
summarised in Figure 3.1. These include conventional risk factors such as age, smoking 
and total LDL-cholesterol levels, for which a link with CVD has been well established. In 
addition newer ‘novel factors’ for CVD risk (e.g. inflammatory factors) are becoming 
apparent with more research.
Non-m odifiable  
risk factor ^  Affect a  C V D
risk factor
M odifiable risk 
factor> .  C V D  risk factorÎ  Age
Ethnicity
Smoking Atherogenic 
lipid profileMale
Gender
Novel factors
(inflammatory 
makers) .
CVDiS E S
Diabetes
Genetics
tStress
Hypertension
Inactivity Obesity
Figure. 3.1 Modifiable and non-modifiable risk factors for CVD. Adapted from the
report of the British Nutrition Foundation task force, (2005).
SES - socio-economic status
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Many of these CVD risk factors (gender, age, atherogenic lipid profile, systolic blood 
pressure, antihypertensive medication status and smoking) are also criteria for diagnosis of 
the metabolic syndrome (National Cholesterol Education Program Adult Treatment Panel 
(NCEP ATPni) criteria, 2002) Metabolic syndrome is ‘a cluster of metabolic abnormalities 
with insulin resistance as a major characteristic’ (Wilson and Grundy, 2003, pl422). The 
association between metabolic syndrome and CVD has been demonstrated in a prospective 
cohort study (Malik et a l, 2004). Over six thousand subjects from the Second National 
Health and Nutrition Examination Survey were followed for 13.3 [3.8] years. Metabolic 
syndrome, as defined by the NCEP ATPIII criteria, (2002) more strongly defined CVD as 
well as CHD and total mortality risk than its component criteria. Thus it was concluded, 
‘CHD, CVD and total mortality are significantly higher in US adults with, than those 
without, metabolic syndrome’ (Malik et a l, 2004, p i245)
3.1.2 Effect of lifestyle on CVD
Lifestyle has a substantial impact on modifiable CVD risk factors via dietary intake and 
activity levels (in addition to smoking, alcohol consumption and stress management).
3.1.2.1 Diet
The composition of the diet has a role in the overall CVD risk of an individual through its 
effects on individual risk factors (see Table 3.1).
Table 3.1 The effect of dietary components on CVD risk factors 
Nutrients Risk factors
Saturated fatty acids TLDL, îlhrombogenesis
Cholesterol fLDL
Lin oleic acid {moderate quantities) j lD L
Linoleic acid (excessive quantities) Might Î LDL oxidation
n-3 fatty acids (from fish) 1 Platelet aggregation,
ithrombogenesis
Oleic acid Might fHDL, |  LDL
Transunsaturated fatty acids TLDL, |H D L
Total fa t T haemostatic factors, especially
factor VII
Antioxidant nutrients ILDL oxidation
Non-starch polysaccharides ILD L, thyperglycaemia
(especially soluble)
Folate, vitamin B 12, riboflavin, folic fHomocysteine
acid supplements or fortification
Sodium TBlood pressure
Fruits and vegetables iBlood pressure
Low fat dairy products______________ jBlood pressure____________________
Mann, (2002)
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Diet also affects CVD risk through its role in maintaining energy balance, with total energy 
intake being one half of the first law of thermodynamics which states that the body’s 
energy stores = energy intake -  energy expenditure. A disruption to this balance by 
increased energy intake will lead to weight gain and over time an individual will become 
overweight or obese. ‘Obesity may affect the heart through its influence on known risk 
factors such as dyslipidemia, hypertension, glucose intolerance, inflammatory markers, 
obstructive sleep apnea/hypoventilation, and the prothrombotic state, in addition to as-yet- 
unrecognized mechanisms’ (Poirierera/., 2006, p898).
3.1.2.2 Physical activity
Physical activity is defined as ‘any bodily movement produced by skeletal muscle that 
results in energy expenditure beyond resting expenditure’ (Thompson et a l, 2003, p3109). 
Activity, alongside energy intake, is crucial in maintaining energy balance thus preventing 
obesity and its associated CVD risks. Physical activity can also help prevent or reduce 
additional CVD risk factors; hypertension, insulin resistance, raised TAG levels and low 
levels of (high density lipoprotein) HDL-cholesterol. In addition combining exercise with 
weight loss can induce reductions in LDL-cholesterol and assist in maintenance of HDL- 
cholesterol levels. The American Heart Association (AHA) scientific statement (Thompson 
et a l, 2003, p3109) concluded that habitual physical activity ‘prevents the development of 
coronary artery disease and reduces symptoms in patients with established CVD.’ The 
AHA statement (Thompson et a l, 2003) re-emphasized the recommendations made by the 
Centers for Disease Control and Prevention and the American College of Sports Medicine 
(Pate et a l, 1995) that all adults should exercise at moderate intensity for a minimum of 30 
minutes on most, if not all, days of the week.
3.1.3 Tackling obesity
Obesity can affect CVD risk through its impact on individual risk factors but also as an 
independent risk factor for CVD (Poirier et al, 2006). The consequences of obesity extend 
beyond CVD. Co-morbidities associated with obesity include type 2 diabetes, hypertension, 
dyslipidaemia, osteoarthritis and gallstones (Freedman et a l, 2001). It has been predicted 
that, compared to the year 2000, overweight and obesity will result in a 33% increase in 
loss of healthy life in 2020 (WHO, 2002). The rising levels of obesity which have been 
discussed in Chapter 2, and the impact of this for the future health of the nation has been
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acknowledged in the UK White Paper titled, ‘Choosing Health, Making Healthy Living 
Easier’ (Department of Health, 2004^).
3.1.3.1 Weight management strategies
With the rising incidence of obesity there has been a concurrent rise in dieting strategies. A 
survey of 107,804 US adults found that more than two thirds of the population were 
currently attempting to lose or maintain body weight (Serdula, 1999) with similar trends 
being likely in the UK. Unfortunately in the long-term weight loss success is low with less 
than 10% of people typically maintaining a 5% reduction in initial body weight after 5 
years (Gosselin and Cote, 2001). Therefore it is evident that traditional weight loss 
strategies, (hypocaloric, reduced fat regimens) are failing to impact on obesity prevalence.
There are a multitude of weight loss regimens available, each reducing energy intake by 
one means or another (for example, altered macronutrient balance, controlling portion size 
or meal substitution). The efficacy of four commercially available diets were compared in 
Diet Trials, a randomised controlled trial (RCT) with 298 subjects over 5 centres across the 
UK (Truby et al, 2006). Subjects were randomised to Weight Watchers, Rosemary Conley, 
Slimfast, Atkins or a control group for a period of 6 months. There were no significant 
differences in weight loss between the four diets tested and it was apparent that each of 
these weight loss regimens was effective in producing weight loss if adhered to. It has been 
concluded that choosing the right weight loss diet for an individual is the key to success 
(Herriot et al 2008). In order for health professionals to assist individuals in weight 
management access to reliable information is needed to allow available treatment options to 
be discussed.
3.1.3.2 Low carbohydrate diets
The Atkins Nutritional Approach (Atkins, 2003) is probably the most renowned and 
commercialised example of a very LCD. It was one of the commercial weight loss diets 
investigated in the UK wide ‘Diet Trials’ study. It was found to be effective with, ‘no 
detrimental effects on total cholesterol concentrations or renal function’ (Truby et a l, 2006, 
pl313). Reduction of dietary carbohydrate offers one possible strategy for weight 
management and may be a useful and novel weight loss tool for some individuals. Whilst a 
growing body of research has investigated this dietary approach in recent years limited 
evidence is available of the effects of this dietary approach on novel CVD risk factors.
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Further information is needed to assist health professionals in advising their patients of the 
merits and drawbacks of LCDs. One area in particular in which information is lacking is 
the effects of LCD with and without exercise as highlighted in the systematic review by 
Bravata et a l, (2003). This study addresses this gap in the literature.
3.1.3.3 Current research investigating low carbohydrate diets and physical activity
The importance of physical activity alongside weight loss in order to reduce CVD risk and 
improve overall health has been discussed. Therefore it is surprising many previous studies 
investigating LCD have either not considered exercise (Foster et ai, 2003; Samaha et a i, 
2003; Stem et al., 2004; Nobels et a i, 1989) or exercise has been encouraged but the type, 
level, duration or intensity of exercise is not reported (Brehm et ai, 2003; Noakes et a l, 
2005; Westman et a l, 2002; Yancy et al, 2004). In an attempt to control for exercise other 
researchers including Brehm et al, (2005), Sharman et al, (2004), Skov et al, (1999^) and 
Volek et al (2004“) have instructed subjects to maintain baseline levels of activity.
The work of Dansinger et al, (2005) is an example of one study that did report exercise 
levels. The Atkins, Ornish, Weight Watchers, and Zone diets were compared with 40 
overweight or obese adults following each diet. All subjects were advised to take at least 60 
minutes of exercise a week. No significant difference in activity between diet groups was 
evident but subjects significantly increased their exercise levels from baseline (P<0.05). 
The possible benefits of including physical activity alongside dietary intervention were 
illustrated by the association identified between weight loss and changes in exercise level 
(P=0.001). However this may be a reflection of compliance to the study rather than the 
effects of exercise alone as this significant association no longer existed once dietary 
adherence was taken into account. No associations between change in exercise and any 
measured cardiac risk factor were seen. This may be due to the fact the change in exercise 
was insufficient to allow these effects to be observed and because the study was not 
powered to investigate the effects of exercise on cardiac risk factors.
Chapter 6 of this thesis presents a review of the current evidence investigating the efficacy 
of reduced carbohydrate diets with exercise as a weight loss intervention and the 
implications of this approach on CVD risk factors. Very limited research has been 
published in this area with only 2 studies (Layman et al, 2005; Meckling and Sherfey, 
2007) available for inclusion within the review.
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An exercise intervention was combined with a high protein, reduced carbohydrate diet or a 
low protein, higher carbohydrate diet in the study by Layman et al, (2005). This was a 2 x 
2 block design with subjects, (overweight or obese women, n=48), being in the control 
exercise group (lifestyle activity only) or on a supervised exercise program, (5 days/week 
walking and 2 days/week resistance training) for 4 months. Exercise was seen to increase 
loss of body fat and better preserve lean mass. The high protein, reduced carbohydrate diet 
with additional exercise improved body composition during weight loss. Lipids were also 
measured and were affected by diet group only. Although the dietary intervention in this 
study varies from many LCDs, as energy intake was restricted and carbohydrate intake was 
substantially higher than in many LCDs (high protein group =141.3 [4.7] g/day, high 
protein + exercise group =126.8 [4.2] g/day), the combined effect of diet and exercise is 
shown.
More recently Meckling and Sherfey (2007) investigated the effect of a hypocaloric, high- 
protein diet, with and without exercise on weight loss, fitness and metabolic syndrome 
markers in overweight and obese women. Sixty women were randomised to one of four 
groups, a control diet, a control diet with exercise, a HP diet or a high protein diet with 
exercise (HPEx) for 12 weeks. The exercise programme consisted of 3 x 36 minute 
supervised circuit-training programme per week consisting of both resistance and 
endurance exercises. The high protein diet was designed to have a protein to carbohydrate 
to protein ratio of 1:1 with a 500 kcal/day energy deficit. Although this resulted in a 
carbohydrate intake substantially lower than at baseline, (127g carbohydrate in the HP 
group and llOg in the HPEx group during the intervention) this level of carbohydrate is 
above that of a typical LCD. Results from this study showed that exercise was associated 
with improved weight loss when combined with either a HP or a low fat, high carbohydrate 
diet. Positive changes across several risk factors for CVD, metabolic syndrome and type 2 
diabetes were seen in all 4 intervention groups to a similar degree. Therefore an additive 
effect on weight loss but not markers of the metabolic syndrome was demonstrated in those 
subjects following an exercise programme (Meckling and Sherfey, 2007).
3.1.4 The effects of LCDs on CVD risk factors
3.1.4.1 Effects of LCDs on obesity
Obesity is defined using body mass index (BMI) whereby individuals with a BMI of above 
30 kg/m^ are classified as obese (Arterbum and Hitchcock Noel, 2001). BMI is unable to
34
determine the composition of any excess weight and does not consider individual 
differences in lean body mass. As ‘the co-morbidities of obesity are probably more related 
to the amount of fat tissue that an individual carries than to their total weight’, (BNF, 2005, 
p30) percentage body fat is seen as a better indicator of CVD risk than BMI. However as 
BMI is highly correlated with body fat, weight and BMI measurements remain widely used 
as outcome measures in dietary interventions. These simple parameters demonstrate clearly 
the effects of a weight loss intervention and can be used alongside body composition 
measurements which determine body compartment changes.
The efficacy of LCDs in producing weight loss is well documented. Table 3.2 illustrates the 
most recent studies investigating this dieting approach, demonstrating the degree of weight 
loss that can be expected over a 6-month period. Mean weight losses of between 5.8 to 
12kg have been achieved by individuals following a LCD within different populations.
35
Table 3.2 Weight loss reported on LCDs compared to low fat diets in recent studies 
(2002 onwards)
Study Sample Weight Loss (kg) (mean (SDJ)
Low CHO Low Fat Low CHO Low Fat
3 Months 3 Months 6 Months 6 Months
Foster et al, 
2003
63 obese men & 
women
6.8 [5.0] 2.7 [3.7] 7.0 [6.5] 3.2 [5.6]
Brehm et al, 
2003
53 obese females 7.6 [0.7] 4.2 [0.8] 8.5 [1.0] 3.9 [1.0]
Dansinger et al, 
2005
160 overweight or 
obese men & 
women
N/A N/A 5.8 [8.6] 6.7 [8.0]
Samaha et al, 
2003
132 severely obese 
men & women
N/A N/A 5.8 [8.6] 1.9 [4.2]
Truby et al, 
2006
293 overweight & 
obese men & 
women
N/A N/A 6.0 [6.4] 6.6 [5.4]
Westman et al, 
2002
51 overweight & 
obese men & 
women
N/A N/A 9 [5.3] N/A
Yancy et al, 
2004
120 overweight, 
hyperlipidémie 
men & women
N/A N/A 12.0 6.5
CHO -Carbohydrate 
N/A -  Not applicable
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3.1.4.2 Effects of LCDs on body composition
Adipose tissue is an active endocrine organ producing adipocyte products which affect 
CVD risk. Examples of these are cytokines, tumour necrosis factor alpha (TNF-a) and 
interleukin-6 (IL-6) as well as hormones, leptin and adiponectin. TNF-a and IL-6 increase 
vascular permeability and expression of adhesion molecules in the artery walls thereby 
having a role in atherosclerosis (BNF, 2005). Therefore the negative consequences of a 
high percentage body fat on CVD risk are extensive. In addition to these effects a higher 
body fat percentage and waist:hip ratio has been associated with dyslipidaemia and 
increased levels of TAG levels and apoB (Poirier et a l ., 2003).
There is increasing evidence that LCDs result in a preferential loss of body fat mass. Table
5.1 (Chapter 5) summarises the studies which have measured body composition as part of a 
LCD intervention. The distribution of adipose tissue is also recognised to be critical in 
CVD development and there is a growing body of evidence that visceral fat, (measured 
using waist:hip ratio (WHR)) with its detrimental metabolic actions such as development of 
insulin resistance (Miyashita et a l, 2004), confers a greater risk over adipose tissue 
elsewhere. The distribution of body fat loss was measured by Miyashita et al, (2004) in a 
study where subjects with type 2 diabetes followed a LCD for 4 weeks. Computerised axial 
tomography was used to measure visceral and subcutaneous fat and significant decreases in 
total visceral fat and visceral fat to subcutaneous fat ratio were seen in the LCD group only.
The effect of a very LCD, compared to a low fat diet on body composition was investigated 
by Volek et a l in 2004“. Twenty-eight healthy, overweight or obese men and women 
followed a hypocaloric (-500 kcals/day) very LCD and low fat diet in a crossover design. 
The LCD caused a preferential loss of fat in the trunk region. As excess fat in the 
abdominal area is associated with diabetes, insulin resistance, dyslipidaemia and 
atherosclerosis (Gasteyger and Tremblay, 2002) this LCD induced change in body 
distribution is likely to have positive health implications.
3.1.4.3 Effects of LCDs on blood pressure
Blood pressure is one of the major modifiable risk factors for CVD and is strongly 
associated with obesity (Sharma et al, 2001). A systematic review of the efficacy and safety 
of LCDs (Bravata et al, 2003) concluded that there were no significant adverse effects of 
this dietary approach on blood pressure based on the short term evidence currently
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available. However it has been noted that the small number of studies published at the time 
of review resulted in a lack of power to detect small changes in this measure (Crowe, 
2005).
A diet inducing weight loss would not be expected to induce detrimental effects on blood 
pressure. Indeed the ‘Diet Trials’ study (Truby et a l, 2006) reported decreases in blood 
pressure in subjects following all four different diet interventions, (Atkins, Weight 
Watchers, Slimfast and Rosemary Conley). The mean change in systolic blood pressure 
(5.7 mm/Hg [12.7]) of dieters following the Atkins diet was greater than in other diet 
groups but there was a significant difference between the Atkins and the Slimfast group 
(0.5 mm/Hg [11.4]) only. Reductions in systolic (P<0.001) and diastolic (P<0.01) blood 
pressure were seen when 51 overweight or obese volunteers followed a LCD, (<25g/day) 
for 6 months (Westman et a l, 2002). Foster et al, (2003) also found diastolic blood 
pressure to have fallen significantly at 6 and 12 months compared to baseline in subjects 
following a LCD. However other studies (Brehm et a l, 2003, Samaha et a l, 2003) have 
reported no significant time or group interaction in blood pressure when subjects followed 
either a low carbohydrate or more conventional low fat, hypocaloric diet.
Therefore current research indicates that LCDs have no detrimental effect on blood 
pressure and may reduce this parameter but perhaps not more so than conventional diets. A 
recent meta-analysis of RCTs investigating the effects of LCDs compared to low fat diets 
on weight loss and CVD risk factors found no differences in blood pressure between these 
two dietary approaches (Nordmann et a l, 2006).
3.1.4.4 Effects of LCDs on insulin levels
Insulin has a multitude of physiological effects within the body including;
• Increased glucose uptake and glycogen synthesis
• Reduced glycogenolysis
• Increased fatty acid synthesis
• Increased estérification of fatty acids
• Reduced lipolysis
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• Reduced proteinolysis
• Increased amino acid uptake
• Arterial muscle tone 
(Adapted from BNF, 2005)
Therefore fasting insulin levels and the body’s response to these has far reaching 
consequences for a range of health related outcomes. The ability of insulin to carry out its 
function of stimulating glucose disposal varies more than 6 fold in otherwise healthy 
individuals (Reaven et a l, 2004). The reduced ability of insulin to increase glucose uptake 
and utilization in an individual is known as insulin resistance. Insulin resistance with 
compensatory hyperinsulinemia is associated with hypertension, dyslipidaemia, endothelial 
dysfunction and increased levels of fibrinogen and CRP (Reaven, 2005) thereby increasing 
CVD risk. These symptoms are collectively known as ‘syndrome X’ which is closely 
associated with the metabolic syndrome (BNF, 2005).
Diet can affect insulin resistance via weight loss, which enhances insulin sensitivity and 
reduces plasma insulin levels, and alteration of macronutrient balance through modification 
of the level of circulating insulin needed to maintain glucose homeostasis (Reaven, 2005). 
Low fat, high carbohydrate, isocaloric diets have been shown to accentuate insulin 
resistance and its associated symptoms (Reaven, 2005).
Therefore the use of LCDs, which induce weight loss and reduce the carbohydrate intake of 
the diet, would seem an ideal dietary solution to reduce insulin resistance.
Indeed reduced fasting insulin levels have been reported in LCD interventions. Baba et al 
(1999) placed obese, male, hyperinsulinémie volunteers on either a high-protein (45% 
protein, 25% carbohydrate) or high-carbohydrate (HC) diet (12% protein, 58% 
carbohydrate). Both diets provided 80% energy requirements as measured by resting 
energy expenditure. Weight loss was greater in the HP group than the HC group (8.3 kg 
[0.7] vs. 6.0 kg [0.6]. At the end of the four-week study fasting insulin levels had fallen 
significantly in both groups. Although there was no significant difference between the 
groups, insulin levels decreased to within normal levels in the HP group only. The authors 
use these results to conclude that a high-protein (lower carbohydrate) low-energy diet is 
favourable for those with insulin resistance. However, this conclusion is weakened by the
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lack of significance between the groups and the fact that baseline insulin levels were lower 
in the HP group than the HC group. Stem et al, (2004) saw fasting insulin levels fall 
further in subjects following a LCD compared to those following a low fat diet. The more 
substantial fall in insulin levels observed by Stem et al, (2004) and Baba et al, (1999) may 
be explained by the greater weight loss that was also observed in these groups. But this has 
been contradicted by the findings of Golay et al, (1996) who reported no significant 
difference in weight loss between high and low carbohydrate groups despite significant 
reductions in fasting insulin in the LCD group. Similarly lower insulin levels were 
observed when healthy men followed a low carbohydrate (2% energy) eucaloric diet 
compared to a high carbohydrate (85% energy) or control (44%) energy diet (Bisschop et 
al, 2000). LCDs have also been seen to have advantageous effects in reducing insulin levels 
compared to low fat diets in subjects with type 2 diabetes (Miyashita et a l, 2004) and in 
healthy (overweight or obese) subjects (Meckling et a l, 2004) when similar decreases in 
body weight are seen between groups.
These equivocal findings of the effect of LCDs on insulin levels are demonstrated further 
by studies which have reported decreases in fasting insulin levels when LCDs were 
followed but with no added effect compared to a low fat diet (Dansinger et a l, 2005; 
Noakes et al, 2006).
It is evident that reducing carbohydrate intake can reduce insulin levels, however a similar 
effect may be achievable with a high carbohydrate, hypocaloric diet. A recent review of the 
safety of LCDs (Crowe et a l, 2005) summarised that LCDs have been shown to improve 
insulin sensitivity with and without weight loss but the composition of the diet may 
ameliorate these effects. It has been suggested the protein content of LCDs may lead to 
insulin resistance as protein foods have been seen to elicit a greater insulin response than 
some carbohydrate foods (Holt et al, 1997). In addition a review evaluating the evidence of 
dietary composition and insulin resistance (Schwenke, 2005) concluded that the higher fat 
content of LCDs may exacerbate insulin resistance in the long term.
However concems over high intakes of these macronutrients, (protein and fat) may be 
unfounded as no increase in absolute intakes have been reported when LCD are followed 
(Boley et a l, 2004).
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3.1.4.5 Lipaemîc effects of LCDs
Hyperlipidaemia has an integral role in the initiation and development of atherosclerosis. A 
review of the evidence concerning lipoproteins, nutrition and CHD published in 2002 
(Schaefer) summarised the independent lipoprotein risk factors for CHD to be;
• Decreased HDL- cholesterol levels (<0.9 mmol/1)
• Elevated LDL-cholesterol levels (>4.1 mmol/1)
• Elevated lipoprotein a levels
Despite hyperlipidaemia being identified as a potential health risk associated with LCD use, 
which do not restrict fat rich foods (Council on Foods and Nutrition, 1973), beneficial 
changes in lipids have been observed with these diets. As the efficacy of LCDs in 
producing weight loss has been demonstrated positive changes in lipid profile would be 
expected. Weight loss decreases serum LDL-cholesterol and triglyceride (TAG) levels and 
when weight loss is maintained improvements in serum HDL-cholesterol are observed 
(Klein et a l, 2004). In addition, as high carbohydrate diets increase TAG levels and are 
associated with low HDL-cholesterol levels (Roche et a l, 1999) LCDs might be expected 
to have a beneficial effect on these lipid levels compared to more conventional weight loss 
approaches. Therefore, the lipaemic changes observed in studies investigating LCD, 
(summarised in Table 3.3) are generally as would be predicted. The evidence for changes to 
total cholesterol levels remains equivocal with increases, (non-significant) in both short 
(Larosa et a l 1980; Volek et a l 2004*’) and longer-term studies (Foster et a l 2003; Samaha 
et a l 2003) but significant decreases in the studies of Brehm et a l, (2003), Sharman et al,
(2004), Westman et al, (2002) and non-significant decreases reported by Dansinger et al,
(2005).
Similar responses were seen for LDL-cholesterol. These inconclusive results are likely to 
be due to high levels of individual variability in both the magnitude and direction of lipid 
responses seen when a LCD is followed (Volek et a l, 2005). The differing population 
groups in each study, which in many cases are composed of both men and women, would 
also have led to variation along with the fact that the studies, (with the exception of 
Sharman et al, 2004) were not powered sufficiently to demonstrate potential differences as 
lipid fraction changes were not the primary outcome variable of interest.
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Most studies have observed an increase in HDL-cholesterol after a LCD was followed. The 
most dramatic change in lipid levels, seen in all of these studies, is a fall in TAG levels.
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Table 3,3 Summary of recent studies describing the lipaemic effects of LCDs (from 2002)
§
Lipaemic change
1 î I III111 ii l l il il Üg"5 ■s
Brehm 53 healthy Very LCD 3 7.6 kg r Î i* i*
et al, obese (<10% energy 6 [0.7] P<0.01 Î * P<0.01 P<0.01
(2003) women as CHO) 8.5 kg 
[1.0]
i P<0.01 i i
Dansinger 160 Atkins diet 2 4.7 kg i Î * Î r
et al, overweight [2.9] P<0.01 P<0.01
(2005) or obese F<0.01 i
men & 6 5.8 kg i Î* i
women [5.3] P<0.01 i
12 P<0.01 i i
3.9 kg
[6.0] P<0.01
P<0.01
Foster 63 healthy LCD 3 6.8% Î Î* Î
et al. obese men (<20g [5.0] P<0.05 P<0.05
(2003) & women CHO/day P<0.05
initially then 6 7.0% Î ÎÎ) [6.5] Î * Î *
12 P<0.05 Î P<0.05 Î
P<0.05
4.4% r
[6.7] P<0.05 P<0.05
P<0.05
Samaha 132 severely LCD 6 5.8 kg Î Î i
et al. obese men (<30g [8.6]
(2003) & women 
(39% DM, 
43% MS)
CHO/day)
Sharman 15 healthy Very LCD 6 wks 6.1 kg i* i i r
et al. overweight hypoenergic (part [2.9] P<0.05 P<0.05
(2004) men (<10% energy 
as CHO)
of 12 
wk 
cross 
over)
Westman 51 healthy Very LCD 6 9.0 [5.3] r Î * i* i*
et al. overweight «25g P<0.001 P<0.006 P<0.001 P<0.01 P<0.001
(2002) & obese 
men & 
women
CHO/day \ 
To 50g /day)
Volek 13 Very LCD 4 wks 2.96 kg Î T Î i
et al. normolipide (<10% energy (part [1.45]
(2004*’) mic women as CHO) of 8 
wk 
cross 
over)
-
*Significantly different from baseline value.
CHO- carbohydrate
DM- diabetes
MS- metabolic syndrome
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With the recognition of the importance of emerging risk factors research has begun to 
investigate the effects of LCDs on postprandial lipaemia, LDL-cholesterol and HDL- 
cholesterol particle size and distribution.
Postprandial lipaemia ‘reflects an integrated measure of an individuals metabolic capacity’ 
(Patsch et al, 2000, p232) and is commonly measured by taking repeated measurements of 
plasma TAG levels after a standardised meal. Case-control studies have demonstrated an 
exaggerated postprandial lipaemia in people with CHD (Karpe, 1999). An elevated 
postprandial lipaemia is often associated with raised TAG levels, low levels of HDL- 
cholesterol and an abundance of small, dense LDL-cholesterol particles (BNF, 2005), 
collectively this is know as an atherogenic lipoprotein profile (ALP). This, together with 
the atherogenic lipoprotein particles produced in the postprandial state, (chylomicrons and 
very low lipoprotein (VLDL) remnants) explain the increased CHD risk of an exaggerated 
postprandial lipaemia. An ALP ‘is formed after long-standing moderate 
hypertriglyceridaemia or repeated bouts of exaggerated post-prandial 
hypertriglyceridaemia’ affecting the composition and concentration of atherogenic 
lipoprotein particles (BNF 2005, p53). As hypertriglyceridaemia is affected by dietary 
intake, in particular carbohydrate and alcohol, the importance of macronutrient proportions 
are clear. Recent evidence has shown that post-prandial lipaemia in response to a fat-rich 
meal is dramatically reduced after a LCD (Volek et al, 2005). This effect was seen in a 
study comparing the effects of a hypocaloric LCD and low fat diet on postprandial lipeamic 
responses in women. Thirteen normolipidemic, overweight women followed a LCD and a 
low fat diet, both for a period of 4 weeks. An oral fat tolerance test was performed at 
baseline and after both dietary interventions and postprandial lipaemia was reduced 
(significantly) to a similar extent following the LCD and low fat diet. Although not evident 
in this study (Volek et al, 2005), postprandial lipaemia has been seen to be significantly 
lower after a LCD has been followed compared to a low fat diet in overweight (Sharman et 
al, 2004) and normal weight men (Sharman et al, 2002) and normal weight women (Volek 
et al, 2003).
CVD risk is also increased with an increase in the number of small dense LDL particles 
present. This is likely to be due to; the influx of small dense LDL particles into the arterial 
wall being rapid due to the reduced particle size, a higher affinity of small dense LDL for 
subendothelial matrix within the intima and the increased susceptibility of these particles to 
oxidation (Griffin, 1999) thus leading to foam cell formation. Plasma TAG levels are
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critical in the formation of small dense LDL. The pathway by which small dense LDL is 
formed is shown in Figure 3.2. This pathway is accelerated when TAG levels are increased 
thus concentrations of small, dense LDL are higher (British Nutrition Foundation (BNF), 
2005).
TAG HL
VLDL
CETP Small
dense
LDL
Gholesteryl
esters TAG
Figure 3.2 Pathway for production of small dense LDL (BNF, 2005)
CETP- Gholesteryl ester transfer protein 
HL- Hepatic lipase
Whilst many researchers have not investigated lipid changes at the level of subfractions 
Westman et al, (2002) measured this important parameter in obese, hyperlipidémie 
subjects fed a LCD along with fish, borage and flaxseed oil supplements for 6 months. 
Weight was reduced by 13.8% in this group, along with a reduction in VLDL, increase in 
HDL-cholesterol and a change from small to large LDL-cholesterol. These changes reflect 
a positive change to a less atherogenic profile and hence a lower CVD risk. A hypocaloric 
LCD was also seen to increase LDL size in overweight and obese women with small, 
atherogenic LDL particles over a short time period (four weeks) in a study by Volek et al, 
(2004^). A beneficial change from ‘pattern B’ (predominance of smaller LDL particles) to 
‘pattern A’ (predominance of large, less atherogenic particles) was seen in a greater 
percentage of overweight men who followed a hypocaloric, very LCD (75%) compared to a 
low fat diet (42%) for 6 weeks (Sharman et al, 2004). When women with a healthy weight 
followed an isoenergetic, very LCD for 4 weeks no significant changes in LDL particle size 
were observed compared to baseline (Volek et al, 2003). However a significant increase in 
mean and peak LDL diameter was seen in normal weight men with a predominance of 
small dense LDL particles at baseline after a 6 week ketogenic diet (Sharman et al, 2002). 
A small number of subjects (30%) had a predominance of small, dense atherogenic LDL
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particles in the study where no significant changes in LDL particle size was observed 
(Volek et al, 2003), therefore suggesting beneficial changes to LDL particle size is 
dependant on the distribution of these particles at baseline. These studies have small sample 
sizes therefore further studies of longer duration and with a larger sample size are needed to 
determine the effect of a LCD on LDL subfractions.
Individuals with a predominance of small dense LDL particles also have a high number of 
small dense HDL particles (Krauss et al, 1988). As with LDL particle size the distribution 
of HDL particles is dependant on TAG levels with a greater number of large HDL particles 
being present when TAG concentrations are lower (BNF, 2005). This is explained in Figure
3.3 which shows the exchange of cholesterol between VLDL and HDL subclasses.
CETP-
mediated
exchange
VLDL
HL
TAG
TAG
Gholesteryl
esters
Figure 3.3 Exchange of cholesterol between VLDL and HDL subclasses
VLDL - very low density lipoprotein 
CETP - cholesterol ester transfer protein 
HL - Hepatic lipase
Adapted from the BNF Report (2005) and Volek et al., (2005)
CETP-mediated intravascular exchange occurs between TAG-rich lipoproteins and HDL. 
As CETP is regulated by TAG levels a high TAG concentration leads to more TAG-rich 
HDL particles. These are susceptible to modification by hepatic lipase (HL) resulting in 
small dense HDL3 particles. This increases CVD risk as HDL3 particles have a reduced
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plasma residence time therefore reverse cholesterol transport is reduced and less cholesterol 
is removed from peripheral cells.
As LCDs have been seen to be effective in significantly reducing TAG levels is it therefore 
unsurprising this dietary approach has also been seen to increase the distribution of larger 
cardioprotective HDL particles (HDL2). Seventy-eight severely obese subjects (86% with 
diabetes or metabolic syndrome) followed a LCD or a conventional diet for 6 months 
(Seshadri et al, 2004). The concentration of large HDL increased while small HDL 
decreased. Similar effects on LDL and HDL subfractions were seen following both diets. 
An increase in large HDL particles could not be predicted by weight loss, insulin sensitivity 
or gender. HDL particle size was seen to significantly increase (P<0.01) with a 39% 
increase in these large HDL particles seen when men followed a carbohydrate restricted 
(10% of energy) diet for 12 weeks (Wood et al, 2006).
Also important in the production and transport of cholesterol within the body are 
apolipoproteins. These are proteins which are major components of lipoprotein particles 
with apolipoprotein B (apoB) being the main protein in LDL-cholesterol and apolipoprotein 
A-1 (apoA-1) the major protein in HDL-cholesterol. Thus high levels of apoB are 
associated with an increase CHD risk and apoA-1 is protective. BMI has been positively 
associated with apoB levels and inversely associated with HDL-cholesterol and apoA-1 
(Chu et al, 2001) therefore a LCD which reduces body weight may alter levels of these 
apolipoproteins in a direction which reduces CVD risk. Indeed a 26% reduction in apoB 
levels was seen by Vermeulen (1990) after obese women (n=51) consumed a protein 
sparing modified fast for 4 weeks. However the diet provided only 400 kcals so is unlikely 
to resemble the ‘typical’ LCD. Less beneficial changes were also seen with a reduction in 
HDL-cholesterol and apoA-1 also reported, however overall the diet intervention resulted 
in a less atherogenic profile.
Non-esterified fatty acids (NEFA) are often measured alongside other lipaemic parameters 
as they have been associated with abdominal obesity, insulin sensitivity and CVD risk 
(Frayn, 2005). NEFA are an important metabolic fuel and concentrations vary throughout 
the day depending on nutritional status, physical activity and stress. Postprandially plasma 
NEFA levels fall as insulin suppresses adipose tissue lipolysis. Concentrations then rise in 
the fasting state (Frayn, 1998). Dysregulation of NEFA levels can have detrimental effects 
on impaired glucose uptake and insulin sensitivity however the usefulness of NEFA as a
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marker for CVD remains uncertain (Frayn, 2005). This is likely to be partly due to the large 
variation in plasma NEFA concentrations. Few studies have investigated the effects of 
dietary intervention on NEFA.
3.1.4.6 Haemostatic and inflammatory effects of LCDs
The effects of emerging risk factors such as haemostatic and inflammatory changes on 
CVD continue to be investigated. However, there is evidence that markers of haemostasis 
such as fibrinogen (Rajecki et al, 2005) as well as the inflammatory marker CRP (Rutter et 
al, 2004) are significant predictors of CVD events. Indeed subjects with atherosclerosis 
and diabetes show signs of chronic low-grade systemic inflammation as indicated by such 
markers (BNF, 2005).
In addition, further novel risk factors for CVD are currently of interest and other 
inflammatory markers involved in the inflammatory cascade such as tumour necrosis 
factor-alpha (TNF-a) have been shown to increase the risk of the rupture of an unstable 
atherosclerotic plaque (Blake and Ridker, 2001).
This can be explained as CRP and fibrinogen are acute phase proteins produced in the liver 
in response to increasing circulating levels of pro-inflammatory cytokines such as TNF-1, 
IL-6 and interleukin-1 (IL-1). These cytokines have roles in increasing vascular 
permeability and expression of adhesion molecules (BNF, 2005) and therefore contribute to 
atherosclerosis.
Favourable effects of a high protein, LCD on inflammatory markers, (namely CRP as well 
as soluble intercellular adhesion molecule, (sICAM-1)) were evident in obese 
hyperinsulinémie subjects after a sixty-eight week intervention (Brinkworth et al, 2004). 
Although this diet was low in carbohydrate (40% energy) this is considerably higher than 
many popular LCDs, therefore these results may not be comparable.
Similarly in a study by Due et al (2005), a reduction in CRP from baseline was observed in 
overweight subjects following a diet with 45% of energy provided as carbohydrate. This 
effect was not significant and was also seen in subjects consuming 58% energy as 
carbohydrate. Due and colleagues used cross sectional analysis to illustrate that body fat is 
positively associated with serum CRP levels. A significant reduction in CRP levels was 
seen to be associated with weight loss, but independent of macronutrient composition of the 
diet, when 41 obese women followed either a low fat or LCD for 3 months (O’Brien et al,
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2005). These results suggest that, whilst LCDs may reduce inflammatory response, using 
CRP as a marker, this may not be to a level of significance and could be due to reductions 
in body fat rather than carbohydrate intake per se.
Conversely, a study published recently by Wood et al, (2006) reported significant 
reductions in CRP, as well as TNF-a, (P<0.05) after 29 overweight or obese women 
followed a carbohydrate restricted diet for 12 weeks, an effect that was independent of 
weight loss. This confirms the need for further research investigating the association 
between LCDs and these relatively ‘new’ but important CVD risk factors.
Bo and colleagues (2004) measured fibrinogen levels and other metabolic and 
anthropometric parameters in 87 non-obese men using regression analysis to evaluate 
associations between variables. The authors reported that fibrinogen, as well as CRP, was 
associated with body fatness and concluded that this could be due to adipose tissue 
regulation of these acute phase reactants. Although there is currently a lack of evidence 
showing the effect of LCDs on fibrinogen levels, a positive relationship between insulin 
resistance and fibrinogen has been reported (Chen et al, 2004). Therefore is could be 
postulated that a LCD which improves insulin sensitivity (Samaha et al, 2003) may reduce 
fibrinogen levels indirectly via its insulin sensitising effect.
A haemostatic factor considered to be a CVD risk factor is vWF, an acute plasma reactant 
(Jager et al, 1999). vWF has a role in thrombosis by mediating platelet plug formation at 
sites of endothelial damage, thus leading to thrombus formation (Mannucci, 1998). 
Investigation of the effects of LCDs on vWF have not yet been conducted.
3.1.5 The effects of physical activity on CVD risk factors
Regular physical activity has far-reaching effects on CVD risk factors such as reduced 
adiposity, insulin resistance, hypertension, inflammation and improved lipid profile (BNF 
Report, 2005; Thompson et al, 2005).
3.1.5.1 The effects of physical activity on weight
A meta-analysis of the effect of exercise with and without dieting (Garrow and 
Summerbell, 1995) concluded that aerobic exercise without dieting induced a modest 
weight loss. A similar result was found when 25 years of weight loss research were 
examined in a meta-analysis by Miller et al, in 1997. The authors reported the average
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weight loss over 15 weeks to be -10.7 kg [0.5], -11.0kg [0.6] and -2.9 kg [0.4] through diet, 
diet and exercise and exercise alone respectively. However it was recognised that many of 
these studies were generally of short intervention and did not cover a broad population, 
with most subjects being middle aged and moderately obese. Studies investigating reduced 
carbohydrate diets with and without exercise reported additional weight losses of 2.4kg 
(Layman et al, 2005) and 2.8 kg (Meckling and Sherfey, 2007) in those subjects following 
an exercise programme. However the meta-analysis combining the weight results from 
these studies found no significant additive effect of exercise as compared to control when 
combined with a reduced carbohydrate diet (section 6.3.4.1).
Nevertheless, there is evidence suggesting that substantial weight losses are achievable 
through the use of exercise alone. In a study by Ross et al., (2000) obese men (n=52) were 
randomised to one of 4 study groups for 3 months; diet-induced weight loss, exercise- 
induced weight loss, exercise without weight loss or control. Weight was reduced by 7.4 kg 
and 7.6 kg in the diet and the exercise-induced weight loss groups but did not change in the 
other two groups. Therefore it was concluded that daily exercise, with or without energy 
restriction, was an effective strategy for weight reduction. The more dramatic weight loss 
achieved through exercise were thought to be due to the well matched groups, substantial 
energy deficit, (-700kcals/day) and 24 hour energy intake and expenditure being accurately 
measured. Although this study had small numbers in each group it illustrates the usefulness 
of exercise in weight loss. Elsewhere combining exercise with an energy deficit has been 
demonstrated to have the most beneficial effects on weight loss and weight maintenance 
(Miller et al, 1997; Avenell et al, 2004). Physical activity also has a role in longer term 
weight control as illustrated by data from the US National Weight Control Registry (Wing 
et al, 2001); where 81% of individuals who maintained >10% body weight loss for a 
minimum of 1 year reporting increased daily activity levels.
3.1.5.2 The effects of physical activity on body composition
Physical activity has beneficial effects on body composition. Combined with a hypocaloric 
diet the loss of lean body mass which occurs with diet induced weight loss is reduced 
(Klein et al, 2004). A review of studies published from 1966-2000 (Ross and Janssen,
2001) reported exercise induced weight loss to be positively associated with a reduction in 
total body fat (evidence from short term studies only (16 weeks or less). In addition 
exercise-induced weight loss was associated with a reduction in abdominal obesity.
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A recent study demonstrating the effects of exercise on body composition recruited 48 
overweight or obese women to follow one of two diets, (higher protein, low carbohydrate 
or lower protein, high carbohydrate) for 4 months with or without exercise, (walking 5 
days/week and resistance training 2 days/week). The authors concluded that the exercise 
component increased the loss of body fat and preserved lean mass (Layman et al, 2005). 
Additive effects on body composition were seen by combining diet and exercise. However 
a review of reduced carbohydrate diets with exercise (Chapter 6) concluded there that were 
no significant added effects of exercise, combined with a reduced carbohydrate diet, on 
body composition. Very limited evidence was available for inclusion within this review.
The exercise-induced changes in the distribution of fat mass as well as total body fat 
changes were investigated by Ross et al, (2000). Fifty-two obese men were randomised to 
one of four groups (see 3.1.5.1) for 3 months and although total body fat was significantly 
reduced (P<0.001) in both weight loss groups the average reduction was 1.3 kg greater in 
the exercise-induced weight loss group compared to the diet-induced weight loss group 
(P<0.03). Abdominal subcutaneous and visceral fat were significantly (P<0.001) reduced in 
both weight loss groups to a similar degree. Exercise without weight loss also significantly 
reduced (P=0.001) both abdominal and visceral fat.
Therefore the current evidence illustrates that physical activity induces beneficial body 
composition changes and when combined with a hypocaloric diet these changes are, in 
most cases, enhanced.
3.1.5.3 The effects of physical activity on blood pressure
The evidence for the effects of physical activity on hypertension has been long established, 
with RCTs showing the hypotensive effects of moderate physical activity (Erlichman et al,
2002). The average reduction in systolic and diastolic blood pressure after an exercise 
training programme has been reported to be 3.4 and 2.4 mm Hg respectively (Thompson et 
a l ., 2003). Intensive exercise is not necessary in order to see a reduction in blood pressure. 
Dunn et al, (1999) demonstrated that a lifestyle intervention had significant beneficial 
effects on blood pressure as did a traditional structured exercise programme.
3.1.5.4 Glycaemic effects of physical activity
The combined effects of diet and exercise on glucose levels were reported in the Diabetes 
Prevention Program. Knowler et al,. (2002) described the effects when 3234 subjects
51
without diabetes were randomised to one of three groups; placebo, metformin or lifestyle 
intervention, (incorporating goals of losing at least 7% body weight and at least 150 
minutes of activity per week). At follow up (mean follow up=2.8 years) both metformin 
and lifestyle interventions were effective in reducing fasting glucose levels. The lifestyle 
intervention reduced the incidence of diabetes by 58% (compared to 31% reduction in the 
metformin group). These powerful results show the benefit of exercise in conjunction with 
weight loss but do not allow the effects of activity alone to be distinguished. An 
intervention (Watkins et al, 2003) which randomised subjects (53 men and women with 
characteristics of syndrome X) to an aerobic exercise programme, an exercise plus weight 
loss programme or a control group allowed the effects of exercise with and without weight 
loss to be seen. A significant reduction in the hyperinsulinémie response to glucose was 
seen in both the exercise and exercise with weight loss group. Insulin response was 
improved most in those with the greatest weight losses (47% reduction in exercise and 
weight loss group compared to 27% in exercise only group). Thus exercise combined with 
weight loss appears to have the most beneficial effects on glycaemic responses.
No significant additive effect of exercise (when combined with a reduced carbohydrate 
diet) on insulin levels, was evident in the review described in Chapter 2. However only 2 
published studies were available for inclusion in this review.
3.1.5.5 Lipaemic effects of physical activity
There is clear evidence for the effects of exercise on improving lipid profile, especially 
increasing levels of HDL-cholesterol. This was summarised by a review of the effects of 
diet and exercise interventions on lipids and lipoproteins by Leon and Sanchez, (2001). The 
most common change seen was an increase in HDL-cholesterol levels with reductions in 
TAG, total cholesterol, and LDL-cholesterol observed in some studies. The authors 
concluded that, ‘moderate-hard intensity aerobic exercise training inconsistently results in 
improvements in blood lipid profile’ (pS502). Inconsistencies in the extent and direction of 
lipid changes, as well as a limited amount of published work were reasons given for the 
conclusion reached in a recent review (Chapter 6) that there is no added effect of exercise, 
alongside a reduced carbohydrate diet, on lipids.
Elsewhere, everyday activity has been associated with lipaemic improvements. The 
relationship between walking and total/HDL-cholesterol ratio was investigated by Tucker 
and Friedman (1990) and the relative risk for a ratio of 5.0 or greater, which signifies
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increased CVD risk, was higher in those who did not walk for exercise (1.1) compared to 
those who did (0.46).
The effects of physical activity on lipid profile are thought to be due to the reduction in 
body fat as well as an enhanced metabolic capacity for TAG which impacts on TAG and 
cholesterol circulation (Hardman, 1999).
3.1.5.6 Haemostatic and inflammatory effects of physical activity
The associations of physical activity with inflammation and coagulation markers were 
investigated by Pitsavos et al, (2005). Over 3000 men and women with no clinical signs of 
CVD, of which 33% men and 13% women were classified as having metabolic syndrome, 
(NCEP ATPlll criteria, 2002) were recruited and asked to report activity levels. Fifty six 
percent of men and 58% of women without metabolic syndrome were classified as 
sedentary as were 58% of men and 72% of women with metabolic syndrome. ‘Physically 
active individuals with metabolic syndrome had 36% lower levels of GRP,’ as well as, 
‘15% lower levels of TAF-a, 30% lower levels of lL-6 and 15% lower levels of fibrinogen’ 
Pitsavos et al, 2005, pl51) compared to the sedentary group (P<0.05). Similar results were 
seen in those without metabolic syndrome.
A four-week physical training program was seen to lead to a ‘near normalisation’ of GRP 
levels in subjects with impaired glucose tolerance or type 2 diabetes (Oberbach et al,
2006). This inverse association between physical activity and GRP has been seen 
consistently (Kasapis and Thompson, 2005). The mechanism causing a reduction in GRP 
levels is unknown but it has been postulated to be due to; reduced cytokine production, 
increased insulin sensitivity, improved endothelial function and reduced body weight.
Although there is limited evidence of the combined effect of diet and physical activity on 
haemostasis it is known that both regular activity and a reduction in body fat, individually, 
can reduce body fat and improve blood lipids thus reducing the risk of thrombosis 
(Rauramaa and Vaisanen, 1999).
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3.1.6 Justification of current research
The major public health problem of both obesity and CVD is well recognised. In order that 
health professionals may assist their patients in managing their weight an understanding of 
the available weight loss options is required. LCDs provide a novel approach to weight 
management but to be able to confidently provide comprehensive information to the lay 
person regarding this weight loss approach a greater understanding of their effects on health 
is crucial. The need for further research providing information on the effect of exercise in 
conjunction with weight loss, and more specifically LCDs, is evident from the gaps in the 
literature currently available. The importance of emerging CVD risk factors is becoming 
apparent and this research project therefore sets outs to investigate the combined effect of a 
LCD with exercise on both traditional and novel CVD risk factors.
3.1.7 Aims
This study aimed to:-
• Comprehensively investigate the lipaemic and haemostatic effects of a 6-month LCD in 
relation on CVD risk in overweight and obese men.
• Investigate the potential additive effects of regular moderate exercise in the positive 
mediation of CVD risk factors via a LCD in overweight and obese men.
3.1.8 Hypotheses
The hypotheses to be tested are that: -
A LCD will result in a significant reduction in CVD risk over 6 months as measured by 
improvement in lipaemic profile, body fat mass and fasting insulin levels.
Subjects on a LCD with an added exercise programme will experience a significantly 
greater reduction in CVD risk factors and improved body composition compared to 
those who do not increase their activity.
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3.2 Methodology
3.2.1 Ethics
3.2.1.1 Ethical approval
Ethical approval was requested and granted from the University of Surrey Advisory 
Committee on Ethics and the South East Multi-Centre Research Ethics Committee (MREC) 
(Appendix A). Participation in this study required informed consent from subjects and their 
general practioners.
3.2.1.2 Ethical issues
All care was taken to ensure the safety and wellbeing of subjects who participated in this 
study. The following cautionary measures were taken;
A standard multivitamin and multimineral supplement was provided to all subjects to 
ensure reference daily intakes (RDI) for all vitamins and minerals were met. The diet was 
supervised by a registered dietitian, the researcher, who supported and advised subjects 
fully using goal setting and motivational interviewing to encourage and support change in 
the participants.
Renal function was monitored throughout the study. No changes in renal function were 
anticipated based on results from Diet Trials (Truby et al, 2006) which found no evidence 
of renal deterioration in 57 subjects following a LCD over 6 months.
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3.2.2. Study design
The study design, a randomised trial, is summarised in Figure 3.4. Subjects were randomly 
assigned to either a LCD alone or a LCD with an additional exercise programme.
Advertising
Subject and G .P  consent 
forms sent to subjects 
m eeting inclusion & 
exclusion criteria
Com pleted consent 
forms returned
Baseline testing
Random ised into 2
groups
LC D  G roup LCD + Exercise  
Group
M easurem ent 1 
2 months Bike delivered  
or gym passes  
provided
M easurem ent 2 
4  months
M easurem ent 3  
6 months
12 month follow-up
Figure 3.4 Flow diagram of the study design
The study could not be blinded or masked as the researcher needed to monitor and support 
subjects requiring the group allocation to be known and subjects had to be informed of their 
allocation to ensure any exercise recommendation could be adhered to.
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3.2.3 Primary outcome measure
The primary outcome measure was change in insulin sensitivity as this confers an 
independent effect on CVD risk. Secondary measures were anthropometric, glycaemic, 
lipaemic, inflammatory and haemostatic CVD risk factors as well as body composition, 
blood pressure, diet and physical activity measurements.
Fasting insulin levels are an indirect measure of insulin sensitivity (BNF, 2005). During the 
Diet Trials Study (Truby et al, 2006) significant changes in insulin levels were observed 
amongst all subjects, which would then be expected to confer a substantial reduction in 
cardiovascular risk.
3.2.4 Sample
3.2.4.1 Sample size
Power calculations were used to estimate the required sample size to detect a 40pmol/L 
difference in the change in fasting insulin between subjects following a LCD alone and 
those following a LCD with the addition of exercise. These calculations were based on 
results from our previous research where the standard deviation in change in insulin for 
men on the Atkins diet was 45.2 pmol/L over a 6 month period and the mean predicted 
decrease in insulin for men on the Atkins diet, with an average level of fitness, was 40 
pmol/L. These data were used to calculate the sample size for this study as there were no 
other studies available at that time for comparison purposes.
Standard equation for sample size estimation to have an 80% chance of detecting a true 
difference with a significance level of 5%.
n=2 (1.96 +0.842)^
d"
where s = standard deviation of difference (45.2) 
where d=difference (39.76)
= 2 x  7.84 X 1.29 
= 20.3
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Therefore in order to detect a 40pmol/L difference in the change in fasting insulin between 
the diet and the diet & exercise groups over the course of the intervention with a power of 
0.8 and significance at the 0.05 level 20 subjects per group are required before withdrawals 
are accounted for.
Allowing for a 50% drop out rate the target number of subjects to recruit was 30 in each 
group.
3.2.4.2 Subjects
Participants were selected for the study if they met inclusion and exclusion criteria (see 
Table 3.4). General Practioners were asked to provide a certified medical consent form 
prior to subjects undergoing baseline tests.
Table 3.4 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Male Current or prior history of coronary heart 
disease or have a pace-maker in situ
21-65 years of age Known type 1 or type 2 diabetes
BM I27-40 kg/m^ Current or prior history of renal failure
Not currently losing weight Current or prior history of gout
Live within travelling distance of Guildford Current of prior history of liver failure
Physically able to exercise at a moderate 
intensity
History of, or are currently being treated 
for clinical depression, use of 
antidepressant medication and other 
psychological disorders
History of eating disorders including 
anorexia and bulimia nervosa
History of obesity of known cause e.g. 
Cushings disease
Currently using any weight loss 
drug/preparation or use of such within the 
30 days prior to enrolment
Previous gastric/obesity surgery
History of drug or alcohol abuse within the 
last 2 years
Uncontrolled thyroid disease or an
abnormal TSH based on G.P opinion
Treatment with lipid lowering or anti­
hypertensive medication
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3.2.5 Procedure
3.2.5.1 Recruitment
Recruitment utilised media advertising in the form of radio interviews and newspaper 
adverts. Posters and flyers were also used around the University, Guildford and 
neighbouring areas. Advertising within the University included an advert on the University 
webpage and on the plasma screens located around the campus.
An additional source of advertising was via an advert in the ‘Dr Atkins New Diet 
Revolution’ book. An advert was placed in the inside cover of these books in local 
bookshops once permission had been gained from the retailers.
Subjects responding to the advert were contacted by the researcher. If they met the age and 
BMI entry criteria (self-reported height and weight were used to allow BMI to be 
estimated) and lived within easy travelling distance of the University of Surrey they were 
then sent further information on the study and a letter for their general practioners (GP) to 
complete. When the subjects returned both their completed consent form and the GP 
consent form confirming they met the entry criteria, they were considered eligible to enter 
the randomisation process. This process is illustrated in Figure 3.4.
3.2.5.2 Randomisation
Subjects were randomised to one of the two intervention groups (see Figure 3.4.) using a 
pre-determined sequence using computer generated numbers. The researcher was blinded to 
groups until randomisation had occurred.
3.2.6 Intervention
3.2.6.1 Intervention groups
The two intervention groups to which subjects were randomised were either;
• Low Carbohydrate Diet only Group
Subjects followed a modified, dietitian directed, LCD and were asked to maintain baseline 
levels of activity
Or
• Low Carbohydrate Diet plus Exercise Group
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Subjects followed the same modified, dietitian directed, LCD and were instructed to carry 
out additional exercise. As the cohort were all males, the wives and partners were 
encouraged to attend the dietary counselling sessions to encourage dietary change in the 
home environment. To ensure intervention fidelity across the two treatment arms, a 
standardized manual including protocols, procedures and participant materials was used. 
The primary investigator completed all the dietary counseling and follow-up participant 
sessions were held at the University clinic with motivational phone calls occurring 
routinely. Further dietary counseling was provided by telephone in weeks 2, 4 and 6  and 
these sessions followed a pre-determined outline to ensure consistency across treatment 
arms. The dietetic intervention was deliberately intensive to maximize compliance and to 
try and minimize the attrition rate. It is recognized that as with any lifestyle advice, dietary 
recommendations must be delivered using a client-centered approach and motivational 
interviewing in tandem with behavioral components including problem-solving, goal- 
setting and self-motivation were employed.
3.2.6.2 Low carbohydrate diet
The LCD used in this study was a modified version of the Atkins diet (Atkins, 2003) with a 
very low intake of carbohydrate initially (20g/day) increasing up to ~50g/day after two 
weeks. Modifications were made to ensure the diet was as nutritionally balanced as 
possible. These included introducing nutrient dense foods such as fruit, nuts and beans at an 
early stage and giving dieters advice to ensure potassium rich foods were included 
(Appendix B) as we have previously shown that potassium intakes tend to be low in 
subjects following the Atkins diet. Diet sheets were devised to provide detailed and 
practical advice to subjects. They were designed by the researcher to educate and assist 
subjects in adhering to a LCD. Diet sheets included foods that could be eaten freely and 
those to avoid, meal and snack ideas, recipes, a suggested shopping list, a carbohydrate 
counter and carbohydrate values of common supermarket foods. The following diet sheets 
were produced and can be seen in Appendices B-I;
Induction
On-going weight loss
Pre-maintenance
Maintenance
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Shopping List
Carbohydrate values of supermarket foods
Constipation
Potassium
Initial dietary advice was provided during the first appointment, of -90 minutes duration, to 
ensure subjects understood how to follow a LCD and to assist them in considering the ways 
in which they would make appropriate changes to meals. Monitoring of diets was 
undertaken by the researcher during 1 hour follow-up visits to ensure they remained as 
nutritionally balanced as possible.
3.2.6.3 Exercise
Subjects in the LCD plus exercise group were asked to perform three sessions per week of 
self-directed moderate endurance exercise of thirty minutes duration. This could be 
achieved by brisk walking, use of an exercise bike or using a gym with a target of 50-70% 
of maximum heart rate as assessed by heart rate monitors. To ensure that subjects reached 
and maintained this level of intensity level during each exercise session they were provided 
with heart rate monitors to use and asked to complete weekly exercise logs (Appendix J), as 
a means of promoting and monitoring compliance with activity instructions. Subjects were 
offered a choice of an exercise bike or gym passes being provided for the duration of the 
study. Those subjects who reported already exercising regularly were asked to increase the 
amount of exercise carried out at baseline with the aim being to achieve an increase in 
fitness in all those in this group (LCD & exercise).
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3.2.7 Measurements
Measurements were taken at baseline, 2, 4 and 6  months as shown in Table 3.5.
Table 3.5 Measurements taken over the study period
Measurement Time (months)
Baseline
Weight
Height
Waist & hip 
circumference
Body composition 
(BIA)__________
Blood pressure
Insulin & Glucose
Lipid profile 1*
Lipid profile 2
Inflammatory
response
Haemostasis
(fibrinogen)
Renal function
(U & Es)
Diet & Activity diary
Fitness
* Lipid profile 1 -Total cholesterol, LDL-cholesterol, HDL-cholesterol and TAG 
 ^ Lipid profile 2 -  LDL and HDL sub-fractions, apoA-1, apoB, NEFA 
$ Inflammatory markers - CRP, TNF-a, vWF
3.2.7.1 Dietary intake
Subjects were asked to complete a 7-day quantified diet diary at baseline and after 
following the LCD for 6  months. À previously used 7-day combined food and activity diary 
was the main measurement tool (Appendix K). This was developed for use in previous 
studies (Raats, 1999). Dietary intake was recorded by subjects who were given full 
instructions on how to complete the food diary using household measures where 
appropriate or by comparison of food eaten with colour photographs of standard portions of 
many food items. All food recorded over this 7 day period was entered into a nutrient 
analysis programme (WinDiets research version) to assess total energy intake,
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macronutrient and micronutrient composition and the results compared to reference nutrient 
intakes (DOH, 1997).
In order to assess the validity of the diet diaries the energy intake reported was compared to 
predicted total energy expenditure (pTEE). This was achieved by calculating the physical 
activity level (PAL) of each subject using the information provided in activity diaries. The 
diaries were coded into minutes per day of time spent in sleeping, light, moderate and 
vigorous activity. These were multiplied by a metabolic equivalent (MET) value, using 
values from the Compendium of Physical Activities, (Ainsworth et al, 1993 and Ainsworth 
et al, 2000): sleeping (MET 1), light (MET >1.5 < 3.5), moderate (MET 4 - 6 ), vigorous 
activity (MET >6 ), to give a total MET value per day. This was then summed to give a 
mean MET score for the week and divided by 24 hours producing a PAL. Each subject was 
assigned a physical activity level based on their PAL score. The Institute of Medicine of the 
National Academies for overweight and obese adults formulae, (2000) were used to predict 
total energy expenditure (pTEE) from age, height, weight, gender and physical activity 
based on PAL score. The reported energy intake (rEI) to pTEE ratio (rELpTEE) was thus 
calculated for each subject at baseline where sufficient information was available (n=24).
Identification of those subjects who were likely to be reporting their energy intake (El) 
accurately was determined using the method described by McCrory et al, (2002).
The within subject errors associated with each parameter are taken into account in this 
method which is based on the principals of the agreements between PAL and rEI and basal
metabolic rate (BMR) (Black, 2000). They include a value of 8.2% being the coefficient of
variation of the technical error for measuring TEE using doubly labelled water (CV tmTEE) 
and 17.7% for measurement errors in predicted TEE ( C V w p te e ) .
ISD =V (CV2 w E l/ d) + CV2 wTEE + CV2 tmTEE
CVwEi= within subject coefficient of variation in El
d= number of days of food records
This equation was used as followed;
ISD = V  (26% / 7) + 313.3 + 67.2
=19.6
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Therefore those reporters with a rEI of <80% difference from pTEE were identified as 
under-reporters as their rEI is physiologically implausible. Those subjects with a difference 
of >120% between rEI and pTEE would also normally be deemed as ‘over-reporters’. 
However because this was a group of overweight individuals who were recruited on the 
basis they were not to be currently losing weight and asked to maintain their normal diet at 
the time baseline diaries were recorded, it is possible their energy intake exceeded ‘usual 
parameters’.
3.2.7.2 Physical activity
Physical activity over the 7-day period was recorded in the combined food and activity 
diaries. Subjects were asked to record every activity they participated in on all 7 days 
including, for example, time spent lying whilst asleep and sitting at work or at home. 
Physical activity was then coded to assess total time spent in light, moderate and vigorous 
activity over each 24 hour period (Ainsworth et al, 1993 and Ainsworth et al, 2000). The 
number of minutes spent at each activity level during the 7 day period was calculated to 
allow within and between group differences in activity over the study period to be 
determined.
3.2.7.3 Fitness
Subjects’ fitness levels were assessed using the aerobic adaptation test (ATT) (Church et 
al, 2001). The protocol used can be seen in Appendix L. This test detects changes in sub- 
maximal work capacity with minimal participant discomfort. A sub-maximal fitness test 
was used with this study population (of overweight men) as it allowed fitness to be 
measured without discomfort and risk of harm to subjects and without the cost and time 
implications associations with maximal exercise tests (Stevens and Sykes, 1996).
Before commencing the fitness test information was collected from the subjects, (age and 
physical activity rating, (PAR)) and used along with BMI to calculate their individual 70% 
maximum heart rate and to determine the ramp rate of the test. The ramp rate is the term 
given for the increment in wattage each minute of the test. The test was performed on an 
exercise bike with ongoing heart rate measurement (using a heart rate monitor) throughout 
the test. Subjects were asked to maintain a constant speed (60rpm) throughout and wattage 
was gradually increased each minute until 70% maximum heart rate was achieved. At this 
point subjects were asked to maintain the wattage achieved for 3 minutes (the plateau
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period). Recorded outcomes are wattage achieved when subjects reach 70% of their 
maximum heart rate and heart rate at each minute of the test including the plateau period.
3.2.7.4 Weight
Subjects were weighed in light clothing, (without shoes) to the nearest 0.1kg using stand-on 
scales. The same scales were used throughout the study (SEGA 770 high capacity floor 
scales).
3.2.7.5 Height
Height was measured, (without shoes) to the nearest 0.5cm using a wall-mounted 
stadiometer. BMI was calculated from the above measures (weight/height^).
3.2.7.6 Waist and hip circumference
Both waist and hip circumference were measured to the nearest 0.5cm using a Holtain tape 
measure. Waist circumference was taken at 1 cm above navel. Hip circumference was taken 
at the widest point around the buttocks.
3.2.7.7 Body composition
Body fat mass was estimated using bioelectrical impedance which measures total body 
water. The Bodystat 1500 MDD was used which is a four-point bioelectrical impendence 
analyser (BIA). Subjects were asked to lie in a supine position whilst measurements were 
taken. Electrodes were placed on the right hand and foot and percentage and absolute body 
fat and lean tissue were estimated by the BIA using inbuilt algorithms. The validity and re­
test reliability of this method has been previously examined (Barratt, 2005).
3.2.7.8 Blood pressure
An electronic sphygmomanometer was used to measure blood pressure (Omron M4). The 
mean of 3 blood pressure readings, taken with the subject sitting at rest, was calculated to 
give a mean systolic and diastolic blood pressure for each subject. If a subject was found to 
be hypertensive their G.P. was informed and permission for the subject to continue the 
study obtained.
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3.2.T.9 Fasting blood sample
A sample of fasting blood was drawn prior to the fitness test for measurement of insulin, 
glucose, lipids, CRP, fibrinogen and inflammatory markers. Urea, creatinine, sodium and 
potassium were also measured to allow monitoring of renal function. Fifty mis of venous 
blood was drawn at baseline and 6  months and 35mls at 2 and 4 months. Trained 
phlebotomists were used throughout to take blood samples. The blood samples were 
handled in the following way;
Blood sample extracted using a butterfly and syringe
i
Blood transferred to appropriate tubes
^  \  I X
Fluoride oxalate Lithium heparin EDTA Citrate
(Glucose) (Insulin / (Lipids/ (Fibrinogen)
renal function inflammatory
tests) markers)
Tubes inverted several times
i
Centrifuged at 2000g for 12 minutes
i
Plasma from each tube drawn off using a sterile pipette 
and decanted into labelled cryovials for analyses as detailed in Table 3.5.
i
Samples stored at -80°C 
Figure 3.5. Handling of blood samples
Plasma samples were frozen at -80°C until the end of the study period thereby allowing 
analysis to be conducted (by Dr Badriyah Al-Jazzaf at the University of Surrey) once all 
samples for each subject were available. Variation due to different freezing time would be 
minimal compared to that caused by analysing samples for each subject separately. The 
exceptions to this were the renal function tests, (urea, creatinine, potassium and sodium) 
and also fibrinogen which were undertaken at the Royal Surrey County Hospital (RSCH).
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To enable renal function to be monitored throughout the study renal function tests were 
carried out at the first opportunity after collection.
3.2.7.9.1 Analyses using a SPACE auto-analyser
A SPACE auto-analyser (Alfa Wassermann, Woerden, Netherlands) was used for analyses 
of plasma glucose, TAG, HDL-cholesterol, LDL-cholesterol, apo-Al, apo-B and NEFA. 
This system uses spectrophotometeric and potentiometric methods to perform analyses. 
The appropriate manufacturer’s procedure was used in each analysis. Quality controls (QC) 
were repeated at the beginning and end of each run and the assays were run only if the QCs 
were within the accepted limit as specified in the supplier’s catalogue.
Table 3.6 Within and between assay CVs for samples analysed using the SPACE auto­
analyser
Within %CVfor Control Between %CVfor Control
Analyte level 1 level 2 level 3 level 1 level 2 level 3
Glucose (mmol/1) 1.63 1.25 0.42 0.43
Total cholesterol (nunol/1) 2.86 1.56 3.22 3.02
TAG (mmol/1) 2.31 4.00 3.03 3.54
NEFA (mmol/1) 5.44 5.58 4.88 5.44
LDL-C(mmol/l) 4.66 3.82 0.95 5.66 4.73 1.77
HDL-C (mmol/1) 4.17 4.93 4.92 6.85 5.0 5.29
Apo A1 (g/1) 3.8 1.1 7.3 0.58 1.50 5.31
Apo B (g/1) 8.3 4.6 6.8 8.69 6.00 8.05
3.2.7.9.2 Analysis of lipoprotein subclasses 
i HDL subclasses
A polyacrylamide gradient gel electrophoresis (PAGE) system was used to identify HDL 
subclasses. This method separates HDL particles according to size over an approximate 
molecular weight of 50,000-2,000,000.
The process began by adding potassium bromide (KBr) to the whole plasma thereby 
adjusting its density to 1.21 kg/1. One ml of this adjusted plasma was transferred to a 
Beckman Ultra-Clear centrifuge tube (12ml) along with a solution of KBr 1.21 kg/1, 1% 
EDTA. These tubes were placed in a Beckman 70.1 Ti rotor and centrifuged for 20 hours at 
147,000g and 15°C. All samples from each subject were run at the same time using the
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same rotor. Following centrifugation the upper yellow band (200 pi) was aspirated in 
preparation for analysis.
An aliquot of the band was mixed with bromophenol blue and 10 pi of this sample was then 
loaded onto 4-30% polyacrylamide gradient gel walls, (pre-equilibrated at 70 V, 65mA for 
30 minutes). The gels were then run at 20V, 50mA for 20 minutes, then 70 V, 65mA for 30 
minutes and finally 120 V, 100mA for 24 hours. In the next step gels were removed from 
their casing and transferred to a fixing solution, (sulphosalicylic acid, 10% w/v) for 30 
minutes. Protein staining for 1 hour then followed using 0.1%w/v comassie blue R250, 
methanohglacial acetic acidiRO water in a 5:1:4 ratio. Destaining of the gels was conducted 
over 2-3 days using methanohglacial acetic acid:RO water 50:75:874 (ml) with the de-stain 
being changed regularly throughout this period. Gels were photographed with a Nikon 
DIX digital camera and analysed using Total-Lab ID gel scan software v2.01. Through the 
electrophoretic migration distance (Rf) the software allowed identification of two primary 
peaks, HDL2 and HDL3. The within assay %CV for %HDL2 was 2.98 and the between 
assay %CV was 0.30.
ii LDL subclasses
LDL subclasses were determined using iodixanol density gradient ultracentrifugation as 
detailed by Davies et a i, (2003). The methodology employed in this investigation deviated 
from this technique in that a 16 pocket rota was used with Rf calculations appropriately 
adjusted for this change. Samples were centrifuged for 2 hours 30 minutes at 341,000g at 
16°C in a Beckman Optima XL-100 ultracentrifuge using the acceleration and deceleration 
program 5. All samples from each subject were run at the same time using the same rotor. 
Once centrifugation was complete the samples were photographed using a Nikon DIX 
digital camera and these images of stained LDL bands were analysed using Total-lab ID 
gel-scan software. An electrophoretic migration distance (Rf) was determined to the peaks 
which were then converted to density using a cut-off density of 0.031 kg/1.
The within assay %CV for %LDL3 and LDL peak density were 2.26 and 0.14. The 
between assay %CV were 0.30 and 0.02 respectively.
3.2.T.9.3 Insulin
The MLT immunochemiluminometric assay was used to measure insulin levels. This is a 
two site immunoassay using an insulin specific solid phase antibody and a soluble antibody
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labelled with a chemiluminescent acridinium ester. The assay was carried out using the 
following procedure;
- Standards were reconstituted by adding 1ml of deionised water.
- The wash buffer was prepared by diluting 1 part wash buffer concentrate in 9 parts 
deionised water.
- 900 pi of labelled antibody concentrate was pipetted into the labelled antibody diluent and 
mixed.
- Labelled antibody solution was pippetted into appropriate wells in 100 pi aliquots.
- 25 pi of standard or sample solution were pipetted into wells. Each was run in duplicate.
- Plates were sealed and incubated for 2 hours at 37°C.
- The plates were then washed three times using the wash buffer.
- Plates were read in the luminometer which calculates the relative luminescence values 
which were converted to mU/1 using Micro Win 2000 software.
Table 3.7 Within and between assay CVs for insulin
Within %CV for Control Between %CV for Control
Analyte level 1 level 2 level 3 level 1 level 2 level 3
Insulin (pmol/I) 4.90 8.07 7.59 6.60 6.03 11.73
3.2.7.9.4 Estimation of insulin resistance
Insulin resistance was estimated using homeostasis model analysis (HOMA) employing the 
following formula (Matthews et al, 1985);
Fasting glucose (mmol/1) x fasting insulin (pu/ml) /22.5
3.2.7.9.5 Inflammatory markers 
iCRP
An ‘in-house’ high sensitivity enzyme-linked immunosorbent asssay (ELISA) was used to 
determine CRP levels. All samples were measured twice, in triplicate. Ninety-six well, 
immunolon, maxisorb plates, (NUNC, Fisher Scientific, UK) were coated with 50 pl/well
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polyclonal rabbit anti-human CRP, (DakoCytomation, Denmark) at a 1/4000 dilution in 
O.IM carbonate/bicarbonate buffer pH9.6 and incubated overnight at 4°C.
The plates were washed with phosphate buffered saline with tween, (PBS-T) (0.05%) and 
the wells blocked with 2 0 0  pl/well phosphate buffered saline with bovine serum albumin 
(PBS-BSA) (1%) for 60 minutes at 37°C. Washing was then repeated. Human CRP 
standard serum, (DakoCytomation, Denmark) was serially diluted from 0.9 ug/ml to 
O.Olng/ml. Plasma samples were diluted from 1/200 to 1/6000. All samples and standards 
were diluted in PBS-T-BSA (0.2%), added in triplicate at 50 pl/well and incubated for 60 
minutes at 37°C. Peroxidase-conjugated rabbit anti-human CRP (DakoCytomation, 
Denmark) (50 pl/well), was added after further washes then was diluted in PBS-BSA 
(0.2%) to a final concentration of 0.5 ug/ml and incubated at 37 °C for 60 minutes. Final 
washes were carried out with PBS-T and citrate phosphate buffer then tetraethyl benzidine 
(TMB) substrate (Sigma Aldrich, UK) (50 pl/well) was added to develop. The reaction 
was stopped with 12.5 pl/well 2M H2SO4 and the plates read at 450nm.
ii TNF-a
TNF-a was quantitatively measured using a human TNF-o/TNFSFlA immunoassay 
(Quantikine ® HS). In the first step of this sandwich ELISA technique a microplate was 
pre-coated with a monoclonal antibody specific for TNF-a. Two hundred microlitres of 
sample or standards were then pipetted into the wells and any TNF-a present was bound by 
the immobilized antibody. Plates were then incubated at room temperature for 3 hours and 
then washed. Two hundred microlitres of an enzyme-linked polyclonal detecting antibody 
specific for TNF-a was added to the wells which were incubated for 2 hours. Plates were 
then washed again thus removing unbound antibody-enzyme reagent and then 50pl of 
substrate solution added to each wells. After incubation for 1 hour, 50 pi of amplifier 
solution was added to the wells commencing colour development which is proportionate to 
the amount of TNF-a bound in the initial step. Wells were incubated for 30 minutes before 
50 pi of stop solution was added to each well. A microplate reader, set to 490nm, was used 
to measure the optical density of each well.
iiivWF
vWF was measured in triplicate (on different days) using an ‘in-house’ vWF detection 
ELISA. Plates were coated with 50 pl/well rabbit anti-human vWF (DAKOcytomation,
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A0082) at 2pg/ml in O.IM Carbonate/bicarbonate buffer pH9.6, 0/N, 4°C. Plates were then 
washed using PBS-T (0.05%) and the wells blocked with PBS-BSA (1.0%) 150 pl/well for 
60 minutes at 37 °C. Washing was then repeated. vWF standard stock (1 ampule =11.0 lU) 
resuspended in 1ml sterile, distilled water at 11.0 lU/ml National Institute for Biological 
Standards and Control (UK) (NIBSC, 00/514) was diluted from 1.0 lU/ml 1/3 dilutions to 
0.00003 lU/ml, with PBS-T-BSA (0.2%). Samples were diluted in PBS-T-BSA (0.2%) 
1/200. Samples and standards were added in triplicate and incubated for 60 minutes at 
37°C.
Rabbit anti-human-vWF-horseradish peroxidase (DAKOcytomation P0226) was added 
after further washes then diluted in PBS-T-BSA (0.2%), 50pl/well and incubated for 60 
minutes at 37°C. Final washes were carried out with PBS-T and a citrate phosphate buffer 
then TMB substrate added to develop. The reaction was stopped with reaction with 
12.5pl/well 2M H2SO4 and the plates read at 450nm. The intra-assay CVs for this analysis 
were 5.9-8.3% and the inter-assay CVs were 9.5-21.1%.
3.2.7.10 Metabolic syndrome
Metabolic syndrome was assessed using the NCEP ATPIII criteria, (2002). This tool has 
been used to define metabolic syndrome as it does not focus on a single cause, unlike other 
diagnostic criteria, and in addition it is widely used and accepted with many studies having 
been conducted evaluating its use for defining metabolic syndrome (Grundy et al, 2005). 
The NCEP ATPIII criteria define metabolic syndrome when three of the following are 
apparent;
• Fasting plasma glucose >6.1 mmol/1
• Hypertension > 130/85 mmHg
• Waist circumference >102 cm (men)
> 8 8  cm (women)
• HDL-cholesterol <1.07mmol/l
• TAG > 1.69 mmol/1
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3.2.8 Statistical analysis
Descriptive statistics were used to describe the study population. All data was assessed for 
normality of distribution using the Kolmogorov-Smimov Z samples test.
An initial, completers analyses was conducted to investigate changes in all parameters 
following the exclusion of those subjects who had withdrawn from the study. An intention 
to treat (ITT) analysis was then carried out to investigate the primary outcome measure, 
fasting insulin as well as weight changes, using baseline values carried forward for missing 
data. Where intermittent values were missing the most recent prior measurement was 
imputed.
To investigate the effects of each intervention, a LCD or a LCD plus exercise on measured 
parameters within group effects were investigated using paired t tests.
In order to test the hypothesis that a LCD with exercise has additional positive effects on 
CVD risk compared to a LCD alone between group differences in changes in parameters 
were explored. Where measurements were taken at more than 2 time-points a mixed within- 
between subjects analysis of variance (ANOVA) was used to investigate these changes 
over the study period. Independent t tests were used to investigate changes between 
baseline and 6  months.
Pearsons coirelation analysis was used to investigate the direction and strength of 
relationship between variables. Multiple regression techniques were used to explore the 
relationships between biochemical values and potential predictive factors, such as weight 
and body fat loss.
A P Value of 0.05 was considered statistically significant. Analyses were performed using 
SPSS, version 12 for Windows.
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3.3 Results
a) Subjects
Recruitment began in January 2004 and the first subjects commenced the study in March 
2004. Advertising, recruitment and data collection were continuous after this point until the 
final subject completed the six month study in March 2006. Fifty-seven subjects were 
recruited into the study, 95% of the planned sample size of 60. The subject numbers 
throughout the study can be seen in Figure 3.6.
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Figure 3.6 Flow of subjects and attrition through the study
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3.3.1 Baseline characteristics of the subjects
All subjects were Caucasian males living in the Guildford area. Although socio-economic 
status (SES) was not specifically measured, 100% were in full time employment and 8 8 % 
were in professional occupations. Smoking was not an exclusion criteria but the vast 
majority of subjects were non-smokers (n=54). The baseline characteristics of all subjects 
who started the study are shown in Table 3.8. No significant differences were evident in 
age, weight, fasting insulin levels or fitness between the two groups. The mean baseline 
BMI was significantly greater in the diet & exercise group compared to the diet group.
Table 3.8 Baseline characteristics of the subjects
Characteristic Diet
n=27
Diet & Exercise 
n=29
P Value
Mean [SD] median
Age (years) 45.7 [7.6] 48.1 [9.7] 0.32
45 49
BMI (kg/m2) 31.413.1] 33.1" [3.4] 0.049
30.7 33
Weight (kg) 102.1 [13.1] 105.5 [13.2] 0.33
99.6 102.4
Fasting insulin 70.8 [46.9] 77.9 [54.8] 0.65
(pmoI/1) 60.8
(n=2 0 ) (n=23)
Fitness (watts) 129.4 [41.3] 131.3 [35.9] 0 .8 6
135 135
(n=26) (n=27)
Significant difference between groups (P<0.05)
Baseline characteristics of subjects who withdrew from the study were compared to 
completers. Subjects who completed the study were significantly (P=0.019, r=2.428) older 
(48.3 [8.4] years) than non-completers (41.5 [8.4] years). The mean baseline weight and 
BMI of completers (101.8 kg [11.2] and 31.8 kg/m^ [3.2]) were significantly lower 
(P=0.015, f=-2.502 and f =0.036, r=-2.146 respectively) than those of non-completers, 
(112.4kg [17.5] and 34.1 kg/m^ [3.4]). No significant differences in baseline fitness were 
evident in subjects who withdrew from the study compared to completers.
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3.3.2 Attrition
Of the 56 subjects who commenced the study 11 withdrew over the 6  month study period 
(20% attrition rate). Figure 3.6 shows the reasons given for withdrawal. There was no 
significant difference in the number of subjects who withdrew from the diet (2 2 .2 %) and 
diet & exercise group (17.2%).
b) Intervention
This study involved subjects following a LCD and instructions regarding their activity 
levels. This section of results investigates if subjects adhered to the LCD and instructions to 
increase or maintain their activity levels and the consequences this had on their nutritional 
intake and fitness levels.
The actual amount of exercise carried out by subjects in the diet and the diet & exercise 
group was determined via analysis of exercise logs and activity diaries. Therefore 
compliance to instructions regarding exercise in both groups could be assessed.
3.3.1 Exercise logs
Exercise logs were kept by the diet & exercise group only therefore compliance to exercise 
in the diet group was assessed by self reported exercise at each appointment. Eighty-six 
percent of subjects in the diet group complied with instructions not to alter their exercise 
levels over the study duration. Sixty-three percent of subjects in the diet & exercise group 
complied with instructions to increase their exercise levels from baseline. Compliance to 
instructions regarding exercise is explored further in Chapter 4. The nature of the exercise 
carried out by subjects in the diet & exercise group as recorded in exercise logs is shown in 
Table 3.9 below.
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Table 3.9 Type, frequency, duration and intensity of exercise carried out by subjects 
in the diet & exercise group over the study period
Exercise Mean Total Mean Main Mean HR
episodes exercise exercise exercise method of (heats/min)
(n) episodes time time per exercise
per week (mins) episode used
(n) (mins)
Baseline 
to 2 
months
19.8 [9.9] 3.3 [1.6] 818.3
[597.3]
40.0
[17.3]
Bike=ll
Gym=7
Running=3
Squash=l
126.6
[1 1 .8 ]
(n=21) 
(weeks 3-8)
Walkings 1
2 to 4 
months
(n=21)
26.4 [9.7] 3.6 [1.5] 1118.8
[816.4]
40.3
[23.6]
Bike=7
Gym=8
Runnings]
Squashs 1 
AerobicssI 
Swimmings I 
Walkings 1 
Tennissl
127.5
[10.9]
4 to 6 
months
(n=19)
26.5
[10.7]
3.8 [2.0] 1088.9
[694.8]
40.9
[18.0]
Bikes4
Gyms7
Runnings]
Squashsl
AerobicssI
Walkings2
Tennissl
127.9
[15.7]
Mean [SD]
3.3.2 Activity
3.3.2.1 Physical activity ratings (PAR)
PAR at baseline are shown in Table 3.10 and allow baseline activity levels to be assessed. 
Subjects in the diet and the diet & exercise group had similar activity levels at baseline. 
Thirty-four percent of subjects in the diet group and 33% of those in the diet & exercise 
group had a PAR value of 1 or less which equates to no regular participation in recreational 
sport or activity and only occasionally exercising sufficiently to cause heavy breathing or 
perspiration. Only 2 subjects in the diet group and 3 in the diet & exercise group had a PAR 
value which suggests that at baseline they met current UK recommendations to exercise for 
30 minutes or more at least 3 times per week. Overall these PAR values are indicative of a 
sedentary group of men.
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Table 3.10 Physical activity rating (PAR) of all subjects at baseline
PAR value n(% )
Diet Diet & Exercise
0 1(5) 1(4)
1 6(29) 7(29)
2 3(14) 2 (%
3 3(14) 3(E%
4 3(14) 5 (2 n
5 3(U0 3(13)
6 1(5) 3(13)
7 1(5) 0
Exercise logs completed by subjects in the diet & exercise group allowed PAR at 2, 4 and 6  
months to be determined (Table 3.11). The mean PAR of subjects in this group was 3 at 
baseline and increased significantly, (P<0.001, /=-6.43) to 6  at 6  months. Therefore most 
subjects in the diet & exercise group did not participate in any heavy / vigorous activity at 
baseline but increased this to 1 to 2  hours per week of heavy or vigorous activity by 6  
months.
Table 3.11 Physical activity rating of subjects in the diet & exercise group throughout 
the study
Mean PAR [SD]
Baseline 3.0 [1.90]
(n=24)
2  months 6.1 [0.70]
(n=2 1 )
4 months 6.0 [0.77]
(n=2 1 )
6  months 6.3 [0.49] *
(n=18)
^Significantly different from baseline (P<0.001, r=-6.43)
3.3.2.2 Activity diaries
Activity levels, measured by 7-day diaries at baseline and 6  months in subjects in both 
groups were used alongside exercise logs to allow compliance to instructions regarding 
exercise to be assessed. All completed diaries in subjects who completed the 6  month study 
are used in this analysis.
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The changes in time spent in activity of different levels from baseline to 6  months in each 
group can be seen in Figure 3.7. In the diet group, time spent sleeping was greater at 6  
months compared to baseline (+30.54 minutes per day [62.41]), and time spent in light, 
moderate and vigorous activity decreased over this time period in the diet group. Whilst 
time spent asleep was also greater at 6  months compared to baseline in the diet & exercise 
group this change was less substantial (+7.36 minutes per day [23.91]). Time spent in 2 
categories of light activity, (2.0 and 2.5 metabolic equivalent (MET)) decreased but more 
time was spent in light activity of categories 1.5 and 3.0 MET and also in moderate and 
vigorous activity. None of these changes were significant. A comparison of activity levels 
(MET values) (see Figure 3.7) shows that there were no significant differences between the 
groups.
800
0) 300
□ Diet Group - Baseline 
(n=11)
□ Diet Group - 6 months 
(n=11)
□ Diet & Exercise Group 
Baseline (n=14)
□ Diet & Exercise Group 
6 months (n=14)
Asleep Light (1.5) Light(2.0) Light (2.5) Light (3.0) Moderate Vigourous 
(0.95) (4.0) (7.0)
A ctivity L ev el (MET) |
Figure 3.7 Time spent in each activity level in the diet and diet & exercise group at 
baseline and 6 months
Error bars represent standard error of the mean (SEM).
In order to explore the changes in activity levels further, the time spent asleep and in light 
activity of all categories was summed together as was the time spent in moderate and 
vigorous activity. As would be expected in subjects instructed to increase their activity
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levels, (diet & exercise group) a decrease in time spent asleep or in light activity and an 
increase in time spent in moderate or vigorous activity was seen from baseline to 6  months 
(Table 3.12).
In the diet group a significant, (P =0.033, t =-2.48) increase in time spent asleep or in light 
activity was seen over the 6  months. The change in time spent in moderate and vigorous 
activity decreased significantly (P=0.035, r=2.60) from baseline to 6  months.
Independent t tests showed no significant differences in the change in summed activity 
levels from baseline to 6  months between groups.
Table 3.12 Change in summed activity levels in the diet and diet & exercise group 
from baseline to 6 months
Change in time spent (minutes) 
in activity levels per day from baseline to 6 months
Asleep and Light Moderate and Vigorous
Diet Group +11.45 [15.35]* -15.25 [16.58]*
Diet & Exercise Group -2.62 [40.29] +4.25 [28.02]
Mean [SD]
* Significantly different from baseline (P<0.05)
3.3.3. Fitness
3.3.3.1 Change in fitness assessed by final wattage achieved.
Fitness, as defined by the change in final wattage during the AAT, remained virtually 
unchanged over the study period for the diet group (Figure 3.8).
Fitness levels increased during the first 4 months in the diet & exercise group with the most 
substantial changes being between 2 and 4 months (P=0.039, t =-2.26) so that fitness levels 
were significantly higher at 6  months compared to baseline (P=0.005, t =-3.10) in the group 
who were asked to increase their activity levels (Figure 3.8).
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Figure 3.8 Fitness levels, as assessed by final wattage, in the diet and the diet & 
exercise group throughout the study.
Error bars represent SEM.
Results from Paired t tests within groups; * value significantly different from baseline (P =0.005, r=-3.10); 
' value significantly different from 2 months (P =0.039, r=-2.26)
Repeated measures ANOVA showed no significant differences in changes between groups
Fitness levels increased by 4% in the diet group and 14% in the diet & exercise group over 
the 6  month study (Table 3.13).
Table 3.13 Percentage change in fitness levels in the diet and diet & exercise group 
throughout the study
Change in fitness (%)
Baseline to 2 months Baseline to 6  months
Diet 4.12 [18.75] 3.85 [13.74]
(n=19) (n=18)
Diet & 5.94 [26.76] 13.50 [29.23]
Exercise (n=21) (n=22)
Mean [SD]
Independent t-tests showed no significant differences in the percentage change in fitness, (as defined by final 
wattage) between groups
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3.3.3.2 Change in fitness as defined by heart rate recovery from the aerobic 
adaptation test
Heart rate recovery (HRR) was calculated as the difference in heart rate (HR) of subjects at 
the end of the AAT compared to 2 minutes post test. Therefore HRR results presented are 
the difference between heart rates at these time-points. It would be expected that HRR 
would improve with increased fitness thereby a smaller increase in HR would be seen over 
time.
The changes in HRR in the diet and the diet & exercise group are shown in Figure 3.9. 
HRR decreased by -0.69 [5.6] beats per min at 6  months compared to baseline in the diet & 
exercise group but increased by 3.9 [5.9] beats per min in the diet group over the 6  month 
study. Repeated measures ANOVA found no group effect.
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Figure 3.9 Fitness, as assessed by heart rate recovery, in the diet and diet & exercise 
groups throughout the study.
Error bars represent SEM.
Repeated measures ANOVA showed no group differences
3.3.4 Energy intake
TEE was calculated and compared to reported energy intake in order to gauge the likely 
accuracy of the diet diaries in showing true energy intake. Eleven of the 24 subjects (46%) 
had a EI:TEE ratio which was not physiologically plausible suggesting under-reporting. In
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addition 2 subjects had a EIiTEE ratio above the cut-off value (20%). There was no 
significant association between likelihood of under-reporting and study group, (chi-squared 
test). All analysis, unless stated, uses all available diaries.
The reduction in mean daily energy intake at 6  months compared to baseline in each group 
is shown in Figure 3.10. Energy intake at baseline was 10082 kJ [3023.8] reducing to 7837 
kJ [2168.8] at 6  months in the diet group. A greater decrease in energy intake from baseline 
(10624 kJ [1996.6]) to 6  months (6938.8 kJ [2268.1]) was seen in the diet & exercise 
group. The changes in energy intake within groups were significant, (Diet; P=0.036, 
7=2.46, Diet & Exercise; P=0.001, 7=4.50). The difference in the change in energy intake 
between groups was not significant, suggesting that the same dietary advice was 
successfully given to each group and that there was no bias in terms of energy deficit 
achieved between the groups.
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Figure 3.10 Change in daily energy intake in the diet and diet & exercise group over 
the study period in all completers
Error bars represent SEM
The change in daily energy intake in plausible reporters only is shown in Figure 3.11. It can 
be seen energy intake was reduced more substantially in plausible reporters only as 
compared to all completers in both the diet and the diet & exercise groups. The difference
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in the change in energy intake between the diet and diet & exercise group was not 
significant when looking at plausible reporters only.
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Figure 3.11 Change in daily energy intake in the diet and diet & exercise group over 
the study period in physiologically plausible reporters
Error bars represent SEM
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3.3.5. Macronutrient intake
Carbohydrate intake was significantly reduced from baseline to 6  months in the diet group 
as were carbohydrate and alcohol in the diet & exercise group (Table 3.14). There were no 
significant differences between groups in absolute macronutrient intakes at either time 
point.
Table 3.14 Macronutrient intake for the diet and diet & exercise groups at baseline 
and 6 months
Fat (g) CHO(g) Protein (g) Alcohol (g)
Baseline Diet 105.2 23&9 108.2 11.1
(n=16) [34.7] [83.8] [36.7] [10.7]
Diet& 103.7 238 9Z2 42.2
Exercise [30.3] [95.2] [15.6] [29.2]
(n=19)
6  Months Diet 1 1 1 .2 90.1* 116.4 11.1
(n=1 0 ) [33.9] [69.6] [25] [10.7]
Diet & 104.7 48.7^ 112.3 13.5*
Exercise [45.8] [40.4] [26.9] [14.1]
(n=13)
Mean [SD]
CHO-carbohydrate
* Value significantly different from baseline within group (P=0.001,7=5.28); v^alue significantly different 
from baseline within group (P<0.001,7=6.14); Nalue significantly different from baseline within group 
(P=0.006,7=3.35)
A greater proportion of subjects in the diet & exercise group (69%) consumed carbohydrate 
at the level to which they were instructed at 6  months compared to those in the diet only 
group (40%).
The effect of reducing carbohydrate intake on the percentage contribution of 
macronutrients to energy intake can be seen in Figure 3.12. Although the absolute intake of 
protein and fat intake were not affected by the low carbohydrate dietary advice the 
percentage contribution of protein and fat to total energy intake were significantly increased 
in both group (P<0.05). The percentage contribution of carbohydrate to total energy intake 
was significantly decreased in both groups (P<0.05) at 6  months compared to baseline. The 
percentage contribution of alcohol to energy significantly decreased over the study period 
in the diet & exercise group only (P<0.05).
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Figure 3.12 Percentage contribution of macronutrients to energy intake at baseline and 6  
months in the diet and the diet & exercise group
C HO -c arbohydrate
* Value significantly different from baseline within the diet group (P<0.05); value significantly different from 
baseline within the diet & exercise group (P<0.05)
The amount of saturated fatty acid (SFA), polyunsaturated fatty acid (PUFA) or 
monounsaturated fatty acid (MUFA) consumed did not change significantly from baseline 
to 6  months within the diet or the diet & exercise group (Table 3.15). There were no 
significant differences in the changes in SFA, PUFA or MUFA between groups over the 
study period.
Table 3.15 Fat intake at baseline and 6 months in the whole cohort
SFA (g/day) PUFA (g/day) MUFA (g/day)
Baseline Diet
(n=16)
37.4 [15.6] 13.9 [4.9] 31.8 [12.0]
Diet&
Exercise
(n=19)
40.7 [12.9] 13.1 [5.0] 33.1 [10.2]
6 Months Diet
(n=10)
40.4 [11.6] 15.4 [7.1] 41.5 [15.1]
Diet&
Exercise
(n=13)
40.2 [18.1] 12.3 [6.8] 40.7 [20.8]
Mean [SDJ
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Mean total sugar intake was significantly decreased from baseline to 6  months in both 
groups, (Table 3.16) as was non-milk extrinsic sugar (NMES) intake in the diet & exercise 
group only. Non-starch polysaccharides (NSP) were also significantly decreased over this 
time in both groups and did not meet the recommended intakes for UK adults (18g/day) at 
baseline or 6  months. There were no significant differences in the changes in sugar, NMES 
or NSP intake between groups over the study period.
Table 3.16 Sugar and NSP intake at baseline and 6 months
Sugar (g/day) 
(of which NMES)
NSP (g/day)
Baseline Diet 90.4 [44.3] 14.1 [3.3]
(n=16) (67 [43.7])
Diet & Exercise 115.5 [80.5] 11.7 [3.4]
(n=19) (91.3 [84.8])
6  Months Diet 50.9* [47.2] 9.1* [3.5]
(n=1 0 ) (32.8 [41.0])
Diet & Exercise 29.8* [20.8] 6.1* [2.7]
(n=13) (19.4* [19.4])
Mean [SD]
* Value significantly different from baseline within diet group (P<0.05); * value significantly different from 
baseline within diet & exercise group (P=<0.05)
3.3.6 Micronutrient intake
Mean absolute intake of micronutrients from the LCD consumed at baseline and 6  months 
in the whole sample are shown in Table 3.17. Also shown is the percentage of subjects who 
achieved the reference nutrient intake (RNI) and lower reference nutrient intake (LRNI) for 
each micronutrient. Folate, calcium, magnesium, iron, zinc and copper were significantly 
reduced over the study period, (P<0.05). Selenium and iodine intakes significantly 
increased from baseline to 6  months, (P<0.05). Added salt was not measured therefore it is 
likely sodium intakes were higher than diet diaries suggest.
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Table 3.17 Micronutrient intake at baseline and 6 months in the whole sample
Baseline
(n=35)
6  Months 
(n=23)
Mean
absolute
intake
Percentage
Achieving
RNI
Percentage
Achieving
LRNI
Mean
absolute
intake
Percentage
Achieving
RNI
Percentage
Achieving
LRNI
Vitamin A 
(ug)
1033.3
[828.8]
69% 100% 1068
[713.6]
77% 1 0 0%
Thiamine
(mg)
1.6
[0.4]
91% 100% 1 .6
[0.9]
94% 1 0 0%
Riboflavin
(mg)
1.9
[0 .6 ]
83% 1 0 0% 1.7
[0.9]
80% 1 0 0%
Niacin
(mg)
50
[26]
1 0 0% 1 0 0% 50.9
[11.5]
1 0 0% 1 0 0%
Vitamin b6  
(mg)
2.4
[0.7]
94% 100% 2 ^
[0.4]
97% 100%
Vitamin bl2 
(ug)
6.9
[4.7]
1 0 0 % 100% 8.5
[3.3]
100% 1 0 0%
Folate
(ug)
250.9
[62.9]
8 6 % 100% 218.5*
[63.2]
74% 100%
Vitamin C 
(mg)
85.6
[47.8]
91% 1 0 0 % 85.7
[38.3]
91% 100%
Calcium
(mg)
974
[397]
94% 100% 810.2*
[375.2]
71% 1 0 0%
Magnesium
(mg)
38&2
[358.0]
71% 100% 242.7*
[75.9]
51% 83%
Sodium
(mg)
3311.1
[896.8]
97% 100% 3348.3
[1431.8]
94% 81%
Potassium
(mg)
3377
[702.2]
43% 100% 2755.6
[686.7]
43% 100%
Phosphorous
(mg)
1566.5
[475.1]
1 0 0% 100% 1575.5
[396.6]
1 0 0 % 1 0 0 %
Iron
(mg)
15.4
[7.3]
100% 100% 10.4*
[2.9]
80% 1 0 0%
Zinc
(mg)
27.4
[37.7]
77% 100% 12.4*
[3.4]
8 6 % 1 0 0%
Copper
(mg)
1.4
[0 .6 ]
51% 51 % 0.9*
[0.4]
49% 51%
Selenium
(ug)
65.4
[18.1]
34% 91% 103.9*
[70.1]
74% 1 0 0%
Iodine 118.2
[40.9]
26% 91% 139.5*
[59.1]
57% 97%
Mean [SD]
* Value significantly different from baseline value (P<0.05)
Subjects were also provided with and advised to take a multivitamin and mineral 
supplement, (not included within analysis of micronutrient intake (Table 3.17)) the 
nutritional composition of which can be seen in Appendix M.
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c) Changes in measured parameters
In order to test the hypothesis that subjects following a LCD with an added exercise 
programme will have a significantly greater reduction in CVD risk factors compared to 
those who do not increase their activity a comparative analysis between the diet and the diet 
& exercise group was undertaken.
3.3.1 Insulin
The primary outcome measure was change in insulin following a LCD with or without 
additional exercise. The changes in insulin in the diet and diet & exercise group have been 
analyzed using both a completers and an intention to treat analysis.
3.3.1.1 Completers analysis
All available blood samples were analysed from completed subjects and all blood results 
are reported in this analysis.
Fasting insulin levels were reduced between baseline and 2 months in the diet and the diet 
& exercise group (Table 3.18), and between 2 and 4 months in the diet group only. The 
only significant change in insulin in either group was the decrease seen between baseline 
and 4 months (P=0.016, /=2.728) in the diet group. No significant differences were 
apparent in the changes in insulin between groups.
Table 3.18 Fasting insulin levels in the diet and diet & exercise group throughout the 
study
Insulin
(pmol/1)
Baseline 2
Months
4
Months
6
Months
% Change 
baseline to 
2  months
% Change 
baseline to 
6  months
Diet 70.77 63.00 60.27* 71.88 -4.38 5.26 [63.48]
[46.94] [63.15] [44.03] [64.20] [72.47] (n=20)
(n=20) (n=19) (n=16) (n=20) (n=19)
Diet & 77.91 65.08 66.43 71.21 -937 12.25
Exercise [54.77] [55.18] [45.11] [52.31] [50.48] [88.03]
(n=23) (n=22) (n=20) (n=23) (n=22) (n=23)
Mean [SD]
Repeated measures ANOVA showed no significant group effect 
*Significantly different from baseline within group {P =0.016) (Paired t test)
Insulin resistance is defined in those subjects with a fasting insulin level within the highest 25% of the cohort
The percentage change in insulin appeared to increase in both groups over the whole study 
period with a more substantial increase in the diet & exercise group. As the change in
insulin in absolute terms decreased in the diet & exercise group contrary to our hypothesis 
and also the range of insulin levels was not consistent with previous analysis, further 
investigation was warranted. There was high degree of variation in the percentage change 
in insulin between subjects, (indicated by the large SDs, Table 3.18). The variation in 
percentage change in insulin from baseline to 2  months and baseline to 6  months is 
illustrated in Figures 3.13 and 3.14 respectively. Two outliers were apparent in each 
dataset. These outliers were removed and the analysis repeated (Table 3.19).
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Figure 3.13 Percentage change in insulin from baseline to 2 months in the diet and 
diet & exercise groups illustrating the variation between subjects and the 2 outliers, 
(defined as >2 SD from mean).
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Figure 3.14 Percentage change in insulin from baseline to 6 months in the diet and 
diet & exercise groups illustrating the variation between subjects and the 2 outliers, 
(defined as >2 SD from mean).
After outliers were removed there was a decrease in the percentage change in insulin in 
both the diet and diet & exercise group over the 6 month study. The difference between 
groups in percentage insulin between baseline and 2 months or baseline and 6 months were 
not significant.
Table 3.19 Change in percentage insulin in the diet and diet & exercise group 
throughout the study with outliers removed
Percentage change Percentage change
baseline to 2 months baseline to 6 months
(%) (%)
Diet -24.69 [41.04] -5.87 [40.50]
(n=17) (n=19)
Diet & Exercise -9.37 [50.48] -3.89 [42.92]
(n=22) (n=22)
Mean [SDJ
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3.3.1.2 Intention-to-treat analysis
As only the blood samples of those subjects who completed the study were analysed the 
intention to treat (ITT) analysis was carried out looking at the change in insulin from 
baseline to 6 months with zero entered for those subjects who withdrew. Data remained 
normally distributed therefore parametric tests were employed. A decrease in fasting 
insulin (NS) was seen in the diet & exercise group where as a small increase (NS) was 
apparent in the diet group (Table 3.20). The differences in these changes between groups 
were not significant.
Table 3.20 Change in fasting absolute insulin levels in the diet and diet & exercise 
group from baseline to six months, using ITT analysis
Group Absolute change in Insulin (pmol/1) from
baseline to 6 months
Diet 0.82 [29.10]
(n=27)
Diet & Exercise -5.32 [32.26]
(n=29)
Mean [SD]
No significant changes within or between groups
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3.3.2 Weight changes
As it was not possible to conduct an ITT analysis of insulin data using the planned 
methodology (see 3.2.7) both ITT and completers analyses were carried out on weight 
changes in order that the two methods could be compared.
3.3.2.1 Completers analysis
Absolute weight loss of all subjects over the 6 months in the diet and diet & exercise group 
are shown in Figure 3.15. There was no significant difference in the total mean weight loss 
between the diet group, (-8.41kg [2.70]) and diet & exercise group, (-8.02 kg [6.0]) over the 
duration of the 6 month study. A wide range of weight losses was achieved by individuals 
in both the diet and diet & exercise group. One subject in the diet group gained 1.2 kg in 
the 6 month study. In the diet & exercise group one subject gained 0.4kg and one subject 
was the same weight at 6 months as at baseline.
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Figure 3.15 Absolute weight changes of subjects in the diet and diet & exercise groups 
between baseline and 6 months, showing the range of weight loss achieved.
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Clinically significant weight losses were achieved in the majority of subjects by 2 months 
(Figure 3.16). Twenty-five percent of subjects in the diet & exercise group achieved a 
weight loss of >10% by 2 months compared to 14.3% of the diet group. By 6 months equal 
numbers of subjects in the diet and diet & exercise group achieved >10% body weight loss.
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Figure 3.16 Percentage of subjects in the diet and diet & exercise group who achieved 
a clinically significant weight loss at 2 and 6 months
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The rates of weight loss over time in each group are illustrated in Figure 3.17. Initial weight 
loss, from baseline to 2 months, was rapid in subjects within the diet group, (-6.05 kg 
[3.05]) and diet & exercise group, (-7.02 kg [3.63]). After this point, weight loss slowed 
down in both groups, (-1.86 kg [2.55] in the diet group and -1.92 kg [2.73] in the diet & 
exercise group between 2 and 4 months). A significant difference, (F=0.011, f=-2.68) in 
weight change was only apparent between groups from 4 to 6 months. The mean weight 
loss in the diet group continued to fall during this time, (-0.81 kg [1.39]) where as there was 
some rebound weight gain in the diet & exercise group (0.56kg [1.80]).
Diet &
Time (months)
Figure 3.17 Mean absolute weight loss of subjects in the diet and diet & exercise group 
throughout the 6 month study period showing the rate of weight loss over time.
Error bars represent SEM
Repeated measures ANOVA showed no significant group differences.
Results from Paired t tests within groups; *value significantly different from baseline (P <0.001); ' value 
significantly different from 2 months (P<0.01); ■ value significantly different from 4 months (P =0.02)
94
Figure 3.18 shows the changes in mean percentage body weight in both groups throughout 
the study. There were no significant differences in percentage weight loss between the 
groups between baseline and 2 months or 2 and 4 months. However, between 4 and 6 
months there was some rebound weight gain in the diet & exercise group and further 
weight loss in the diet only group, (P=0.008, r=-2.8)
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Figure 3.18 Mean percentage bodyweight losses in subjects in the diet and diet & 
exercise group throughout the study.
Error bars represent SEM
^Significant difference between groups (P=0.008, t =-2.8)
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3 3.2.2 Intention to treat analysis
An ITT analysis of changes in weight was carried out, using baseline values carried 
forward for missing data. Where intermittent values were missing the most recent prior 
measurement was imputed.
The rate of weight loss over time in each group is illustrated in Figure 3.19. There was no 
significant difference in the total mean weight loss between the diet group, (-6.54kg [6.11]) 
and diet & exercise group, (-6.62 kg [6.25]) over the duration of the 6 month study.
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Figure 3.19 Mean absolute weight loss of subjects in the diet and diet & exercise group 
throughout the 6 month study period showing the rate of weight loss over time, using 
an ITT analysis.
Error bars represent SEM
Repeated measures ANOVA showed no significant group differences.
Results from Paired t tests within groups; *value significantly different from baseline (P <0.001); ” value 
significantly different from 2 months (P<0.05); ^value significantly different from 4 months (P <0.05)
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3.3.3 Anthropometric changes
The remaining analysis of the diet and diet & exercise groups was conducted using 
completers only.
BMI decreased by similar amounts in the diet group (-2.62 kg/m^ [1.76]) and diet & 
exercise group (-2.55 kg/m^ [1.87]) over the 6 month study. BMI decreased at each time­
point throughout the study in both groups with the exception of a small increase, (0.15 
kg/m" [0.54]) between 4 and 6 months in the diet & exercise group. As there was a 
significant difference in BMI between groups at baseline this was adjusted for when 
comparing the change in BMI between groups. Baseline BMI was used as a co-variate in a 
repeated measures ANOVA which showed there was no significant difference between 
groups (Figure 3.20).
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Figure 3.20 Mean changes in BMI throughout the study in subjects in the diet and diet 
& exercise group.
Error bars show SEM
Repeated measures ANOVA, (using baseline BMI as a co-variate) found no significant effect o f group 
Paired t tests show significant differences within groups; *value significantly different from baseline 
(P<0.001); value significantly different from 4 months (P<0.05)
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The significant decreases in waist circumference were most rapid between baseline and 2 
months in both the diet, (P<0.001, r=7.823) and diet & exercise groups, (P<0.001, r=7,430) 
(Figure 3.21). These decreases then continued at a slower pace in both groups for the 
duration of the study. Waist circumference was reduced further by subjects in the diet 
group, (-8.38cm [6.36]) than those in the diet & exercise group, (-7.78 [4.43]) over the 
study period but these differences were not significant (Table 3.21).
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Figure 3.21 Changes in waist circumference throughout the study in subjects in tbe 
diet and diet & exercise group.
Error bars show SEM
Dashed line indicates waist circumference above which is associated with increased CHD risk (>94cm) 
Repeated measures ANOVA found no significant effect of group
Paired t tests show significant differences within groups; *value significantly different from baseline 
(P<0.001); value significantly different from 4 months (P<0.05)
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In the first two months of the study hip circumference decreased significantly more in the 
diet & exercise group than in the diet group, (-3.79 cm [3.15] and -1.29 cm [3.81] 
respectively, F=0.02, t=2.5l) (Table 3.21). As illustrated in Figure 3.22 some rebound 
regain in hip circumference was seen in the diet & exercise group between 4 and 6 months, 
(1.57 cm [3.80]) and this change was significantly different, (P=0.006, t=-2.88) to the 
changes seen in the diet group, (-1.45 cm [2.44]) over this time period. Over the 6 month 
study hip circumference decreased further in the diet & exercise group than in the diet 
group, (Table 3.21). These changes were significant within the diet (P=0.001, f=3.94) and 
diet & exercise group, (F<0.001, t=6.06) (Figure 3.22) and between groups, (F<0.001, 
F=6.84), (Table 3.21).
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Figure 3.22 Changes in hip circumference throughout the study in the diet and diet & 
exercise group
Error bars show SEM
Repeated measure ANOVA showed a significant effect o f group (P<0.001, F=6.84)
Paired t tests show significant differences within groups; *value significantly different from baseline 
(P<0.001); value significantly different from 4 months (P<0.05)
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WHR was calculated using waist and hip measurements (Table 3.21). WHR was 
significantly reduced in both the diet and diet & exercise groups between baseline and 2 
months and baseline and 6 months (Figure 3.23). The decrease in WHR was significantly, 
(P=0.031, F=2.72) greater in the diet group compared to the diet & exercise group between 
baseline and 2 months (Table 3.21).
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Figure 3.23 Mean changes in waist: hip ratio throughout the study in subjects in the 
diet and diet & exercise group
Error bars show SEM
Dashed line indicates waistrhip ratio above which is associated with an increased CHD risk in men (>0.95) 
Repeated measure ANOVA showed significant effect o f group, (P=0.032, F=3.29)
Paired t tests show significant difference within groups; *value significantly different from baseline (Diet 
P<0.001), (Diet & Exercise P=0.007); value significantly different from 4 months (P<0.05)
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Table 3.21 Changes in anthropometric measurements in the diet and diet & exercise 
group
Baseline to 2 
months
2 to 4 months 4 to 6 
Months
Baseline to 6 
months
BMI Diet -1.91 -0.53 -0.27 -2.62
(kg/m^) [1.01] [0.77] [0.42] [1.76]
(n=21) (n=19) (n=19) (n=21)
Diet & -2.20 -0.62 0.15 -2.55
Exercise [1.14] [0.85] [0.54] [1.87]
(n=24) (n=21) (n=21) (n=24)
Waist Diet -5.66 -1.92 -1.24 -8.38
(cm) [3.32] [3.61] [3.77] [6.36]
(n=21) (n=19) (n=19) (n=21)
Diet & -5.44 4138 -0.48 -7.78
Exercise [3.59] [2.67] [1.78] [4.43]
(n=24) (n=21) (n=21) (n=24)
Hip Diet -1.29* -0.95 -1.45* -3.36
(cm) [3.81] [1.47] [2.44] [3.90]
(n=21) (n=19) (n=19) (n=21)
Diet & -3.79* -2.76 1.57* -4.67
Exercise [3.15] [3.81] [3.80] [3.78]
(n=24) (n=21) (n=21) (n=24)
WHR Diet -0.04* -0.01 0.00 -0.05
[0.46] [0.04] [0.37] [0.06]
(n=21) (n=19) (n=19) (n=2l)
Diet & -0.02* 0.00 -0.02 -0.03
Exercise [0.03] [0.04] [0.04] [0.03]
(n=24) (n=21) (n=21) (n=24)
Mean [SD]
*Significant differences between groups (P<0.05)
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3.3.4 Body composition
The changes in body composition over time in the diet and the diet & exercise groups can 
be seen in Figure 3.24 and Table 3.22. Body composition changed positively over time with 
a mean decrease in percentage fat mass and an increase in percentage lean mass in subjects 
in both groups. Significant changes in body composition were seen within each group and 
are indicated in Figure 3.24. Absolute fat mass decreased more in the diet & exercise group 
from baseline to 2 months (-5.09 kg [2.78]) compared to the diet group (-3.75 kg [3.71]) 
(NS). Despite fat mass decreasing more substantially in the diet group than the diet & 
exercise group between 2 and 6 months the overall change, (from baseline to 6 months) in 
fat mass remained greater in the diet & exercise group (-5.85 kg [3.96]) compared to the 
diet group (-5.37 kg [4.66]) (NS). In addition the changes in lean body mass and body 
water were less in the diet & exercise group compared to diet group over the 6 month study 
(Table 3.22) (NS).
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Figure 3.24 Change in body composition over the study period in the diet and diet & 
exercise group.
Repeated measures ANOVA showed no significant effect o f group in absolute fat mass, lean body mass or 
water mass.
Paired t tests show significant differences within groups; *'value significantly different from baseline within 
group and parameter (* P<0.001,  ^P<0.05); * value significantly different from 4 months within group and 
parameter (P<0.05)
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Table 3.22 Changes in body composition throughout the study in the diet and the diet 
& exercise groups.
Group Baseline to 2 
months
2 to 4 months 4 to 6 
months
Baseline to 6 
months
Body Diet -1.97 [2.87] -1.19 [1.83] 0.09 [2.02] -3.06 [3.20]
fat (n=21) (n=18) (n=18) (n=21)
(%)
Diet& -3.01 [2.12] -1.03 [2.82] 0.15 [2.60] -3.83 [3.57]
Exercise (n=21) (n=18) (n=19) (n=22)
Body Diet -3.75 [3.71] -1.65 [1.65] 0.00 [2.13] -5.37 [4.66]
fat (n=21) (n=18) (n=18) (n=21)
(kg)
Diet& -5.09 [2.78] -1.48 [3.01] 0.41 [2.41] -5.85 [3.96]
Exercise (n=21) (n=18) (n=19) (n=22)
Lean Diet 1.97 [2.87] 1.19 [1.83] -0.09 [2.02] 2.82 [7.82]
Body (n=21) (n=18) (n=18) (n=21)
Mass
(%) Diet & 3.01 [2.13] 1.02 [2.81] -0.15 [2.60] 2.59 [8.92]
Exercise (n=21) (n=18) (n=19) (n=22)
Lean Diet -2.31 [2.27] -0.30 [2.82] -0.70 [2.01] -3.39 [2.92]
Body (n=21) (n=18) (n=18) (n=21)
Mass
(kg) Diet & -2.26 [2.45] -0.42 [2.70] 0.33 [2.67] -1.90 [3.6]
Exercise (n=21) (n=18) (n=19) (n=22)
Body Diet 1.51 [2.88] 1.31 [2.36] -0.39 [2.43] 2.50 [2.91]
water (n=19) (n=14) (n=14) (n=19)
(%)
Diet & 2.14 [2.52] 1.59 [2.80] -0.48 [2.35] 2.91 [3.83]
Exercise (n=16) (n=13) (n=16) (n=19)
Body Diet -1.47 [2.45] 0.49 [2.93] -0.73 [2.42] -1.88 [2.68]
water (n=19) (n=14) (n=14) (n=19)
(kg)
Diet& -1.68 [2.72] 0.66 [2.37] -0.24 [2.29] -1.29 [3.59]
Exercise (n=16) (n=13) (n=16) (n=19)
Mean [SD]
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3.3.5 Blood pressure
Diastolic and systolic blood pressure was reduced further in subjects in the diet group than 
the diet & exercise group during the first 2 months and over the whole study period, (see 
Table 3.23). However these differences were not significant.
Table 3.23 Changes in blood pressure in the diet and diet & exercise group
Baseline to 2 
months
2 to 4 months 4 to 6 
Months
Baseline to 6 
months
Systolic
blood
Diet -9.95* [11.75]
(n=21)
-1.05 [8.90] 
(n=19)
-0.47 [8.77] 
(n=19)
-10.95* [12.78]
(n=2l)
pressure
(mmHg)
Diet & 
Exercise
-6.21 [11.24]
(n=24)
0.38 [9.28]
(n=21)
-0.95 [13.41]
(n=21)
-5.75 ' [13.40] 
(n=24)
Diastolic
blood
Diet -7.67* [6.49]
(n=21)
-0.95 [8.41]
(n=19)
2.05 [6.82] 
(n=19)
-6.81* [8.04]
(n=21)
pressure
(mmHg)
Diet & 
Exercise
-5.42' [9.49] 
(n=24)
-0.90 [7.55]
(n=21)
0.52 [9.43]
(n=21)
-5.04 [11.98]
(n=24)
Mean [SD]
A blood pressure of >140/ 90 is considered to increase CHD risk
Repeated measure ANOVA showed no significant effect of group on systolic or diastolic blood pressure over 
the course of the study
Paired t tests show significant difference within groups; change between time-points significantly different 
within group (* P<0.001, ' P<0.05)
3.3.6 Change in fasting glucose and HOMA
All biochemical changes are presented as absolute changes over time.
3.3.6.1 Baseline glucose (screening using glucometer)
Glucose screening at the baseline visit found one subject to have a fasting glucose level of 
>7mmol/l which is the cut-off point used to diagnose diabetes. The plasma sample was 
therefore checked and re-measured as 6.5mmol/l. No subjects were withdrawn from the 
study on the basis of hyperglycaemia.
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3.3.6.2 Plasma glucose and HOMA
The changes in plasma glucose within each group are shown in Figure 3.25. The mean 
glucose level of subjects in the diet group decreased from baseline to 2 months, (-0,25 
mmol/1 [0.66]). Glucose then increased between 2 and 6 months resulting in almost no 
overall change in glucose, (0.01 mmol/1 [0.84]) in the diet group over the whole study 
period. In the diet & exercise group glucose continued to fall throughout the study with the 
greatest decrease occurring between 4 and 6 months. The mean glucose level was 0.49 
mmol/1 [1.89] lower at 6 months compared to baseline in this group (NS). Variation in 
glucose measurements at 6 months was considerable (Figure 3.25). No significant changes 
in glucose levels were evident within or between groups.
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Figure 3.25 Changes in glucose throughout the study in the diet and diet & exercise 
group.
Error bars indicate SEM
Dashed line indicates level associated with impaired fasting glucose and increased CHD risk (>6.1) 
Repeated measures ANOVA showed no significant effect of group on glucose
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Insulin resistance was estimated using HOMA. The greatest changes in insulin resistance 
occurred between baseline and 2 months in both the diet and the diet & exercise group 
when a decrease in HOMA was seen (Figure 3.26). However, in the diet group HOMA 
levels increased between 4 and 6 months resulting in a small overall increase (0.07 [1.81]) 
in HOMA over the study period. In contrast HOMA levels fell in the diet & exercise from 2 
to 6 months consequently an overall decrease in HOMA was seen in this group in the 6 
month study (-0.62 [1.75], NS).
The only significant change in HOMA within either group was a significant decrease in 
HOMA from baseline to 4 months in the diet group (F=0.04, t=2.21). There were no 
significant differences in the changes in HOMA levels between groups.
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Figure 3.26 Changes in insulin resistance (HOMA) throughout the study in the diet 
and diet & exercise group.
Error bars indicate SEM
Repeated measures ANOVA showed no significant effect of group
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3.3.7 Changes in blood lipids
Total cholesterol levels changed very little within either the diet or the diet & exercise 
group over the course of the study and were 0.07mmol/1 [0.97] and 0.11 mmol/1 [1.39] 
higher (respectively) at 6 months compared to baseline. These changes are shown in Figure 
3.27.
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Figure 3.27 Changes in total cholesterol levels throughout the study in the diet and 
diet & exercise group.
Error bars indicate SEM
Dashed line indicates the total cholesterol level which is associated with increased CHD risk, (>5mmol/l) 
Repeated measures ANOVA showed no significant effect of group on total cholesterol
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HDL-cholesterol levels at each time-point during the study are shown in Figure 3.28. 
Levels of FlDL-cholesterol increased by 0.12 mmol/1 [0.42] in the diet group and 0.12 
mmol/1 [0.35] in the diet & exercise group over the 6 month study. There were no 
significant between group differences in the changes in HDL-cholesterol.
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Figure 3.28 Changes in HDL-cholesterol levels throughout the study in the diet and 
diet & exercise groups.
Error bars indicate SEM
Dashed line indicates HDL-C level associated with increased CHD risk, (<1.0mmol/l)
Repeated measures ANOVA showed no significant effect of group
* Value significantly different from value at 4 months within group {P<0.05) (Paired t test)
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LDL-cholesteroI levels, (shown in Figure 3.29) changed very little over the course of the 
study in the diet group with and levels rising by 0.14 mmol/1 [0.67] in 6 months. In the diet 
& exercise group LDL-cholesterol decreased significantly from baseline to 2 months, 
(P<0.05, t=2.63) but a significant increase was then seen from 2 to 4 months, (f<0.05, t=- 
2.50) resulting in a total fall of -0.09 mmol/1 [0.72] over the 6 month study (NS).
m Diet
□  Diet & 
E xerc ise
3 2 8
n = 2 0 n =22 n =18 n = 2 3 n = 1 5 n =19 n = 2 0 n =21
0 ^ Time (m onths) ^
Figure 3.29 Changes in LDL-cholesterol levels throughout the study in the diet and 
diet & exercise group.
Error bars indicate SEM
Repeated measures ANOVA showed no significant effect of group on LDL-cholesterol
* Value significantly different from value at 2 months within group (f*<0.05) (Paired t test)
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The most substantial lipaemic changes were seen in TAG levels (Figure 3.30). In the diet 
group TAG levels were significantly lower at 4, (P=0.005, t=331) and 6 months compared 
to baseline, (P=0.035, /=2.27) and decreased by -0.35 mmol/1 [0.68] over this time. TAG 
levels were significantly lower at 2 and 6 months (-0.38 mmol/1 [0.79] decrease overall) 
compared to baseline in the diet & exercise group, (/=3.19 and t=2.22 respectively, 
P<0.05).
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Figure 3.30 Changes in TAG levels throughout the study in the diet and diet & 
exercise group.
Error bars indicate SEM
Dashed line indicates TAG level associated with increased CHD risk (>2.0mmol/l)
Repeated measures ANOVA showed no significant effect of group
* Value significantly different from value at baseline within group (P<0.05) (Paired t test)
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NEFA decreased slightly in both groups over the study period. These changes (Figure 3.31) 
were non-significant.
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Figure 3.31 Changes in NEFA levels throughout the study in the diet and diet & 
exercise group.
Error bars indicate SEM
Repeated measures ANOVA showed no significant effect of group
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3.3.8 Changes in apolipoproteins
Changes in levels of apoB, which is positively associated with CHD risk and apoA-1, 
which is protective, are shown in Figure 3.32. ApoA-1 increased by 0.11 g/1 [0.25] from 
baseline to 6 months in the diet group and by 0.17 g/1 [0.49] in the diet & exercise group. 
Minimal changes in apoB were seen from baseline to 6 months in the diet group, (0.07 g/1 
[0.19]) and diet & exercise group (0.01 g/1 [0.37]). The changes within or between groups 
were not significant.
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Figure 3.32 Changes In levels of apolipoproteinA-1 and B throughout the study in the 
diet and diet & exercise group.
Error bars indicate SEM
Repeated measures ANOVA showed no significant group effect on ApoA-1 or ApoB
3.3.9 Changes in lipid suhfractions
Analysis of lipoprotein subfractions provided further information on the changes to lipid 
profiles when a LCD was followed. HDLz, the large buoyant cardioprotective HDL sub­
fraction increased over the study period in the diet group, (5.24% [10.46]) and the diet & 
exercise group, (6.68% [7.51]) (see Table 3.24). LDLiii, the small dense atherogenic LDL 
sub-fraction, decreased more in the diet & exercise group (-13.81% [15.67]) than in the diet 
group (-8.29 % [17.57]). The changes within groups were not significant. LDL peak density 
provides a reference point which allows LDL mobility to be compared. LDL peak density
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decreased significantly within both the diet, (P=0.014, r=2.74) and diet & exercise group, 
(P=0.001, f=4.01) but the differences in these changes between groups was non-significant. 
Although subjects in the diet group (n=2) and diet & exercise group (n=5) had phenotype B 
at baseline no subjects retained this phenotype at 6 months.
Table 3.24 Changes in lipoprotein sub-fractions and LDL peak density in the diet and
Diet Diet & Exercise
Baseline 6 Months Baseline 6 Months
HDL2 % 36.2 [18.4]) 41 [13.6] 27.9 [9.9] 34.2 [8.9]
(n=20) (n=17) (n=21) (n=19)
HDL3 % 63.8 [18.4] 59 [13.6] 72.1 [8.9] 65.8 [9.0]
(n=20) (n=17) (n=21) (n=19)
LDL iii % 28.7 [15.8] 17.1 [9.7] 30.8 [21.8] 1.03 [0.0]
(n=20) (n=18) (n=22) (n=19)
LDL peak density (g/ml)^ 1.028[0] 1.026*[0] 1.03 [0] 1.025  ^[0]
n=20) (n=18) (n=22) (n=19)
Phenotype A 18 18 17 19
(n) B 2 0 5 0
Mean [SD]
Paired t tests show significant difference from baseline within groups; 
exercise ^(F=0.001, f=4.01)
diet *(P=0.014, /=2.74) and diet &
There were no significant differences in the changes between groups in any lipid fraction.
3.3.10 Fibrinogen
Mean changes in fibrinogen, a marker of haemostasis, within each group are presented 
below (Table 3.25). Fibrinogen levels were reduced by -0.34 g/L [2.04] in the diet group 
over the study period and increased by 0.30 g /I [0.78] in the diet & exercise group. There 
were no significant changes in fibrinogen levels within or between groups.
Table 3.25 Change in fibrinogen levels in the diet and diet & exercise group
Baseline to 6 months 
(g/1)
Diet -0.34 [2.04]
(n=19)
Diet & Exercise 0.30 [0.78]
(n=20)
Mean [SD]
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3.3.11 Inflammatory markers
There were 3 outliers (3 individual subjects), one in the CRP results (diet & exercise 
group), (Figure 3.33) and two in TNF-a results (one in the diet group and one in the diet & 
exercise group), (Figure 3.34) (>2SD from mean) which were excluded before analysis of 
inflammatory marker data was conducted.
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Figure 3.33 Scattergraph of individual changes in CRP during the study period 
illustrating the outlier.
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Figure 3.34 Scattergraph of individual changes in TNF-a during the study period 
illustrating the outliers.
There were no significant changes in CRP, vWF or TNF- a within either the diet or diet & 
exercise group from baseline to 6 months (Table 3.26). Flowever comparison of results 
between groups showed the change in CRP was significantly different in the diet group 
(0.34 pg/ml [0.96]) compared to the change in the diet & exercise group (-0.23 pg/ml 
[0.56]) (P=0.043, r=2.11) with the diet & exercise participants showing a mean decrease in 
CRP over the study period compared to a mean increase in the diet alone group.
Table 3.26 Changes in inflammatory markers over the study in the diet and diet &
CRP vWF TNF-a
(pg/ml) (pg/ml) (lU/ml)
Diet 0.34 [0.96] 0.53 [1.78] -0.04 [0.62]
(n=15) (n=15) (n=12)
Diet & Exercise -0.23* [0.56] 0.59 [1.53] 0.03 [0.70]
(n=17) (n=18) (n=16)
Mean [SD]
Value significant different from that in the diet group (*P=0.043, t=2A 1) (independent t test)
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3.3.12 Metabolic syndrome
Using the NCEP ATPIII criteria 45% of subjects in the diet group and 50% of those in the 
diet & exercise group were categorized as having the Metabolic Syndrome at baseline. This 
was reduced to 26% and 19% respectively at 6 months.
3.3.13 Renal function tests
Urea and electrolytes, (sodium, potassium and creatinine) were measured to monitor renal 
function at baseline, 2, 4 and 6 months and no detrimental changes in renal function were 
observed during the study period.
3.3.14 Relationships between factors
Relationships between parameters were investigated within each group over the 6 month 
study using Pearsons correlations (Table 3.27 and 3.28).
In order to explore CVD risk further, relationships between CVD risk factors were 
investigated and results are shown in Table 3.27 (diet group) and 3.28 (diet & exercise 
group). In the diet group, weight loss was significantly and positively correlated with a 
reduction in fat mass, waist circumference, TAG, LDL3 and also reduction in carbohydrate 
intake.
Table 3.27 Relationships between CVD risk factors in the diet group using Pearsons 
correlation
Parameter correlates with Parameter N Correlation (r) P
Weight change Change in fat mass 21 0.877 <0.001
Change in waist circumference 21 0.791 <0.001
Change in TAG 20 0.530 0.016
Change in LDL3 18 0.600 0.008
Change in CHO intake 10 0.661 0.037
CHO- carbohydrate
In the diet & exercise group weight loss was significantly and positively correlated with a 
reduction in fat mass, fat free mass, waist circumference, systolic and diastolic blood 
pressure and insulin and also negatively associated with changes in Apo-al and B. A 
change in insulin was seen to be positively correlated with a change in BMI, waist 
circumference, fat mass, systolic and diastolic blood pressure, total cholesterol and LDL- 
cholesterol indicating that with decreasing insulin levels these parameters also decrease.
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Table 3.28 Relationships between CVD risk factors in the diet & exercise group using 
Pearsons correlation
Parameter correlates with Parameter N Correlation (r) P
Weight change Change in fat mass 22 0.722 <0.001
Change in fat free mass 22 0.651 <0.001
Change in waist circumference 24 0.895 <0.001
Change in systolic blood pressure 24 0.581 0.003
Change in diastolic blood pressure 24 0.546 0.006
Change in insulin 23 0.523 0.010
Change in Apoal 21 -0.479 0.028
Change in ApoB 21 -0.437 0.048
Change in insulin Change in BMI 23 0.569 0.005
Change in waist circumference 23 0.445 0.033
Change in fat mass 21 0.593 0.005
Change in systolic blood pressure 23 0.561 0.005
Change in diastolic blood pressure 23 0.611 0.002
Change in total cholesterol 21 0.572 0.007
Change in LDL-C 21 0.514 0.017
In order to learn more about the relationships between biochemical values and factors 
which may be related to changes in these CVD risk factors multiple regression was used. 
This allows testing of multiple independent variables simultaneously. Multiple regression 
models were carried out within the diet and the diet & exercise group with the same 
independent variables used, (change in weight, waist circumference, fat mass and fitness) in 
relation to each biochemical parameter, (the dependant variable). Table 3.29 shows the 
outcome of multiple regression analysis investigating each biochemical parameter and the 
independent variables of interest within the diet group. Multiple regression analysis showed 
56% of the variance (R^=0.555) in the change in TAG from baseline to 6 months could be 
explained by the change in waist circumference over this time period. All other independent 
variables were excluded from the model. In addition 78% of the variance (R^=0.779) in the 
change in LDL3 could be explained by the change in fitness and weight over the study 
time. Scattergraphs showing the plot of residuals are showed in Appendix N. These are 
reasonable for both models.
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Table 3.29 Multiple regression analysis investigating relationships between 
biochemical parameters and independent variables within the diet group
Dependant
variable
Independent
variables
Unstandardized
Coefficients
Standardi
zed
Coefficien
ts
t P
B Std Error Beta
Change in TAG Change in waist 
circumference
0.072 0.016 0.745 4.468 <0.001
Change in 
LDL3
Change in fitness 
(watts)
0.513 0.122 0.571 4.214 0.001
Change in weight 1.602 0.405 0.536 3.959 0.002
Table 3.30 shows the outcome of multiple regression analysis investigating each 
biochemical parameter and the independent variables of interest within the diet & exercise 
group. Multiple regression analysis showed 35% of the variance (R^=0.345) in the change 
in insulin from baseline to 6 months could be explained by the change in fat mass over this 
time period. All other independent variables were excluded from the model. Thirty -eight 
percent of the variance (R^=0.381) in the change in CRP (with outliers excluded) could be 
explained by the change in fitness over the study duration. The change in waist 
circumference and change in fat mass explained 44% of the variability (R^=0.444) in the 
change in NEFA over the study period. Scattergraphs showing the plot of residuals are 
showed in Appendix O. These are reasonable for all models.
Table 3.30 Multiple regression analysis investigating relationships between 
biochemical parameters and independent variables within the diet & exercise group
Dependant
variable
Independent
variables
Unstandardized
Coefficients
Standardi
zed
Coefficien
ts
t P
B Std Error Beta
Change in 
insulin
Change in fat 
mass
5.736 1.917 0.587 2.992 0.008
Change in CRP Change in fitness 
(watts)
0.026 0.009 0.618 2.831 0.014
Change in 
NEFA
Change in waist 
circumference
0.050 0.015 0.859 3.343 0.005
Change in fat 
mass
-0.037 0.017 -0.573 -2.231 0.043
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3.4 Discussion
This study aimed to comprehensively investigate the lipaemic and haemostatic effects of a 
6-month LCD in relation to CVD risk in overweight and obese men. This has been 
achieved by taking measurements of CVD risk factors in subjects before and whilst 
following a LCD.
Despite scientific opinion of LCDs being irresolute and LCDs seen by some as an approach 
not to be recommended, (Astrup, 2004; Stevens, 2006) no detrimental effects of this dietary 
approach were noted across anthropometric, lipaemic, glycaemic or inflammatory 
parameters with no negative changes being evident in renal function. Indeed significant 
positive effects were seen in subjects following a LCD across weight, BMI, WHR, body fat 
mass, systolic blood pressure and TAG all of which contribute to a reduced CVD risk. 
Metabolic syndrome was evident in 45% of subjects in the diet group and 50% in the diet & 
exercise group at baseline and only 26% and 19% respectively after following a LCD for 6 
months. It was hypothesised that a LCD would result in a significant reduction in CVD risk 
as measured by improvement in lipaemic profile, body fat mass and fasting insulin levels. 
Whilst the evidence reported from this study shows subjects who followed a LCD had 
reductions in CVD risk across numerous parameters including body fat mass and TAG it is 
apparent this is associated with the changes in weight and body composition achieved 
rather than a reduction in carbohydrate intake per se. No significant improvements were 
seen across other CVD risk factors such as fasting insulin levels. Therefore this hypothesis 
is supported in part by the evidence from this study as LCDs are seen to an effective 
method of inducing an energy deficit allowing individuals to reduce their weight and body 
fat mass thereby reducing CVD risk factors; WHR, blood pressure and TAG.
Although evidence of the efficacy and safety of LCD has been building in recent years this 
is the first study, to the author’s knowledge, to investigate the CVD risk across a wide 
range of parameters including novel risk factors such as apolipoproteins, lipid sub­
fractions, fibrinogen and inflammatory markers over a 6 month period.
In order to test the hypothesis that subjects on a LCD with an added exercise programme 
would experience a significantly greater reduction in CVD risk factors and improved body 
composition compared to those who do not increase their activity a comparative analysis of 
the diet and the diet & exercise group was conducted. The results from this study suggest 
no added CVD benefits of exercise combined with a LCD compared with a LCD alone.
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3.4.1 Effect of a LCD with and without exercise on parameters measured
3.4.1.1 Insulin
The decreases in absolute insulin levels in both intervention groups between baseline and 2 
months and from baseline to 6 months in the diet & exercise group are as expected as a 
LCD causes blood glucose levels to fall and therefore less insulin is secreted from the p 
cells of the pancreas, thereby plasma levels fall. In addition, a reduction in the quantity of 
adipose tissue, which is a consequence of an energy deficient state (or following a weight 
reducing diet), leads to increased insulin sensitivity. Therefore the insulin produced is more 
effective, less is secreted and plasma insulin levels fall.
However the only significant change in insulin was between baseline and 4 months when a 
significant decrease was seen in the diet only group. A significant decrease in insulin was 
the expected outcome based on previous research (Truby et al, 2006) and other published 
data (Baba et al, 1999; Stem et al, 2004; Meckling et al, 2004). Although a significant 
decrease in insulin is the common outcome reported when a LCD is followed this is not 
always the case. Bravata et al, (2003) reported no significant change in fasting insulin 
levels in subjects on lower carbohydrate diets in their review of LCD. No significant 
reduction in mean insulin levels were observed in subjects following the Atkins diet for one 
year in the study by Dansinger et al, (2005). This inconsistency may be explained by the 
wide variation in subject characteristics, dietary intervention and compliance and 
methodology and analysis used. The lack of a significant decrease in insulin within either 
group in the current study over the 6 month study period may be due the high levels of 
between subject variability in insulin changes. The variation in success of individuals to 
lose weight is likely to have affected measured parameters, including insulin.
The procedures put in place to ensure all analytes were measured accurately, including 
using the same experienced researcher to analyse all samples and ensuring all quality 
controls were within accepted limits before assays were mn reduces the likelihood that 
measurement error affected results.
Although absolute fasting insulin levels were decreased to a greater extent in the diet & 
exercise group compared to the diet group in the first 2 months of the study and over the 
whole study period this difference was not significant. Therefore following a LCD with 
additional exercise does not appear to reduce insulin levels further in this group of
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overweight men than a LCD alone. This was unexpected as effects of exercise on 
enhancing insulin sensitivity are well established (Kavouras et al, 2007; Mayer-Davis et 
al, 1998; Thompson et al, 2001).
Fasting insulin was the primary outcome measure in this study and used to calculate the 
sample size. Based on these calculations a 40 pmoVX difference in the change in insulin 
levels between groups was expected. A difference of 7.82 pmoMX was measured, therefore 
the use of this parameter in the sample size calculation could be questioned. Insulin was 
used as it is an independent risk marker for CVD and significant changes in insulin were 
seen in subjects following a LCD in previous work (Truby et al, 2006). A target difference 
in insulin of 40 pmoVX was used as this was the mean predicted decrease in insulin for men 
following a LCD with an average level of fitness. Further evidence used in support of this 
figure was provided by Rice et al, (1999) whereby the change in fasting insulin levels was 
-19 [18.9] pmoMX in obese men following a weight loss diet alone for 16 weeks compared to 
-58.6 [46.6] pmol/1 in those combining a weight loss diet and aerobic exercise.
A significant difference in fasting insulin may not have been seen between groups in the 
current study because of the low level of compliance to exercise instructions which resulted 
in the difference in activity levels between groups being less than expected (see 3.4.2). In 
addition the intensity and duration of exercise may not have been sufficient to induce the 
expected changes. Statistical interrogation of the data using multiple regression analysis 
found the majority of the variation in changes in insulin to be attributable to the reduction 
of fat mass in the diet & exercise group. As the mean loss of body fat mass were equal 
across both the diet and the diet & exercise groups a lack of significant difference in insulin 
between the two groups is not surprising.
Alternatively the effects of exercise at the intensity used in this study may not have had 
additional benefits on insulin levels when combined with a LCD. Only 2 previous studies, 
have since reported the combined effects of a reduced carbohydrate diet with exercise as a 
weight loss intervention (Layman et al, 2005; Meckling and Sherfey, 2007). No significant 
effect of exercise was reported for insulin in either study (please refer to Chapter 6 for 
further details).
Very little difference in insulin results was seen when an ITT analysis was used compared 
to a completer’s analysis. This may be due in part, to the methodology used in the ITT 
analysis. As no biochemical data was available for subjects who withdrew from the study
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zero change was assumed for these subjects. However carrying baseline values forward for 
subjects who withdraw is an accepted methodology for ITT analysis and would give the 
same result. Thus it appears results were not skewed by exclusion of missing data and the 
use of completer’s data for majority of the dataset was appropriate.
3.4.1.2 Weight
A significant mean weight loss was achieved by subjects in the diet and the diet & exercise 
group. Those subjects following a LCD without additional exercise achieved an 8.4 kg 
[2.70] weight loss over 6 months. This degree of weight loss is similar to previous studies, 
(Foster et al .,2003; Brehm et al, 2003; Westman et al, 2002) and at least 25% greater than 
weight losses achieved by subjects in Dansinger et al, (2005), Samaha et al, (2003) and 
Truby et al, (2006). Although clinically significant weight losses were achieved by the 
majority of subjects in both groups over the 6 month study a wide variation in weight loss 
was evident between individuals. This reveals the very different ways people respond to the 
same diet and gives an indication of the varying levels of compliance to the dietary 
restrictions.
The primary hypothesis of this study was that a LCD with additional exercise would have 
significantly greater CVD risk factor reduction compared to a LCD alone. However there 
was no significant difference in the mean weight loss achieved by subjects in the diet only 
group and the diet & exercise group. The level of exercise recommended in this study was 
designed to reduce CVD risk factors rather than induce weight loss per se. If weight 
reduction was the primary outcome of this study an exercise prescription generating a 
substantially higher energy deficit would have been needed. An example of an exercise 
intervention inducing a high energy deficit (700kcals/day) is employed in the study by Ross 
et al, (2000). Through exercise alone a mean weight loss of 7.6kg over 3 months was 
achieved. This is considerably more exercise than was conducted in the present study and is 
an unrealistic level for the general population.
A review of the role of physical activity in producing weight loss published recently 
(Catenacci and Wyatt, 2007) concluded ‘the majority of RCTs show only modest weight 
loss with exercise intervention alone’ (1-3 kg over 4-6 months) ‘and slight increases in 
weight loss when exercise intervention is added to dietary restriction’ (p518). Seventeen 
RCTs were identified which investigated weight loss by food restriction alone compared to 
food restriction with physical activity over a period of 4-16 months. In only 2 of these
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studies was a significantly higher weight loss achieved when physical activity was added 
with an average additional weight loss of 1.5kg. Limitations identified by the authors were 
the level of exercise carried out, adherence to exercise recommendations, compensatory 
increase in energy levels and the changes in body composition associated with increasing 
exercise levels which make interpretation of weight results less clear. Of the two studies 
which have investigated the effects of a reduced carbohydrate diet with exercise, (Chapter 
6) significant additive effects of exercise on weight loss were seen in Meckling and Sherfey 
(2007) but not Layman et al, (2005).
The level of exercise recommended and adherence to this are factors which are likely to 
have contributed to the similar weight losses achieved by subjects in the diet and the diet & 
exercise group in the current study as the percentage reduction in energy from baseline to 6 
months was not significantly different between groups. In addition, a smaller decrease in 
lean body mass was seen in the diet & exercise group compared to the diet group and 
though this difference was not significant it would have impacted on the changes in weight 
in both groups. A greater decrease in mean energy intake was seen in the diet & exercise 
group compared to the diet group, (NS) therefore suggesting a compensatory increase in 
energy intake did not occur in this group.
Initial weight loss was more rapid in the diet & exercise group compared to the diet only 
group. Though this change was not significant it could be an important effect as the amount 
of weight loss in the initial stages of an intervention could influence an individual’s 
motivation to continue with the changes made. Looking at body composition changes it 
appears the increased weight loss seen in the diet & exercise group was due to increased 
losses of body fat in the first 2 months of the study with comparable losses of lean body 
mass.
Comparison of ITT analysis show a lower mean weight loss than the completers analysis 
which would be expected but results are very similar with repeated measures ANOVA 
showing no significant group differences.
3.4.1.3 Anthropometries
Previous research has shown significant decreases in the WHR of subjects after following a 
physical activity programme of 14 weeks, (Houmard et al, 1994) and 20 weeks (Wilmore 
et al, 1999). Therefore when physical activity is combined with a LCD which induces
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weight loss it would be anticipated an additional effect would be seen with greater decrease 
in waist reduction when compared to a LCD alone. Conversely the decrease in WHR was 
significantly greater in the diet only group compared to the diet & exercise group in the 
current study. Although a significant difference was apparent the extent of this difference 
was small. The lack of a significant group difference in waist circumference and the 
significantly greater reduction in WHR in the diet only group is likely to be a consequence 
of subjects not adhering to the exercise recommendations sufficiently to see the expected 
changes in these parameters which have previously been described as small in magnitude 
(Wilmore gr aZ., 1999).
3.4.1.4 Body composition
A review of the role of diet and exercise in maintenance of fat-free mass and resting 
metabolic rate during weight loss (Stiegler and Cunliffe, 2006, p239) concluded that ‘the 
addition of exercise programmes to dietary restriction can promote more favorable changes 
in body composition than diet or physical activity on its own.’ Thus the greater decreases 
in fat mass seen in the diet & exercise group, (73% of total weight loss) compared to the 
diet only group, (64% of total weight loss) would be expected. In addition better 
conservation of lean body mass was seen in the diet & exercise group compared to the diet 
group.
Despite these positive body composition changes the differences in body fat mass changes 
or lean body mass changes between groups were not significant.
This may be due to non-compliance to exercise instructions leading to between group 
differences in exercise levels being insufficient to induce significant differences in body 
composition between the diet and the diet & exercise groups (see 3.4.2).
3.4.1.5 Blood pressure
The greater decreases in diastolic and systolic blood pressure in the diet group compared to 
the diet & exercise group are unexpected as exercise is known to have a hypotensive effect 
(Erlichman et al, 2002). Therefore it would be anticipated those subjects in the diet & 
exercise group who were asked to increase exercise levels would experience more positive 
effects on their blood pressure. These between group differences were not significant 
though and may be due to subjects in the diet group having higher baseline systolic and 
diastolic blood pressure values than the diet & exercise group, (these differences were not
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significant). Blood pressure responses to the intervention may not have been as expected 
due to the differences in exercise levels between groups being insufficient due to non- 
compliance (see 3.4.2).
3.4.1.6 Lipids
Inconsistent improvements in blood lipid profile in response to moderate-hard intensity 
exercise were seen in a review of the effects of diet and exercise interventions on lipids and 
lipoproteins by Leon and Sanchez (2001). Therefore the more positive effects seen in HDL- 
cholesterol and LDL-cholesterol between baseline and 2 months in the diet & exercise 
group would be expected. These changes were not significant which may be because 
lipaemic responses to exercise, (Leon and Sanchez, 2001) and LCDs, (Volek et al, 2005) 
show a large amount of individual variability.
The change in total cholesterol over the 6 month study period in both groups in the current 
study is not surprising as total cholesterol levels are not consistently reduced with exercise 
(Hardman, 1999). It has been suggested (Hardman, 1999) that the effects of physical 
activity on lipid profile are due to reduced body fat and enhanced metabolic capacity for 
TAG which therefore affects TAG and cholesterol circulation. Thus the significant 
decreases in TAG seen in the diet & exercise group between baseline and 2 months would 
be expected alongside the other lipid changes. The enhanced lipid clearance associated with 
exercise may be mediated through improved micro-circulation in skeletal muscle which 
impacts on lipoprotein lipase (LPL). In addition exercise training may increase muscle 
blood flow thus exposing a greater amount of circulating lipoproteins to LPL and 
facilitating TAG degradation as LPL removes TAG from lipoprotein particles (Hardman, 
1999, BNF Report, 2005).
NEFA levels decreased slightly in both the diet and the diet & exercise groups and this is 
likely to be a result of the LCD as well as reduced lipolysis due to the reduced body fat 
mass of subjects.
HDL2 increased in both the diet and the diet & exercise group over the 6 month study and 
LDLiii decreased in both groups over this time, changes which reflect a less atherogenic 
lipid profile which would be expected to reduce CVD risk. The positive changes in lipid 
subfractions were seen to a greater extent in the diet & exercise group. The effect of 
exercise training on lipoprotein subfractions has been shown in previous studies, including
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Altena et al, (2006) in which untrained men and women completed 4 weeks of supervised 
training on treadmills, (30 minutes, five times a week at 75% maximum heart rate). A 
significant increase in HDL2 and LDL particle size was seen with exercise training.
A proposed mechanism for the increased HDL2 levels with exercise is that the increased 
LPL activity increases TAG clearance decreasing plasma TAG levels. Thus fewer TAG 
rich lipoproteins (VLDLs) exist and cholesterol ester transfer protein (CETP) mediated 
exchange is reduced and less TAG is available for removal from HDL2 (see Figure 3.3). 
HDL particles remain large and dense and measurement of HDL particles shows a high 
percentage of HDL2 (Volek et al, 2005).
Small dense LDL subfractions decreased to a greater extent in the diet & exercise group. 
Fewer TAG rich lipoproteins (VLDLS) would be expected in these subjects due to 
increased LPL activity associated with exercise. Therefore CETP mediated exchange of 
cholesterol between LDL and VLDL would be reduced and less TAG would be removed 
from LDL particles, consequently LDL particle size remains larger.
The changes in apoA-1 and apoB suggest a tendency towards a reduced CVD risk in the 
diet & exercise group, though the differences between groups were not significant. Results 
from the one year randomised Oslo diet and exercise study (Holme et al, 2007) found 
middle aged men who exercised, (supervised endurance exercise 3 times per week) had 
reduced their apoB levels and apoB/apoA-1 levels significantly more than non-exercisers. 
Lipoprotein particles are only atherogenic when they contain apoB and this apolipoprotein 
enhances the retention of the lipoprotein particle in the subendothelial matrix due to its 
affinity for the artery wall proteoglycans (Skalen et al, 2002). Therefore if significantly 
lower levels apoB had been seen with exercise reduced CVD risk would be conferred. 
Similarly if apoal was increased significantly more in the diet & exercise group CVD risk 
would be reduced as this apolipoprotein particle is involved in reverse transport pathway 
which is responsible for the transport of cholesterol from peripheral tissues to the liver.
No between group differences were seen in lipids and the non-compliance to exercise 
which is likely to have led to smaller than anticipated differences in exercise between the 
groups may have partially responsible for this (see 3.4.2). However the review of the 
effects of reduced carbohydrate diets with exercise in Chapter 6 concluded there were no 
significant additive effects of exercise, when combined with a reduced carbohydrate diet, 
on lipids (total cholesterol, HDL-cholesterol, LDL-cholesterol and TAG). Thus, the lack of
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between group differences may be because exercise at a moderate level does not induce 
changes in lipids beyond those induced as a consequence of the low carbohydrate weight 
loss diet followed.
3.4.1.7 Fibrinogen
The evidence of the effects of exercise on fibrinogen levels is inconsistent at present with 
insufficient intervention studies of high enough quality to draw conclusions as to any 
associations. However cross sectional studies have shown the acute effects of exercise to be 
an increase in fibrinolytic activity (BNF, 2003). Therefore the increase in fibrinogen 
observed in the diet & exercise group may be a result of stimulated fibrinolytic activity 
from the previous exercise session. In contrast fibrinogen levels decreased in the diet only 
group. There is also a lack of evidence of the effects of LCD on fibrinogen levels although 
this study suggests there may be a trend towards a reduction in this marker of haemostasis 
with adherence to a LCD, an effect which is inverted for LCD to reduce this marker with 
the addition of exercise. However the changes seen within or between groups were not 
significant so further investigation is warranted.
3.4.1.8 Inflammatory markers
No significant changes in CRP, vWF or TNF-a were observed from baseline to 6 months in 
subjects following a LCD with or without exercise. Reductions in CRP have been reported 
elsewhere, (Brinkworth et al, 2004; Due et al, 2005; Wood, 2006; Seshadri et al, 2004) 
when subjects follow a LCD. However these changes were modest in the study by Seshadri 
et al, (2004) and non significant in the study by Due et al, (2005). Therefore significant 
changes in CRP are not seen in all LCD interventions. The subjects in the current study 
following a LCD without exercise had a mean increase in CRP which is unexpected as 
inflammatory markers have been seen to decrease when a LCD is followed. However none 
of the aforementioned studies have an all male sample so are not directly comparable to this 
study.
Subjects in the diet & exercise group had a decrease in CRP levels over the study period. 
Physical activity has been shown to be associated with lower levels of CRP, (Pitsavos et al, 
2005; Plaisance and Grandjean, 2006) therefore the direction of this change is as predicted. 
Although there were no significant within group changes in CRP the difference in the 
change in CRP over the study was significantly different between groups thus suggesting a
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LCD with an exercise programme has a more positive effect on the inflammatory marker 
CRP than a LCD alone.
Changes in vWF and TNF-a were very similar in the diet and the diet & exercise group 
over the 6 month study. An association has been reported between increased physical 
activity and lower levels of TNF-a, (Pitsavos et al, 2005; Wood, 2006) but no evidence on 
the effects of a similar exercise intervention on vWF could be found to allow comparison of 
the results in this study. No within or between group differences were seen in vWF and 
TNF-a. There was a wide degree of variation in the changes in inflammatory markers and 
this may have affected results.
3.4.1.9 Renal function
Despite concerns over the effects of a LCD, (with a potentially increased protein intake), on 
renal function no detrimental effects were seen in subjects following this diet over 6 
months. Similarly no detrimental effects on renal function were observed in our previous 
work where Cystatin C was used as a marker of glomerular filtration rate (GFR) over a 6 
month study period. An advisory statement written by The American Heart Association in 
2001 (St Jeor et al) concluded that high protein diets could lead to potential renal 
abnormalities. Absolute protein intake did not increase significantly in this study or 
previous research (Boley et al, 2004). Hence the warnings of potential renal abnormalities 
may be exaggerated for most individuals following this type of diet. Even if some 
individuals were to increase their protein intake substantially, the evidence that this may be 
a risk to renal function in healthy individuals is weak (Millward, 1999). Skov et al, (1999^) 
compared the effects of a high and low protein diet given for 6 months on parameters of 
kidney function; GFR, kidney volume and renal biochemistry. GFR increased significantly 
after 6 months on a high protein diet with comparative changes in kidney volume 
suggesting that renal function adapts to changes in protein intake. Therefore a high protein 
intake (current safe upper limit = 1.5g/kg body weight) does not appear to have detrimental 
effects on renal function where renal function is initially not compromised. For patients 
with renal disease it has been reported that high protein intakes can lead to renal function 
deterioration by inducing glomerular hyperfiltration (Wiseman et al, 1987).
128
3.4.2 Exercise levels throughout the study
Based on self completed exercise logs 63% of subjects in the diet & exercise group were 
successful in increasing their activity levels over a 6 months period. PAR values were 
significantly increased in this group which is an accomplishment in previously sedentary 
individuals.
Nevertheless a high number of participants in the diet & exercise group (37%) did not 
comply with instructions to increase activity from baseline.
In order to investigate the added effects of exercise with a LCD it was essential this study 
was set up as a randomised design with half of subjects asked not to increase exercise 
levels and half asked to follow specific instructions regarding exercise. However, in free 
living adults it is notoriously difficult to achieve high compliance levels with lifestyle 
changes such as this. Compliance to exercise instructions is discussed further in Chapter 4.
Activity diaries re-enforced the information gathered by exercise logs, showing that an 
increase in activity levels was achieved in the majority of subjects in the diet & exercise 
group. Less time was spent asleep or in light activity at 6 months compared to baseline and 
more time was spent in moderate or vigorous activity. A significant increase in time spent 
asleep or in light activity and a significant decrease in time spent in moderate or vigorous 
activity in the diet group suggests that the self-reported compliance of 86% of subjects in 
this group not to increase activity levels to be an accurate reflection of actual levels. 
Activity diaries were completed for 7 days at baseline and 6 months only therefore provide 
a ‘snapshot’ of activity levels before the study began and at the end of the study but do not 
show levels of activity between these timepoints.
Activity levels were increased in the diet & exercise group and were not increased in the 
diet only group over the course of the study. However there were no significant differences 
in activity levels between groups. This could have been attributable to the high levels of 
non-compliance to exercise instructions in both groups. In addition, activity diaries were 
not returned by all subjects hence lower numbers were available for analysis than planned. 
High levels of between subject variability in activity levels may also have attributed to the 
lack of significant changes in activity levels in the diet & exercise group and no significant 
differences in the changes in activity levels between groups.
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3.4.3 Changes in fitness
The impact of the exercise intervention on fitness levels is demonstrated by the significant 
increase in fitness from baseline to 6 months in the diet & exercise group whilst no 
significant change occurred in the diet only group. It is likely that those participants in the 
diet & exercise group who engaged in increased activity increased their cardiorespiratory 
fitness as a result and were thus able to exercise for longer during the ATT at 6 months 
compared to baseline. The physiological measurement of fitness confirms that the self 
reported information, (physical activity diaries and exercise logs) provided by subjects can 
be relied upon.
No significant differences in change in fitness were evident between the diet and the diet & 
exercise groups. This is likely to be partly due to subjects in both groups failing to comply 
with exercise instructions resulting in a smaller than expected difference in activity between 
groups. A wide variety of activity types were employed by subjects with eight different 
methods used. This is likely to have led to variability in the change in fitness levels and 
may also have affected fitness levels in the diet & exercise group. Although the population 
in this study was sedentary as a whole at baseline there were variations in activity levels 
between subjects. Therefore the increase in exercise achieved varied depending on baseline 
levels of each subject and this may have affected fitness results. It would have been 
extremely difficult to completely standardise the amount of activity being carried out by all 
individuals at baseline in free living volunteers such as these.
The sensitivity of the fitness test (ATT) to detect relatively small changes in fitness was 
considered. However when this method of fitness testing was evaluated by Church et al, 
(2001) it was concluded to be, ‘a reproducible and valid measure of submaximal work 
capacity that can serve as an effective means to evaluate physical activity interventions’ (p 
1770) and a test-retest reliability of 0.85 (P<0.001) was reported. In this study (Church et 
al, 2001) a significant increase in fitness was reported after a 6 month physical activity 
intervention. However no details of the intervention were provided in order that the activity 
can be compared to the current study. A submaximal cycle ergometer exercise test was also 
used in the HERITAGE family study and the authors, Wilmore et al, (1998) reported it to 
have a good reproducibility with coefficient of variation of below 9%. Stevens and Sykes, 
(1996) provided an update in aerobic fitness testing and concluded that although 
submaximal exercise tests are less precise than maximal testing they allow a reasonably
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accurate measurement of fitness without the deleterious effects of discomfort and risk to 
subjects or the cost and time implications associations with maximal exercise tests. A 
maximal VO2 uptake test may have lead to increased withdrawals due to the discomfort 
caused and would not have been appropriate in the sedentary population of the current 
study as these individuals would be unlikely to exercise at maximal exertion levels 
throughout the intervention (Church et al, 2001). Although there is limited evidence on the 
use of the submaximal ATT to detect changes in fitness after different levels of activity 
intervention it remains an appropriate method of evaluating fitness in a sedentary 
overweight group of subjects.
Exercise performance can be affected by weight and diet. However no associations were 
seen between fitness and weight, energy or macronutrient Intake suggesting fitness test 
results were not significantly affected by these potentially confounding variables.
It is noted that use of an exercise bike was the most popular means of exercising by 
subjects during the study. As the fitness test used employed the use of a stationary bike it is 
possible those subjects who were regularly using this method of exercise would respond 
differently to repeated fitness tests than those who used other types of exercise.
The most substantial increase in fitness in the diet & exercise group occurred between 2 
and 4 months and after 4 months a decline in fitness was seen. This may be due to missing 
data at 4 months as 4 subjects did not attend this appointment but returned for 6 month 
measurements to be taken. As 3 of these 4 subjects had a lower than average fitness levels 
at 6 months a greater rise in fitness between 2 and 4 months and a decline in fitness 
between 4 and 6 months would be expected as a result of this missing data.
3.4.4 Compliance with the LCD
Compliance with the LCD was assessed using the diet diaries which all subjects were asked 
to keep. As under-reporting of food intake is a known potential bias, especially in 
overweight individuals, (Livingstone and Black, 2003; Johnson et al, 1994; Price et 
a/., 1997), the validity of the diet diaries at baseline was first assessed using reported energy 
intake. Subjects were not currently losing weight, (as specified in exclusion criteria), 
therefore their energy intake would be expected to equal energy expenditure. However 
body weight was not measured at the end of the 7-day period of recording food intake thus 
it is not possible to determine with certainty if weight loss had occurred in any individuals.
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Forty-six percent of subjects had physiologically implausible energy intakes suggesting 
under-reporting or under-eating at baseline. Excluding data from all subjects with a low 
energy intake can introduce further bias (Livingstone and Black, 2003) therefore the data 
from all available diaries was used with energy intake analysis also being conducted using 
plausible reporters only to allow comparison of the two datasets.
Energy intake was reduced more substantially in plausible reporters as compared to the data 
from all subjects. It could be postulated that those subjects who complied with instructions 
to complete diet diaries accurately were the most motivated and therefore reduced their 
energy intake more substantially than those subjects who reported a low energy intake.
Although the differences in rEI between plausible and non-plausible reporters are of 
concern analysing data from only the plausible reporters increases variability due to small 
subject numbers. Therefore analysis of the remaining nutrient data used all available data 
but interpretation of this data considered the implications of under-reporting and the 
limitations of dietary information gathered.
Mean energy intake of the whole cohort was reduced on average by 3479 KJ /day from 
baseline to an energy intake of 7329 KJ at 6 months. An energy deficit of 32.2 MJ is 
needed for each kg of body weight loss (Hall, 2007) therefore this energy deficit would be 
expected to produce a weight loss of 0.76 kg per week or 19.8 kg over the 6 month study. 
The actual mean weight loss recorded (8.2 kg) is considerably lower than this. This 
discrepancy may be due to dietary energy intake at 6 months being under-reported or the 
energy intake reported while food diaries were kept not being a true reflection of energy 
intake over the whole study period.
There were no significant differences in reported energy intake in subjects in the diet and 
diet & exercise group indicating exercise levels did not affect the amount of energy 
consumed.
Reported carbohydrate intake at 6 months allows compliance to the LCD to be assessed. 
Mean carbohydrate intake at this point was 66.7 g per day. Subjects who had not reached 
their target weight were advised to consume no more than 60g of carbohydrate a day while 
up to lOOg a day was advocated for subjects maintaining their weight. Fifty-seven percent 
of subjects were keeping their carbohydrate intake below the level they were recommended 
at 6 months according to their diet diaries. Therefore 43% of subjects were not complying
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with the LCD based on self-reported intakes. This level of compliance to reducing 
carbohydrate intake is comparable to levels reported by Westman et al, (2002) in the 
overweight and obese subjects on a LCD for 6 months. Sixty-six percent of subjects 
reported following dietary recommendations every day at 2 weeks. This decreased to 61% 
at 12 weeks and 37% at 24 weeks. Despite LCDs being used in many other studies 
surprisingly the authors do not always report if subjects did indeed adhere to the LCD being 
investigated. Dansinger et al, (2005) concludes in reference to the Atkins diet and 3 other 
diets tested that, ‘no single diet produced satisfactory adherence rates’ (p50). Indeed 
carbohydrate intake from 3 day diet records shows the mean carbohydrate intake of 
subjects exceeded recommendations throughout this study.
3.4.5. Nutritional quality & adequacy
Following a LCD not only affects the amount of carbohydrate consumed but has 
implications on overall nutritional content of the diet. Absolute intake of total fat, SFA, 
MUFA and PUFA did not change significantly therefore the concerns that saturated fat 
intake is increased with LCDs (Council on Foods and Nutrition, 1973; Crowe, 2005) appear 
to be unfounded. However, where as more traditional, (low fat, restricted energy) weight 
loss diets would generally lead to fat intake being reduced below guideline recommended 
amounts for the UK populations (95g / day for men) fat intake remained above this level 
(107.5g/ day) at 6 months in this study.
An investigation into the relationship between intake of refined carbohydrate and 
wholegrain foods in relation to CHD and type 2 diabetes by Liu et al, (2002) concluded, 
‘Recent epidemiological data indicate high-fibre whole grains are associated with lower 
risk of CHD’ (p298). Therefore the NSP intake of subjects in this study, which was already 
low at baseline, and decreased to less than 50% of the recommended intake for UK adults 
after being on a LCD for 6 months is of concern. Fibre intake measures poorly on LCD 
compared to conventional low fat diets. Brehm et al, (2003) reported a significantly lower 
intake of fibre compared to a calorie restricted low fat diet in a 6 month randomized trial. 
This may have consequences beyond the CVD risk which is the focus of this study as 
associations between dietary glycaemic index and the incidence of colorectal cancer have 
been seen (Franceschi et al ,2001). The authors found being overweight and having a low 
intake of fibre from vegetables and fruit appeared to increase the negative effect of a high 
glycaemic load.
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Following a LCD led to a significant increase in selenium and iodine which can be 
explained by the food sources of these being low in carbohydrate, (brazil nuts, meat, fish 
and eggs and seafood respectively). A significant decrease in many more nutrients was seen 
though, namely folate, calcium, magnesium, iron, zinc and copper which were all below 
recommended nutrient intakes at 6 months. These are mostly nutrients previously identified 
as being low when LCDs are followed (Freedman and Kennedy, 2001). Low intakes of 
these nutrients for any length of time could have far-reaching effects on health.
In addition to the changes in macro and micronutrients seen when a LCD is followed, 
reducing carbohydrates inevitably results in lower intakes of compounds which have been 
linked to protecting against cancer, (antioxidants, flavonoids, phenols and isothiocyanates) 
as fruit and vegetables are rich sources of these. Indeed fruit and vegetables have been 
implicated in having a protective effect on all the major cancers (Cummings, 1998).
The LCD used in this study was modified to try to encourage subjects to consume a diet 
which was as nutrient dense as possible whilst being low in carbohydrate and a wide 
variety of lower carbohydrate fruit and vegetables were suggested. Therefore the low 
nutritional quality of the diet being consumed and the effects this may have on CVD and 
many other health outcomes is especially concerning as most individuals following a LCD 
would not have the advice of a dietitian to assist them.
Subjects in this study were given a multivitamin and multimineral supplement to prevent 
deficiencies of any micronutrient but this can not compensate for the other positive 
compounds found within carbohydrate rich foods.
No between group differences in macronutrients were apparent suggesting subjects did not 
alter the composition of their diet as a result of increasing activity levels.
3.4.6 Attrition
Twenty percent of the 56 subjects who started the study withdrew before 6 months with ‘no 
longer wishing to diet’ being the most common reason given.
Comparable attrition rates have been seen elsewhere with a 20% attrition rate in subjects 
following a very low carbohydrate diet for 6 months in the study by Westman et al, (2002). 
Brehm et al, (2003) reported that 21% of women following either a very low carbohydrate
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or a low fat calorie restricted diet withdrew by 6 months. In this study fewer subjects 
withdrew from the LCD group compared to the low fat group.
In the current study only two subjects withdrew as a result of being unable to tolerate the 
LCD with both of these individuals being in the diet only group. There has previously been 
concern that LCD would lead to impairment to exercise, (Bilsborough and Crowe, 2003) 
and this decrease in ability and activity could lead to a decrease in performance or 
withdrawal from an exercise program (Butki et al, 2003). If this had been the case in the 
present study it would be expected subjects would have withdrawn from the diet & exercise 
group as a consequence of being unable to tolerate the LCD whilst exercising. In reality 
fewer subjects (n=5) withdrew from the diet & exercise group compared to the diet only 
group (n=6).
This apparent ability to exercise whilst following a LCD may be explained by the intensity 
of exercise being conducted. Miller and Wolfe, (1999) explained the percentage of fat and 
carbohydrate consumed has little effect on exercise performance at exercise intensities 
below 65% VO2 max providing sufficient time is given to a adapt to a high fat diet. As 
subjects were advised to exercise at 50-70% VO2 max and were instructed not to begin 
their exercise regimen for the first 2 weeks of the LCD their ability to exercise may have 
been unaffected as fat oxidation made the prominent contribution to energy utilisation.
It has been noted that many subjects did not comply with instructions to exercise at a 
moderate intensity and exceeded this heart rate range whilst exercising. Despite this, 
difficulty in exercising was not reported by any subject to the researcher and the levels of 
attrition in this group suggest exercise was not a negative experience whilst following the 
LCD.
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3.4.7 Limitations
The main limitation of this study is that the target difference in the primary outcome 
measure, fasting insulin was not achieved between the diet and diet & exercise group. This 
difference in insulin may have been an unrealistic level to set as the control group in this 
study was also an intervention group with subjects following a LCD. Decreases in insulin 
were predicted in this group so perhaps then the target difference should have been smaller 
than 40 pmol/l. However when this study was designed no interventions investigating the 
effects of a LCD with exercise, (other than very short term) had been published therefore 
the only information available at the time was used in the manner thought most appropriate 
for this study.
Although the degree of non-compliance to exercise instructions seen was not greater than 
that seen in previous studies it did make it difficult to determine if measured parameters 
were affected by the addition of exercise to a LCD. This limitation is discussed further in 
Chapter 4.
Under-reporting of energy intake at baseline was identified to be an issue. However 
limitations exist in all methods of assessing dietary intake due to the potential for mis- 
reporting and also variability of food intake in any individual over time. The food intake 
data gathered in this study can still be of use in indicating macro and micronutrient intake 
while following the LCD but caution is used in its interpretation at a group level.
Exercise logs, kept by the diet & exercise group, provided vital information which allowed 
monitoring of activity levels during the study. It may have been of further benefit if the 
participants in the diet group had also been asked to keep exercise logs. However the 
decision not to do this was made as it was felt that this additional recording may have 
contaminated the diet only group by highlighting that activity levels were being monitored.
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3.4.8 Future work
Dissemination of results will continue with the results from this study being written up for 
an external, peer reviewed publication. In addition results will be presented at relevant 
conferences such as The Nutrition Society Summer Meeting, 2008.
As the subjects in this study were all male and the majority were ‘middle-aged’ further 
exploration of these findings could involve looking at the effects of a LCD with and 
without exercise in different population groups, particularly where difficulties with 
‘traditional’ weight loss approaches have been identified.
An investigation of the effects of a LCD combined with a higher amount of exercise on 
CVD risk would allow comparison of a different level of exercise. Conducting this over a 
shorter study period may help to ensure compliance is not deleteriously affected.
The changes in body composition when a LCD is combined with exercise could be 
examined in more detail by measuring the distribution of body fat and how it changes.
This study has focused on aerobic exercise but the effects of resistance exercise combined 
with a LCD would also be of interest.
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3.4.9 Conclusion
This study demonstrates that LCDs are a safe and effective strategy for weight loss in 
overweight and obese men. The only concern highlighted from these results is the 
nutritional adequacy and quality of a LCD. However as the ‘normal’ diet of many 
individuals is not nutritionally balanced the advantages of following a LCD for a limited 
period, i.e. achievement of a lower body weight and lower CVD risk, may outweigh these 
potential disadvantages.
Considerable variation in weight loss success has been demonstrated across individuals in 
this study. This shows the very different responses to a weight loss diet and illustrates the 
importance of individuals following the diet most appropriate for them. Many people have 
failed to lose weight on traditional low fat diets and may have more success using a LCD. 
Men in particular seem to find the LCD an easy to use and enjoyable method to lose 
weight.
The evidence from this study shows a LCD should be included as one option for 
overweight and obese men wishing to lose weight and perhaps those organisations and 
professionals who currently do not recommend the use of LCDs may need to be reconsider 
their advice on the basis of this and other recent evidence.
The lack of evidence for the added beneficial effects of exercise suggests that emphasis 
should be placed on ensuring individuals are following a LCD appropriately with more 
encouragement to exercise given once the diet has been initiated. The importance of 
exercise in maintaining weight loss and overall health and wellbeing as well as the 
réintroduction of nutrient dense carbohydrate are crucial points to emphasis to any 
individual following this type of regimen.
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4. Continued investigation of the effects of a low carbohydrate weight loss regimen, 
with and without the additive effects of exercise, on cardiovascular risk factors in 
overweight and obese men: movers versus non-movers
4.1 Introduction
4.1.1 Background
The study described in Chapter 3 was primarily designed to examine the relative benefits of 
additional regular exercise on CVD risk whilst following a LCD. Due to the extensive 
monitoring and surveillance of participants undertaken during this study, it was clear that 
not all subjects completed the exercise recommendations to the full and also that some ‘diet 
only’ subjects decided to engage in additional physical activity. This chapter explores 
compliance to exercise instructions and further examines the relative benefits of additional 
exercise by re-grouping subjects on the basis of their compliance to exercise 
recommendations.
Compliance in exercise interventions is notoriously low (Kamiya et al, 1995; Westman et 
al, 2002). Despite this, intervention studies investigating a reduced carbohydrate diet with 
and without exercise (Layman et al, 2005; Meckling and Sherfey, 2007) have often not 
reported the levels of compliance to the exercise intervention or discussed the issue of 
compliance.
However compliance to any intervention is vital and has an impact on the changes in 
measured outcomes. Measuring compliance allows the investigator to determine if the 
predicted differences in dependant variables between groups were achieved and this 
information can then be used when interpreting results.
Therefore this chapter reports the level of compliance to the exercise instructions which 
were given to subjects in the LCD and exercise intervention described previously (Chapter 
3) and presents further analysis of the data collected utilising this information.
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4.1.2 Aim
• To investigate the effects on CVD risk factors of subjects following a LCD who 
reported to increase their activity levels from baseline (the movers) compared to 
those who reported they had not increased activity (non-movers).
4.1.3 Hypothesis
• A significantly greater reduction in CVD risk factors will be seen in those subjects 
who reported to increase their activity levels from baseline compared to those who 
reported not to increase activity.
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4.2 Methodology
The study design and parameters measured are described in section 3.2. This data was then 
handled in the following manner.
4.2.1 Assessment of compliance
The level of compliance to the exercise instructions given were assessed by exercise logs in 
the diet & exercise group and self reported exercise in the diet group. Subjects in the diet 
group were asked at each appointment to report their exercise levels over the previous two 
months. A subject in this group was deemed to be compliant when no increase in the 
number, frequency or intensity of exercise over the 6 month study period was reported. The 
diet & exercise group recorded the type, frequency, length and intensity of exercise. 
Subjects were given specific instructions regarding the frequency, intensity and length of 
exercise and they were said to be compliant if 2 of these 3 recommendations were met over 
any 2 month period. If a subject was compliant at each of the 3 time periods, (baseline to 2 
months, 2 to 4 months and 4 to 6 months) they were reported as compliant to the exercise 
instructions overall.
4.2.2 Re-grouping of subjects using reported exercise levels
If subjects increased their exercise levels from baseline they were allocated to the ‘movers’ 
group and if they did not increase exercise levels from baseline they were allocated to the 
‘non-movers’ group as illustrated in Figure 4.1. Analysis was then conducted using these 
new groups to determine if parameters were affected differently.
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Compilers
M aintained  
baseline exercise  
levels  
n=18
Non-compilers
Did not m eet 
exercise  
recom m endations  
n=10
Non-compilers
Increased  
exercise levels 
from baseline  
n=3
Compilers
M et exercise  
recom m endations
n=14
Com pleters= 21
Diet Group
Com pleters = 24
Diet & Exercise  
Group
M overs
n= 17
Non-m overs
n= 28
Figure 4.1 Flow diagram illustrating how subjects were re-grouped into ‘movers’ and 
‘non-movers’ based on tbeir reported exercise levels throughout the 6 month study.
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4.2.3 Statistical analysis
Descriptive statistics were used to describe the study population. All data was assessed for 
normality of distribution using the Kolmogorov-Smimov Z samples test.
A completers analysis compared the changes in measured parameters in subjects who 
successfully increased their activity levels from baseline, the ‘movers’ (n=17) to those 
whose activity levels remained unaltered from baseline, the ‘non-movers’ (n=28).
Paired t tests were used to investigate the effects on measured parameters within each 
group.
In order to test the hypothesis that those subjects who reported to increase activity levels 
from baseline will have a significantly greater reduction in CVD risk factors compared to 
those who reported not to increase activity between group differences in changes in 
parameters were explored. Where measurements were taken at more than 2 timepoints 
repeated measures ANOVA was used to investigate these changes over the study period. 
Independent t tests were used to investigate changes between baseline and 6 months.
Pearsons correlation analysis was used to investigate the direction and strength of 
relationship between variables
A P Value of 0.05 was considered statistically significant. Analyses were performed using 
SPSS, version 12 for windows.
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4.3 Results
4.3.1 Compliance to exercise instructions
Eighty-six percent of subjects in the diet group complied with instructions not to alter their 
exercise levels over the course of the study (Figure 4.2). Fewer subjects (63%) in the diet & 
exercise group complied with instructions to increase their exercise levels from baseline 
(Figure 4.3).
14%
□1 C o m p lia n t  
a N o n  c o m p lia n t
86%
Figure 4.2 Percentage of subjects in the diet group who were compliant to instructions 
not to increase their exercise levels
37%
■  C o m p lia n t  
□  N on  c o m p lia n t
63%
Figure 4.3 Percentage of subjects in the diet & exercise group who were compliant to 
instructions to increase exercise levels
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4.3.2 Analysis after re grouping subjects into ‘movers’ and ‘non movers’
A comparative analysis of those subjects who reported to increase their activity from 
baseline, the ‘movers’ and those who reported not to increase their activity, the ‘non­
movers’ allowed any differences in the changes in CVD risk markers between groups to be 
determined.
4.3.3 Baseline characteristics of ‘movers’ and ‘non-movers’
The baseline characteristics of subjects were compared after allocation to new groups, 
‘movers’ and ‘non-movers’. There was a significant difference in fitness levels (as defined 
by final wattage) and TAGs at baseline between the two groups, (P=0.014, /=-2.152 & 
f =0.010, t=-2.69 respectively). Appropriate analyses were conducted in view of these 
differences. There were no significant differences between the movers and non-movers in 
baseline values of any other measured parameter.
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4.3.4 Activity
The data collected in activity diaries was used to determine if those subjects who reported 
to be ‘movers’ increased their overall activity and the subjects who reported not to have 
changed their activity were indeed non-movers.
The changes in time spent in activity of different levels at baseline and 6 months in each 
group can be seen in Figure 4.4 below. The amount of time spent in light (1.5 MFT) 
activity increased from 706.73 [75.23] minutes per day at baseline to 721 [72.21] at 6 
months in subjects in the movers group where as in the non movers group the amount of 
time spent in light activity decreased between these time periods, (705.57 [85.82] to 677 
[130.12] minutes per day). However the non-movers group increased the amount of time 
spent in light (3.0 MFT) activity during the study period where as the movers decreased the 
amount of time spent in this activity level. None of the changes within groups were 
significant. A comparison of activity levels (MFT values) was conducted (see Figure 4.4) 
and this shows there were no significant differences between the groups.
■ Movers Baseline 
(n=11)
■ Movers 6 months 
(n=11)
□ Non-movers Baseline 
(n=14)
a Non-movers 6 months 
(n=14)
Asleep Light (1 .5 ) L ight(2.0) Light (2 .5 ) Light (3 .0 ) M oderate  Vigourous  
(0 .95 ) (4 .0 ) (7 .0 )
Activity Level (MET)
Figure 4.4 Time spent in each activity level in the movers and non movers group at 
baseline and 6 months
Error bars represent standard error of the mean (SEM).
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In order to analyse the changes in activity levels further, the time spent asleep and in light 
activity of all categories was summed as was the time spent in moderate and vigorous 
activity.
As would be expected in subjects who reported to increase their activity levels, (movers 
group) a decrease in time spent asleep or in light activity and an increase in time spent in 
moderate or vigorous activity was seen from baseline to 6 months (Table 4.1). These 
changes were not significant. In the non movers group a non-significant increase in time 
spent asleep or in light activity was seen over the study period. The change in time spent in 
moderate and vigorous activity decreased non-significantly from baseline to 6 months.
Independent t tests showed no significant differences in the change in combined activity 
levels from baseline to 6 months between groups.
Table 4.1 Change in summed activity levels in the movers and non-movers group from 
baseline to 6 months
Change in time spent (minutes) 
in activity levels per day from baseline to 6 months
Asleep and Light Moderate and Vigorous
Movers Group -2.09 [43.91] 4.0 [30.64]
(n=ll)
Non-Movers Group 8.85 [15.87] -11.10 [17.62]
(n=13)
Mean [SD]
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4.3.5. Fitness
4.3.5.1 Change in fitness assessed by final wattage achieved.
Fitness, as measured by the change in final wattage during the ATT (Figure 4.5), was 
147.44 [21.45] watts at baseline in the movers, increasing (NS) to 153.67 [21.34] watts at 6 
months. The only significant change in fitness in the movers group was a significant 
increase in fitness between 2 and 4 months (P=0.040, r=-2.28). Fitness levels increased 
significantly over the study period in the non-movers group from [121.67 [43.17] watts at 
baseline to 128.27 [39.85] watts at 6 months (P=0.036, r=-2.22). The change in fitness 
between baseline and 4 months was also significant in the non-movers group, (P=0.043, r=- 
2.16).
Baseline fitness levels, as assessed by final wattage, were significantly different in the 
movers and non-movers group ( f =0.014, r=-2.152) therefore a repeated measures 
ANCOVA was conducted with baseline fitness as a co-variant. No significant differences 
in changes between groups were found.
Movers
■ Non 
movers
g, 140
7= 130
100
Time (months)
Figure 4.5 Fitness levels, as assessed by final wattage, in the movers and the non­
movers group throughout the study.
Error bars represent standard error of the mean (SEM).
Repeated measures ANCOVA showed no significant differences in changes between groups 
Results from Paired t tests within groups; Value significantly different from baseline {P <0.05); value 
significantly different from 2 months (*P =0.040)
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4.3.S.2 Change in fitness as defined by heart rate recovery from the aerobic c 
adaptation test
HRR was calculated as the difference in heart rate (HR) of subjects at the end of the ATT 
compared to 2 minutes post test. Therefore HRR results presented are the difference 
between heart rates at these time-points. It would be expected that HRR would improve 
with increased fitness thereby a smaller increase in HR would be seen over time.
The changes in HRR in the movers and the non movers group are shown in Figure 4.6. 
HRR decreased from 7.31 [3.82] beats per min at baseline in the movers group to 6.79 
[4.00] at 6 months but increased from 4.88 [5.57] beats per min in the non-movers group at 
baseline to 7.22 [3.02] at 6 month study. These changes in HRR over time within groups 
were not significant. Repeated measures ANOVA found no group effects.
10
tf> (0
Movers
Non Movers
Time (m onths)
Figure 4.6 Heart rate recovery, in the movers and non-movers groups throughout the 
study.
Error bars represent standard error of the mean (SEM).
Repeated measures ANOVA showed no group differences
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4.3.S.3 Energy intake
The mean reduction in mean daily energy intake at 6 months compared to baseline in each 
group is shown in Figure 4.7. Energy intake at baseline was 10181 kJs [2809] reducing to 
7901 kJs [2162] at 6 months in the non movers. A greater decrease in energy intake from 
baseline (10639 kJs [2072]) to 6 months (6706 kJs [2214]) was seen in the movers. The 
changes in energy intake within groups were significant (movers; P=0.001, t=3.95, non­
movers; P=0.011, t=3.03). The difference in the change in energy intake between groups 
was not significant.
Movers (n=11) Non-Movers (n=12)
-1000
« -2000
-3000
E -4000
-5000
-6000
Group
Figure 4.7 Change in daily energy intake in the movers and non-movers group over 
the study period in all completers
Error bars represent standard error of the mean (SEM)
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4.3.S.4 Macronutrient intake
Carbohydrate intake was significantly reduced from baseline to 6 months in both the 
movers and non movers (Table 4.2). Protein intake was significantly increased and alcohol 
intake was significantly decreased over the study period in the movers only. There were no 
significant differences in the change in any macronutrient from baseline to 6 months 
between groups.
Table 4.2 Macronutrient and alcohol intake for the movers and non-movers at 
baseline and 6 months
Fat (g) CHO (g) Protein (g) Alcohol (g)
Baseline Movers 107.7 243.7 92.6 40.9
(n=14) [32] [105.7] [13.8] [31.4]
Non 104.2 238.1 105.8 25.0
Movers [31.9] [79] [34] [23.3]
(n=20)
6 Months Movers 102 4V 112.6* 13.2*
(n=ll) [43.6] [24.6] [26.4] [13.9]
Non 112.6 90.2* 115.5 11.8
Movers [38.3] [69.4] [25.8] [11.7]
(n=12)
Mean [SD]
CHO-carbohydrate
Paired t tests show significant differences from baseline within groups;* (P=0.001, /=5.59);  ^ (P<0.001, 
r=5.87);  ^ (P=0.017, r=-2.86); *(P=0.009, r=3.23)
A greater proportion of movers (73%) consumed carbohydrate at the level they were 
instructed at 6 months compared to non movers (42%).
4.3.6. Changes in measured parameters
In order to investigate if subjects who reported to have increased their activity levels had a 
significantly greater reduction in CVD risk factors compared to those who reported not to 
increase their activity an analysis comparing the results of subjects in the new groups, 
movers and non-movers, was undertaken. All analysis of the re-grouped subjects was 
carried out on a completer’s dataset.
All available blood samples were analysed from completed subjects and all blood results 
are reported in this analysis.
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4.3.6.I. Insulin
Fasting insulin levels were significantly reduced between baseline and 6 months, (P=0.020, 
r=2.60) and baseline and 4 months, (P=0.034, r=2.41) in the movers group (Table 4.3). 
Insulin levels increased (NS) over the study period in the non-movers group. An 
independent t test showed a significant difference in the change in insulin from baseline to 
6 months between groups (P=0.006, t=2.9\). Repeated measures ANOVA found no 
significant differences in the changes in insulin between groups (P=0.059,/=2.562).
Table 4.3 Mean insulin levels in the movers and non-movers throughout the study
Insulin
(pmol/1)
Baseline 2 Months 4 Months 6 Months
Mean [SD]
Movers
(n=16)
87.74 [61.06] 70.64 [62.17] 58’ [40.75] 66.04* [61.15]
Non-
Movers
(n=27)
66.79 [43] 60.35 [56.80] 66.53 [46.26] 74.77 [56.05]
Mean [SD]
Paired t tests show significant differences from baseline within group;* (P=0.020, r=2.60), * (P=0.034, t=2.4I)
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4.3.6.2 Weight changes
A greater weight loss was achieved in the movers group from baseline to 6 months, (-10.20 
kg [7.16] (f<0.001, t=5.88) compared to the non movers group (-6.99 kg [4.48] (?<0.001, 
t=8.26). The rates of weight loss over time in each group are illustrated in Figure 4.8. 
Repeated measures ANOVA showed a significant effect of group, (P=0.013, /=5.522) 
therefore the weight loss achieved by subjects in the movers group was significantly greater 
than that of the non-movers group.
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Figure 4.8 Mean absolute weight loss of subjects in the movers and non-movers group 
throughout the 6 month study period showing the rate of weight loss over time.
Error bars represent standard error of the mean (SEM).
Repeated measures ANOVA showed a significant effect o f group, (F=0.013,/=5.522).
Results from Paired t tests within groups; value significantly different from baseline 6^T<0.001, r=5.88, P 
<0.001, t=S.26)', value significantly different from 2 months ( P<0.001, r=8.17, P=0.004, r=l 1.43); value 
significantly different from 4 months ( ' P  <0.001,1=8.83, P<0.001, 1=10.02)
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4.3.6.3 Body composition
The changes in body composition over time in the movers and the non-movers group can 
be seen in Figure 4.9. Body composition changed positively over the study period with a 
significant decrease in fat mass in both the movers, (F<0.001, /=7.01) and the non-movers 
(F<0.001, r=6.16) group. Significant changes in body composition were seen within each 
group and are indicated in Figure 4.9. Repeated measures ANOVA showed body fat mass 
decreased significantly more over the study period in the movers, (-7.82kg [4.32]) than the 
non movers (-4.43 kg [3.81]), (F=0.011,/=4.89). No significant differences in the changes 
in lean body mass or water mass were seen between groups (repeated measures ANOVA).
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Figure 4.9 Change in body composition over the study period in the movers and non­
movers groups
Repeated measures ANOVA showed a significant effect of group in absolute fat mass, (P=0.011,7^4.89) but 
not lean body mass or water mass.
Paired t tests show significant difference within groups; value significantly different from baseline within 
group and parameter; movers* non-movers ?<0.001; movers , non-movers' P<0.05; value significantly 
different from 4 months within group and parameter; movers , non-movers P<0.05
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4.3.6.4 Anthropometric changes
BMI decreased by a greater amount in the movers group (-3.21 kg/m^ [2.18], P<0.001) 
compared to the non-movers (-2.2 kg/m^ [1.44], P<0.001) over the 6 month study. 
Repeated measures ANOVA showed a significant effect of group in the change in BMI 
(Figure 4.10).
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Figure 4.10 Mean changes in BMI throughout the study in subjects in the movers and 
non-movers group.
Error bars show standard error of the mean (SEM)
Repeated measures ANOVA found a significant effect of group, (P=0.013, F=5.45)
Paired t tests show significant differences within groups; value significantly different from baseline (movers*, 
non-movers P<0.001); value significantly different from 4 months (movers', non-movers P<0.05)
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Changes in waist and hip circumference and WHR are shown in Table 4.4 below. Waist 
and hip circumference decreased to a greater degree in the movers group compared to the 
non-movers group however a significant effect of group was seen in the change in hip 
circumference only (P=0.024, f=3.15). Due to the larger drop in hip circumference in the 
movers group WHR decreased more in the non-movers group compared to the movers but 
this difference was not significant. Within both groups changes in waist and hip 
circumference and WHR were significant (P<0.05) from baseline to 6 months.
Table 4.4 Change in waist and hip circumference and waist: hip ratio throughout the 
study in the movers and non-movers
Baseline to 2 
months
2 to 4 months 4 to 6 
months
Baseline to 6 
months
Waist
(cm)
Movers -6.02 [3.69] 
(n=17)
-2.4 [2.92] (n=15) -0.8 [3.19] 
(n=15)
-8.78 [5.83] 
(n=17)
Non-
Movers
-5.25 [3.29] 
(n=28)
-2.02 [3.28] 
(n=25)
-0.86 [2.76] 
(n=25)
-7.61 [5.12] 
(n=28)
Hip
(cm)
Movers -3.82 [2.51] 
(n=17)
-1.87 [2.92] 
(n=15)
-0.47 [2.42] 
(n=15)
-5.71 [3.24] 
(n=17)
Non-
Movers
-1.89 [4.08] 
(n=28)
-1.04 [1.86] 
(n=25)
0.38 [2.55] 
(n=25)
-3.05 [3.89] 
(n=28)
WHR Movers -0.02 [0.02] 
(n=17)
0.00 [0.04] 
(n=15)
-0.01 [0.04] 
(n=15)
-0.03 [0.04] 
(n=17)
Non-
Movers
-0.32 [0.05] 
(n=28)
-0.01 [0.04] 
(n=25)
-0.01 [0.04] 
(n=25)
-0.04 [0.05] 
(n=28)
Mean [SD]
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4.3.6.S Blood pressure
Diastolic and systolic blood pressure fell more in subjects in the movers group than the non 
movers group during the first 2 months and over the whole study period (see Table 4.5). 
Repeated measures ANOVA showed a significant effect of group on diastolic, (P=0.002, 
F=5.078) but not systolic blood pressure over the course of the study. Systolic blood 
pressure decreased significantly within both groups between baseline and 6 months, 
(P<0.05) and diastolic blood pressure decreased significantly within the movers only, 
(P<0.05).
Table 4.5 Changes in blood pressure in the movers and non-movers over the study 
period
Baseline to 2 
months
2 to 4 months 4 to 6 
months
Baseline to 6 
months
Systolic Movers -11.47 [11.96] 2.6 [11.01] -4.07 [14.29] -10.53 [13.61]
blood (n=17) (n=15) (n=15) (n=17)
pressure Non- -5.82 [10.89] -2.04 [7.36] 1.28 [8.80] -6.75 [13.03]
(mmHg) Movers (n=28) (n=25) (n=25) (n=28)
Diastolic Movers -9.24 [9.78] -2.60 [10.95] 0.33 [10.0] -10.29 [10.82]
blood (n=17) (n=15) (n=15) (n=17)
pressure Non- -4.79 [6.75] 0.08 [5.27] 1.80 [7.12] -3.18 [9.07]
(mmHg) Movers (n=28) (n=25) (n=25) (n=28)
Mean [SD]
A blood pressure of >140^90 is considered to increase CHD risk
Repeated measures ANOVA showed a significant effect of group on diastolic blood pressure over the course 
of the study, (P=0.002, P=5.078)
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4 3.6.6 Plasma glucose and HOMA
The changes in plasma glucose within each group are shown in Figure 4.11. Glucose 
decreased by -0.62 mmol/1 [2.11] in the movers and -0.03 [0.93] in the non-movers from 
baseline to 6 months, (-0.25 mmol/1 [0.66]). These changes were non-significant. Repeated 
measures ANOVA showed no significant group effect of glucose.
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Figure 4.11 Changes in glucose throughout the study in the movers and non-movers.
Error bars indicate standard error of the mean (SEM)
Dashed line indicates point at which indicates impaired fasting glucose and is associated with increased CHD 
risk (>6.1)
Repeated measures ANOVA showed no significant effect of group on glucose
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The changes in insulin resistance, as defined by HOMA, in the movers and non movers 
group over the study duration are shown in Figure 4.12. Insulin resistance decreased by - 
1.32 [1.53] in the movers over the 6 month study, (P=0.005, f=3.34) and increased by 0.32 
[1.67] (NS) in the non-movers. Repeated measures ANOVA showed a significant effect of 
group (P=0.042,/=2.85).
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Figure 4.12 Changes in insulin resistance (HOMA) throughout the study in the 
movers and non movers
Error bars indicate standard error of the mean (SEM)
Repeated measures ANOVA showed a significant effect of group, (P=0.042, F=2.85)
Paired t test showed a significant difference from baseline within group; * (P=0.005,1=3.34)
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4.3.6.T Lipids
Table 4.6 summarises the changes in lipids over the 6 month study period within the 
movers group and the non-movers group. To investigate if any significant differences in the 
changes in lipids over the 6 month study occurred between the 2 groups either a repeated 
measures ANOVA, (where measures were taken at 4 time points) or an independent t-test, 
(where measures were taken at baseline and 6 months only) were conducted. A repeated 
measure ANCOVA was used to investigate the changes in TAG as baseline values were 
significantly different between groups. These results are also shown in Table 4.6.
Both total cholesterol and LDL-cholesterol decreased in the movers but increased in the 
non-movers (NS). HDL-cholesterol increased non-significantly in both the movers and 
non-movers over the 6 month study. TAG were significantly, (P=0.002, f=3.76) decreased 
from baseline to 6 months in the movers but decreased to a lesser amount (NS) in the non­
movers. A non-significant decrease in NEFA was seen in both the movers and non-movers. 
ApoA-1 increased in both groups, this change was significant in the non-movers only, 
(P=0.012, r=-2.7). Very small, non-significant changes in apoB were seen in both the 
movers and non-movers. HDL2, the large buoyant cardio protective HDL subfraction was 
significantly higher at 6 months compared to baseline in both the movers and non-movers, 
(P=0.015, t= -2.85 and P=0.010, t=-2.S24 respectively). LDLiii, the small dense 
atherogenic LDL subfraction decreased significantly over the 6 month study in both the 
movers and non-movers, (P=0.006, t=3.33 and P=0.020, /=2.51 respectively) though this 
change was more substantial in the movers. No significant between group effects were 
evident
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Table 4.6 Table showing absolute changes in lipids over the study period within the 
movers and non-movers group and between group changes.
Lipid Within Group Changes over 6 month Study Between
Movers Non-Movers Group
Change Paired t 
test
Change Paired t 
test
Change*
Total
cholesterol
(mmol/1)
-0.19
[1.12]
(n=15)
Non
significant
0.25
[1.22]
(n=26)
Non
significant
No 
significant 
group effect
A
LDL-
cholesterol
(mmol/1)
-0.26
[0.66]
(n=15)
Non
significant
0.18
[0.68]
(n=26)
Non
significant
No 
significant 
group effect
A
HDL-
cholesterol
(mmol/1)
0.10
[0.21]
(n=15)
Non
significant
0.13
[0.45]
(n=26)
Non
significant
No 
significant 
group effect
A
TAG
(mmol/1)
-0.75
[0.77]
(n=15)
P=0.002,
^=3.76
-0.14
[0.62]
(n=26)
Non
significant
No 
significant 
group effect
ANC
NEFA
(mmol/1)
-0.06
[0.26]
(n=15)
Non
significant
-0.09
[0.25]
(n=26)
Non
significant
No 
significant 
group effect
I
ApoA-1 (g/1) 0.18
[0.42]
(n=15)
Non
significant
0.12
[0.23]
(n=25)
P=0.012, t=- 
2.7
No 
significant 
group effect
I
ApoB (g/1) 0.02
[0.42]
(n=15)
Non
significant
0.04
[0.19]
(n=25)
Non
significant
No 
significant 
group effect
I
HDL2 % 6.19
[7.83]
(n=13)
P=0.015, 
/= -2.85
5.86
[9.74]
(n=22)
P=0.010, r=- 
2824
No 
significant 
group effect
I
HDL3 % -6.19
[7/83]
(n=13)
P=0.015, 
r= 2.85
-5.87
[9.75]
(n=22)
P=0.010,
r=2.84
No 
significant 
group effect
I
LDL3 % -17.3
[18.7]
(n=13)
P=0.006,
f=3.33
-7.55
[14.75]
(n=24)
P=0.020, 
r=2.51
No 
significant 
group effect
I
Mean [SD]
* From baseline to 6 months.
A- Repeated measures ANOVA used
ANC-Repeated measures ANCOVA used with baseline value as co-variant 
I- Independent t test used
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4.3.6.S Fibrinogen
Fibrinogen increased by 0.06g/L [0.82) in the movers over the study period and decreased 
by -0.06 g/L [1.84] in the non-movers. These changes were non-significant and no 
significant between effects were seen.
4.3.6.9 Inflammatory markers
Before inflammatory marker data was analysed outliers were removed as in section b, 
3.3.9. The only significant change in any inflammatory marker within either group was a 
significant decrease (P=0.017, r=2.91) in CRP in the movers from baseline to 6 months 
with CRP increasing in the non-movers over this time. An independent t test found a 
significant difference in the changes in CRP between the movers and non-movers 
(P=0.021, r=2.44).
Table 4.7 Table showing absolute changes in Inflammatory Factors over the study 
period within the Movers and Non Movers Group and between group changes.
Lipid Witbin Group Changes over 6 month Study Between
Movers Non-Movers Group
Change Paired t 
test
Change Paired t 
test
Change*
CRP -0.45 P=0.017, 0.26 [0.85] Not P=0.021,
(pg/ml) [0.49]
n=10
t=2.9\ n=22 significant r=2.44
vWF 0.49 [2.14] Not 0.60 [1.35] P=0.05, Not
(pg/ml) n=ll significant n=22 t=-2.08 significant
TNF-a -0.23 Not 0.11 [0.70] Not Not
(lU/ml) [0.52]
n=9
significant n=19 significant significant
Mean [SD] 
I^ndependent t test
4.3.6.10 Metabolic syndrome
Using the NCEP ATPIII criteria 53% of subjects in the movers group and 44% of those in 
the non movers group had metabolic syndrome at baseline. This was reduced to 20% and 
24% respectively at 6 months.
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4.3.7 Relationships between factors
Relationships between parameters were investigated within the movers and non-movers 
group over the 6 month study using Pearsons correlations.
CVD risk was explored further by investigating relationships between CVD risk factors as 
shown in Table 4.8 (movers) and 4.9 (non-movers).
Weight loss was significantly and positively correlated with a reduction in fat mass, fat free 
mass, waist and hip circumference and waist to hip ratio. Change in body weight was also 
seen to be positively associated with the change in fasting insulin, apoA-1 and change in 
systolic blood pressure.
Table 4.8 Relationships between factors within the movers group using Pearsons 
correlations
Parameter correlates with Parameter n Correlation (r) P
Weight change Change in fat mass 15 0.778 0.001
Change in fat free mass 15 0.748 0.001
Change in waist circumference 17 0.915 <0.001
Change in hip circumference 17 0.686 0.002
Change in WHR 17 0.749 0.001
Change in insulin 17 0.497 0.050
Change in systolic blood pressure 17 0.489 0.046
Change in apoA-1 15 0.532 0.041
Table 4.9 shows the relationships between CVD risk factors within the non-movers group. 
Weight loss was significantly and positively correlated with a reduction in fat mass, fat free 
mass and waist circumference. Change in body weight was also seen to be positively 
associated with the change in TAGs, LDL3, diastolic blood pressure and the change in 
energy intake, fat intake and protein intake. Thus reductions in these parameters were seen 
alongside weight loss.
A decrease in insulin was associated with a decrease in fibrinogen as illustrated by the 
significant positive correlation between these factors.
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Table 4.9 Relationships between factors within the non-movers group using Pearsons 
correlation
Parameter correlates with Parameter n Correlation (r) P
Weight change Change in fat mass 28 0.793 <0.001
Change in fat free mass 28 0.404 0.033
Change in waist circumference 28 0.758 <0.001
Change in diastolic blood pressure 28 0.388 0.041
Change in TAG 26 0.427 0.030
Change in LDL3 24 0.667 <0.001
Change in energy intake 12 0.587 0.045
Change in fat intake 12 0.583 0.047
Change in protein intake 12 0.608 0.036
Change in insulin Change in fibrinogen 25 0.431
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4.4 Discussion
Low levels of compliance with exercise instructions resulted in smaller than expected 
differences in the amount of exercise carried out between subjects in the diet and the diet & 
exercise group. Therefore where no between group differences in the change in any 
measured parameter were evident it was difficult to conclude if this was due to no additive 
effect of exercise or because differences in exercise were not sufficient between the two 
groups to allow an effect to be seen (Chapter 3). This analysis was therefore designed to 
allow the relative benefits of additional exercise to be examined. Utilising the information 
provided by subjects two new groups were formed based on actual exercise carried out 
rather than the anticipated amount of exercise. The non-movers were thus a group who did 
not alter their exercise levels from baseline whilst the movers increased their exercise levels 
during the study period.
The movers group had significantly greater reductions in weight, body fat mass, diastolic 
blood pressure, glycaemic response and CRP compared to subjects who reported not to 
increase their activity levels. These changes in parameters within the movers group indicate 
a reduction in adiposity, reduced hypertension, improved insulin sensitivity and a reduced 
inflammatory state, all of which may confer a reduction in CVD risk. Therefore the results 
from this analysis support the hypothesis that; in those subjects who reported increasing 
activity levels while following a LCD an additive effect on the reduction of CVD risk 
factors was seen compared to those who reported not to increase activity from baseline.
4.4.1 Fitness
No significant difference in the change in fitness, as assessed by final wattage in the AAT, 
between groups was evident and fitness was seen to increase by a similar amount in the 
‘non-movers’ compared to the ‘movers’. However when fitness was assessed by HRR an 
increase in fitness was seen in the ‘movers’ whilst a decrease in fitness was noted in the 
‘non-movers’. Neither measure of fitness showed a significant difference in the change in 
fitness between ‘movers’ and ‘non-movers’ over the study period and this may be due to 
the large between subject variability in activity levels or the levels of exercise being carried 
out by the ‘movers’ group not being sufficient to induce a significant increase in fitness 
above that seen in the non-movers’ group. Also the study was not powered to examine 
differences in this parameter. Alternatively the ATT fitness test may not be sensitive 
enough to detect relatively small changes in fitness as discussed previously (section 3.4.2).
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Nevertheless, when further analysis was carried out it became apparent that, although the 
differences in exercise between the ‘movers’ and ‘non-movers’ was not sufficient to show 
a significant difference in fitness based on the ATT, the additional exercise did appear to 
have an affect on the changes in measured parameters.
4.4.2 Energy and carbohydrate intake
Further evidence of differences in the behavioural changes made by subjects in the 
‘movers’ compared to the ‘non-movers’ group became apparent when looking at their diet 
diaries. A greater decrease in energy intake was reported by subjects in the ‘movers’ group 
from baseline to 6 months compared to the ‘non-movers’. In addition mean carbohydrate 
intake was lower in the ‘movers’ group compared to the ‘non-movers’. Although the 
differences between groups were not significant they suggest subjects in the ‘movers’ 
group may have been more motivated to lose weight than the ‘non-movers’ which would 
also explain their increased activity levels.
4.4.3 Glycaemic response
An additive effect of exercise on changes in glycaemic response was suggested by a 
significant difference in the changes in fasting insulin levels and insulin resistance, 
(measured by HOMA) between groups with a significant decrease in insulin and insulin 
resistance seen in the ‘movers’.
The effects of physical activity on insulin sensitivity have been established from previous 
research, and discussed previously; (see section 3.4.5.1) therefore the added benefits of 
exercise with a LCD are as expected. The ATTICA study (Kavouras et al, 2007) conducted 
a randomised, cross-sectional health and nutrition survey in over 3000 men and women in 
their investigation of physical activity, obesity status and glycaemic control. Participants 
were classed as inactive, minimally active or health-enhancing physical activity active and 
insulin sensitivity was assessed using HOMA. Results showed physical activity to be a 
significant factor on insulin sensitivity.
Dansinger et al, (2005) is one of the few studies to allow the effects of a LCD and exercise 
to be seen. Subjects following the Atkins diet had a significant decrease in glucose and 
insulin at 2 months compared to baseline but not at 6 or 12 months. A significant difference 
at 6 months may not have been apparent as exercise levels were lower, (minimum of 60 
minutes per week) than in the current study. The effects of a hypocaloric high protein diet
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with and without exercise on weight loss, fitness and markers of the metabolic syndrome 
was recently investigated in a randomised study by Meckling and Sherfey (2007). 
Overweight or obese women (n=60) were randomised to a 1:1 or 3:1 ratio of carbohydrate 
to protein and either participated in supervised exercise 3 times per week or maintained 
baseline activity level. No significant effect of exercise was seen and the authors concluded 
this to be due to lack of power
Insulin sensitivity was measured in 1467 men and women as part of the Insulin Resistance 
Atherosclerosis study (Mayer-Davis et al, 1998). Significantly higher insulin sensitivity 
was associated with increased activity, (total activity, vigorous activity and non vigorous 
activity). However the association was reduced after adjustment for BMI and WHR. 
Thompson et al, (2001) concluded this increase in insulin sensitivity following exercise is 
short term, lasting for only a few days. They explained the insulin sensitising effects of 
exercise are probably due to an increase in skeletal muscle and activity of the GLUT-4 
insulin responsive glucose transporters as well as hexokinase activity. Contrarily Perseghin 
et al, (1996) believed the effects of exercise may be not only due to the residual effect of 
the last session of exercise, but also the contribution of longer term exercise training via up- 
regulation of the numbers and function of the glucose transporters, capillary proliferation 
and the number of type Ila muscle fibres which are more insulin responsive due to their 
higher GLUT-4 protein content.
Whether the effects of exercise on insulin sensitivity are short or longer term the positive 
glycaemic effects seen in ‘movers’ are as expected.
4.4.4 Weight
Significantly greater weight loss was seen in the ‘movers’ compared to ‘non-movers’ with 
over 3kg more weight lost in movers compared to non-movers. This would suggest exercise 
combined with a LCD affects weight loss above and beyond a LCD alone. No significant 
difference was evident in the weight loss achieved in the original groups (Chapter 3). Non 
adherence to exercise recommendations was identified as a potential reason for this. 
Therefore when groups were based on actual exercise conducted, (‘movers’ and ‘non­
movers’) rather than exercise instructions, (LCD and LCD and exercise) so non-compliance 
is no longer a confounding factor and greater differences are apparent.
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Weight losses of 1-3 kg over 4-6 months were reported with an exercise intervention in the 
review by Catenacci and Wyatt, (2007). Therefore the additional weight loss seen in the 
‘movers’ in the current study is at the top end of this expected range.
The greater weight loss seen in the ‘movers’ compared to the ‘non-movers’ may be 
attributable to increased compliance to the LCD as well as the additive effect of exercise. 
This is suggested by the greater reductions in energy and carbohydrate intake seen in this 
group. Whether the additional weight loss in the ‘movers’ was a result of the exercise or 
increased compliance to the LCD, a benefit of combining exercise with a weight reducing 
LCD is evident from this study.
4.4.5 Anthropometries
Although waist circumference was decreased to a greater degree in the movers compared to 
the non-movers the ratio of WHR decreased more in the non-movers over the study period. 
This is likely to be due to the significantly greater decrease seen in hip circumference in the 
movers compared to the non-movers. Thus additional beneficial effects of exercise on 
anthropometries are demonstrated but these are not sufficient to induce significantly greater 
decreases in waist and WHR compared to a LCD alone.
4.4.6. Body composition
Body fat mass was decreased significantly more in the movers compared to the non-movers 
over the study period. Therefore it would appear body composition changes are greater in 
magnitude when subjects were re-grouped compared to original groups.
No significant differences were seen in loss of lean body mass between groups. Although 
lean mass appears to have been preserved in the movers compared to the non-movers in the 
first 2 months of the study, by 6 months similar losses of lean body mass were seen in both 
groups.
These results suggest that exercising whilst following a LCD may help accelerate body fat 
loss and have a tendency to preserve lean body mass, at least, initially.
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4.4.7. Blood pressure
Both diastolic and systolic blood pressure were reduced more in the movers group 
compared to the non-movers and a significant effect of group was seen in diastolic blood 
pressure changes. These additional hypotensive effects of physical activity are as expected.
Opposing results were seen in the original analysis with greater decreases in blood pressure 
seen in subjects in the diet only group. This may be as original groups did not reflect the 
amount of exercise being carried out and therefore changes in parameters didn’t follow 
predictions.
4.4.8 Lipids
No significant group effects were evident across all lipid fractions measured. However 
where any substantial difference in the change in lipids occurred a more positive effect was 
seen in the ‘movers’ compared to the ‘non-movers’. This would suggest exercise alongside 
a LCD may have additional beneficial effects compared to a LCD alone in some 
individuals but this is not always the case. These inconsistencies in changes in lipid in 
response to exercise have been documented previously (Leon and Sandez, 2001). An 
additional effect of exercise on lipids may not be apparent in this study because the subjects 
who increased their exercise levels, ‘the movers’ were compared to the ‘non-movers’ who 
also followed a LCD. This dietary approach has been associated with substantial changes in 
lipids independent of exercise, (Brehm et al, 2003; Dansinger et al, 2005; Foster et al, 
2003; Samaha et al, 2003) and it may then be that no significant additive effects of exercise 
on lipids are seen with a LCD.
4.4.9 Fibrinogen
The changes in fibrinogen, a marker of haemostasis, suggest blood viscosity is not affected 
when a LCD is followed with or without exercise.
4.4.10 Inflanunatory markers
As physical activity has been shown to be associated with lower levels of CRP, (Pitasvos et 
al, 2005; Plaisance and Granjeran, 2006) the significantly greater decrease in CRP levels 
seen in ‘movers’ compared to ‘non-movers’ is as expected. The reduction in CRP seen to 
be associated with exercise may be due to the increased insulin sensitivity and reduced
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body weight of this group as well as cytokine production and improved endothelial function 
(Kasapis and Thompson, 2005).
Although some evidence of a reducing effect of physical activity on TNF-a and vWF has 
been seen, (Pitasavos et al, 2005; Wood, 2006) there is limited evidence on these novel 
risk factors. The lack of significant additional effects of exercise seen on TNF-a and vWF 
in this study could be due to exercise having no additive effect upon them or perhaps the 
amount/intensity of exercise was insufficient to induce change in these inflammatory 
markers.
4.4.11 Compliance
The low levels of compliance to exercise instructions illustrate the difficulties of running an 
intervention in free living subjects based on making positive lifestyle changes. People need 
to be ready and willing to make changes and randomising them into groups and giving 
instructions does not necessarily mean these instructions will be followed.
In a survey of 570 outpatients with diabetes Kamiya et al, (1995) reported that 30% failed 
to comply with the exercise regimen as prescribed. Reasons for non-compliance included 
lack of time, lack of mind set, lack of guidance by the physician, lack of interest and lack of 
understanding of the procedures. The authors suggested improving compliance through 
increased motivation and encouragement, specific approaches for each patient and co­
operation of the family. In an investigation of adherence to a 6 month LCD Westman et al, 
(2002) stated 51% of subjects reported following recommendations to exercise 3 times or 
more per week on average over the study duration.
Exercising at moderate levels does not induce substantial noticeable results therefore many 
individuals find it hard to remain motivated to continue. However, where more rigorous 
and supervised structured training has been employed higher levels of compliance to an 
exercise intervention have been achieved. Ross et al, (2000) randomly assigned subjects to 
one of four groups in an investigation into the effects of diet or exercise-induced weight 
loss on obesity and related conditions. Subjects carried out their daily exercise under 
supervision by appointment for 12 weeks and comprised brisk walking or light jogging on a 
treadmill until 700 kcals had been expended. Ninety-eight percent attendance at exercise 
sessions was reported and this may be due to the instant feedback subjects obtained from 
this higher level of exercise. However it is very likely those subjects taking part in the study
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were those who were highly motivated and unlikely to be non-compliant as over a third 
(34%) of subjects withdrew from the study due to dissatisfaction with group allocation 
immediately after randomisation.
Compliance regarding exercise was considerably higher in the diet only group (86%). This 
is as expected as subjects in this group were asked not to alter activity levels from baseline 
and therefore did not need to alter their behaviour.
In studies where subjects were asked to maintain baseline levels of activity greater 
compliance has been seen. Sharman et al, (2004) used physical activity logs to monitor 
activity levels throughout a 6 week study and reported the subjects who were sedentary or 
moderately active baseline remained so as instructed. Other studies where subjects were 
asked to maintain baseline activity levels do not report any method used to measure activity 
levels during the study and appear to assume subjects complied with these instructions 
(Skov et al, 1999“; Volek et al, 2004).
The low level of compliance to exercise instructions in the diet & exercise group in the 
current study could be due to subjects being advised on 3 aspects of their activity; the 
frequency, length and intensity. In order to be considered as compliant subjects had to 
adhere to 2 of these 3 aspects. Therefore some individuals may have exercised three times a 
week and considered themselves to be following instructions but if the intensity and 
duration fell just below recommendations they would not have been doing so. It has been 
reported (Department of Health, 2004^) that many people have difficulty translating 
physical activity recommendations given as a set of numbers into a behaviour. Therefore 
this could explain the inability of some subjects to comply with exercise instructions.
The exercise instruction subjects found the hardest to comply with was exercising at the 
intensity specified. At the beginning of the study subjects were given a heart rate range to 
maintain whilst exercising to ensure they were exercising at a moderate intensity. Despite 
heart rate monitors being provided to assist with this it appears subjects were not able to, or 
chose not to, adhere to this instruction. Many subjects exceeded the HR range they were 
given. Perhaps by exceeding the instructions given they believed they were being ‘more 
compliant’ rather than non-compliant. Alternatively many subjects may have exercised at 
vigorous rather than moderate levels in the belief this would lead to greater positive effects. 
Emphasising and re-alliterating the importance of adhering to all aspects of instructions in 
order that a comparable and measurable amount of exercise was achieved by all subjects in
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the diet and exercise group may have resulted in more subjects exercising at the level 
specified. In addition increased education on the health benefits of moderate intensity 
exercise at the beginning of the study may have provided further motivation to exercise at 
this level.
The importance of providing individualised advice has been highlighted, (Kamiya et al, 
1995) and this study set out to do this by giving subjects the option of the method of 
exercise they chose. This made it more difficult to give very specific instructions on 
exercise which would have been possible if one exercise method had been used. In addition 
as this was a free-living study very strict monitoring of activity levels carried out by 
subjects was not possible. Yet the methodology used was important as it reflects the 
diversity of exercise carried out by the general population and the self-motivation on a day 
to day level needed to exercise regularly. The low levels of compliance seen are indicative 
of the number of individuals who struggle to maintain sufficient levels of activity to benefit 
health. This has implications on the short and long term health of the population as well as 
those designing exercise intervention studies. In addition the effectiveness of G.P exercise 
prescription programmes could be questioned.
Further research is needed to understand how we can encourage individuals to participate in 
higher amounts of everyday activity.
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4.4.12. Future work
Dissemination of this additional analysis will be done alongside results from the main 
analysis (Chapter 3).
Future investigations could involve using different exercise programmes to explore how 
compliance could be optimised. This information could then be used to design further 
research investigating the use of LCD with and without exercise to see if different levels 
and types of exercise affected outcomes differently and the effect on additional parameters 
such as change in the distribution of body fat.
4.4.13 Conclusion
Levels of compliance to instructions regarding exercise were lower than anticipated in this 
study. After addressing this issue by re-grouping subjects based on reported actual exercise 
levels it is apparent that beneficial effects on CVD risk markers can be achieved with 
relatively modest engagement in physical activity over 6 months. These benefits include 
greater weight loss, greater body fat loss, more substantial reductions in blood pressure and 
inflammatory marker, CRP, and importantly improvements in insulin sensitivity and 
reduction in fasting insulin levels.
Therefore this analysis suggests increasing activity levels while following a LCD may have 
an additive effect on the reduction of CVD risk. As with all individuals wishing to lose 
weight those people following a LCD should be encouraged to exercise at least moderately. 
Whilst it is accepted this advice will not be heeded by everyone the additional positive 
effects on weight loss and CVD risk (in addition to other health benefits) in those who do 
adhere to an exercise program warrant the recommendation of increasing activity levels 
whilst following a LCD.
173
5 A pilot study investigating the rate and composition of the rapid initial weight loss 
achieved via a low carbohydrate diet
5.1 Introduction
5.1.1 Background
The efficacy of LCDs in producing weight loss has been well demonstrated (Bravata et al, 
2003; Dansinger et al, 2005; Stem et al, 2004; Volek et al, 2004; Yancy et al, 2004; 
Tmby et al, 2006). Some debate remains as to whether this dietary approach has 
advantages in terms of weight loss outcomes (Dansinger et al, 2005). However rapid initial 
weight loss is evident when LCDs are commenced, (Volek and Westman, 2002; Erlanson- 
Albertsson and Mei, 2005; Tmby et al, 2006). This can be highly motivating (Elfhag and 
Rossner, 2005; Tmby et al, 2006) and may increase the likelihood of weight loss goals 
being achieved.
5.1.2 Initial weight loss changes induced by low carbohydrate diets
Previous studies have illustrated the majority of weight is lost in the early stages of 
following a LCD. In a study by Foster et al, (2003) subjects lost 94% of their total weight 
loss at 3 months when following a LCD for 6 months. Similarly 89% of the total weight 
lost by subjects in a 6 month LCD study, (Brehm et al, 2003) was lost by the mid-point. 
Compared to other commercial weight loss diets, subjects following the Atkins diet lost an 
additional 4.3 kg or 0.9 kg (in men and women respectively) in the first month (personal 
communication H Tmby).
5.1.3 Possible mechanisms by which low carbohydrate diets facilitate early weight loss
5.1.3.1 Glycogen associated water losses
There are many theories for the rapid initial weight loss seen with LCDs. It has been stated 
that water losses are responsible (Blackburn et al, 2001; Erlanson-Albertsson and Mei, 
2005). When carbohydrate intake is restricted, the body utilizes glycogen stores from the 
liver and muscle to provide glucose (Bray, 2003). The average adult has approximately 
500g of glycogen stores (Denke, 2001) and as each gram of glycogen is stored with 4 g of 
water this would equate to a total weight of 2.5kg. Although it is evident glycogen 
associated water losses would contribute to the weight loss seen when a LCD is 
commenced, several other mechanisms have also been postulated.
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5.1.3.2 Increased energy deficit
i) Reduced energy intake
Evidence suggests the reduced energy intake resulting from a low carbohydrate intake is 
not compensated for by an increase in other macronutrients, such as fat (Brehm et al, 2003; 
Stem et ai, 2004; Hiscutt et al, 2006). Therefore an energy deficit is achieved resulting in 
weight loss. Increased food variety can increase food and thus energy intake (Sorenson et 
al, 2003) therefore LCDs are likely to be successful in producing an energy deficit in many 
individuals due to restricting food choice and limited availability of suitable foods, in 
particular snack foods. As many people’s meals are based upon carbohydrate foods, 
significant adaptation is needed to switch to a LCD. Organisation and imagination are also 
required and it has been suggested energy restriction occurs due to these practical factors 
(Brehm et al, 2003).
Although there is data to challenge the role of an energy deficit, with some studies 
reporting greater weight losses with LCDs even when compared to an isocaloric low fat 
diet (Volek et al, 2000; Brehm et al, 2003), the importance of energy restriction is clearly 
demonstrated by a systematic review of LCDs, (Bravata et al, 2003) which found that 
subjects following diets with the lowest calorie content achieved the greatest weight loss.
ii) Increased energy expenditure
An increased energy deficit could also be induced by greater activity levels. The possible 
contribution of increased activity to weight loss on LCDs can not be determined from most 
previous studies as they have either not considered exercise, (Foster gr al, 2003; Samaha et 
al, 2003; Nobels et al, 1989; Yancy et al, 2004) or exercise has been encouraged but the 
type, level duration or intensity of exercise achieved is not reported, (Brehm et al, 2003; 
Westman et al, 2002). More recently the effects of hypocaloric high-protein diet, with and 
without exercise were investigated (Meckling and Sherfey, 2007). Exercise was associated 
with improved weight loss in subjects following both the high protein diet as well as those 
following a more conventional higher carbohydrate hypocaloric diet with the greatest 
weight loss seen in the HPEx group. However no significant additive effect of exercise was 
reported by Layman et al, (2005) in an investigation where subjects followed a high 
protein, reduced carbohydrate or a low protein, high carbohydrate diet with and without 
exercise for 4 months.
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Brehm et a l (2005) set out to investigate the role of energy expenditure as a component of 
the increased weight loss observed in obese women following a LCD compared to a low fat 
diet. Physical activity was measured using pedometer readings and no significant changes 
over time or between diet groups were seen thus indicating subjects complied with 
instructions to maintain baseline levels of activity. If this measurement is taken to be 
reliable, increased energy expenditure could not be implicated in the greater weight loss on 
the LCDs reported in this particular study. The scant evidence available suggests increased 
activity levels may in some cases contribute to the weight loss seen with LCD but there is, 
as yet, no evidence to suggest activity levels are responsible for the additional early weight 
loss seen with LCD.
5.1.3.3 Increased satiety
Satiety has a powerful effect on food intake therefore could be an important factor in 
weight loss by facilitating a lower energy intake. Stubbs et al, (1996) reported a greater 
satiating effect of a protein rich breakfast compared to either a high carbohydrate or high 
fat breakfast. Fat was found to have a delayed impact on satiety, possibly due to slower 
emptying from the stomach. Stubbs concluded in a review of macronutrient effects on 
appetite (1995) that ‘in the short to medium term, protein is more satiating than 
carbohydrate, which is more satiating than fat’ (psl8).
While absolute protein intake is not significantly increased when a LCD is followed, 
(Hiscutt et al, 2006; Meckling et al, 2004) the contribution of protein to total energy intake 
is increased (Brehm et al, 2003; Hiscutt et al, 2006; Samaha et al, 2003). It has been 
demonstrated in a study by Weigle et al, (2005) that increasing the percentage energy from 
protein can lead to a reduced ad libitum calorie intake. This was associated with increased 
satiety in these subjects consuming a high-protein diet. Therefore it would be expected that 
a LCD would be more satiating and therefore hunger and appetite would diminish.
The mechanism by which protein increases satiety remains unclear (Astrup, 2005; Bowen 
et al, 2006). However recent studies investigating the effects of higher protein diets on 
satiety factors are providing new insights into the possible connection between protein and 
satiety. Bowen et al, (2006) investigated the acute effects of different proteins and 
carbohydrates on appetite and appetite regulating hormones. Nineteen overweight men 
participated in this randomised cross-over study in which subjects consumed four preloads 
(whey, casein, lactose or glucose). Blood samples were taken at regular intervals for 180
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minutes after each preload and participants were then offered a buffet meal. A prolonged 
postprandial suppression of ghrelin and a prolonged elevation of plasma cholecystokinin 
(CCK) were observed after protein consumption. Ghrelin is an orexigenic peptide which is 
released primarily from the stomach. Plasma ghrelin has been shown to rise substantially 
before meals and decrease within 1 hour of food consumption (Cummings et al, 2001). 
CCK, a hunger suppressant, regulates the nutrient delivery rate from the stomach to the 
small intestine (Bowen et al, 2006). Thus the effects seen suggest both ghrelin and CCK 
are implicated in the satiating effects of protein. When a LCD is composed of mixed meals 
the effects on satiating hormones are likely to vary from the effects seen in this study where 
liquid preloads were used. Mixed meals using solid foods were used in the study by 
Lejenue et al, (2006) who investigated 24 hour satiety and satiety related hormones during 
a high protein diet. Glucagon-like peptide (GLP-1), which decreases food intake by 
increasing satiety, was increased to a greater extent following a high protein meal compared 
to an adequate protein meal. Satiety was found to be related to protein intake as well as 
ghrelin and GLP-1 concentrations in those consuming a high protein diet.
In contrast neither alterations in ghrelin or leptin could explain the effects of a higher 
protein diet on increased satiety and reduced energy intake in a study by Weigle et al, 
(2005).
In summary, the increased satiety associated with LCDs is likely to be mediated through 
multiple mechanisms with recent evidence illustrating the potential importance of several 
gastrointestinal hormones involved in appetite regulation.
5.1.3.4 Excretion of ketone bodies
Dr Atkins in his diet book. The Atkins New Diet Revolution’ postulates that the 
production and excretion of ketone bodies is one mechanism that contributes to weight loss 
on LCDs (Atkins, 2003). Due to the lack of dietary carbohydrate, glycogen stores are not 
replaced and when these stores are utilised the body turns to a different fuel for energy, 
namely fat, as illustrated in Figure 5.1.
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Figure 5.1 Diagram illustrating the mechanism involved in the production of ketones 
when a LCD is followed
Although ketone losses have been proposed as a contributor to weight loss on LCDs, 
(Young et al, 1971) it is now acknowledged this is unlikely to contribute to the total weight 
loss. The Council on Foods and Nutrition, (1973) agree that the loss of ketone bodies seen 
in subjects on ketogenic diets (rarely exceeding 100 kcals per day) could not be wholly 
responsible for the quantity of weight loss demonstrated. This consensus has been more 
recently supported in a study comparing a LCD to a hypocaloric, low fat diet on CVD risk 
factors in women (Brehm et al, 2003). Testing of urinary ketone excretion and plasma P- 
hydroxybutyrate revealed ketosis was present in the majority of subjects following the LCD 
but no correlation was evident between plasma p-hydroxybutyrate levels and weight loss.
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5.1.3.5 Metabolic advantage
Greater weight loss has been reported in some studies when subjects are following a LCD 
compared to other dietary approaches with the same energy content, (Volek et al, 2000; 
Brehm et al, 2003) suggesting a possible ‘metabolic advantage’ of LCDs, a stance 
supported by Dr Atkins: ‘When you follow a low-carbohydrate approach, you get what I 
call a metabolic advantage’ (Atkins, 2003, pl6-17). The study by Kasper et al, (1973) was 
quoted as evidence for this statement. Subjects were fed 300-400g of fat /day without 
recording the corresponding amounts of weight gain that would be expected. The lack of 
correlation between energy intake and weight gain was more pronounced when fat was 
given in the form of com oil, therefore it was concluded that high fat intakes (when 
combined with a relatively low carbohydrate and protein intake) cause an increase in 
metabolic rate, particularly when the fat has a high linoleic acid content. The author’s 
further state that ‘under a low carbohydrate, high fat diet regimen, an increased energy 
output takes place, which is emitted in the form of heat’ Kasper et al, 1973, p202. 
However it should be noted that the sample size used for these studies were very small and 
the only evidence provided of an increased energy expenditure were subject reports of a 
sensation of heat and increase tendency to sweat
An increased metabolic rate may occur indirectly as a result of greater preservation of lean 
body mass when LCDs are followed compared to low fat diets. The few studies which have 
measured body composition changes show a growing body of evidence to suggest LCDs 
have an advantage in terms of fat loss thereby inducing a preferential body composition. 
Volek and colleagues (2004^) randomized overweight or obese men (n=15) and women 
(n=13) to follow an isocaloric, low carbohydrate or low fat diet for 30-50 days. Greater fat 
loss was seen in men, and women to a lesser extent, following the LCD compared to the 
low fat diet. Further studies have also demonstrated reduced carbohydrate induced weight 
loss to be comprised mainly of body fat (Layman et al, 2005; Meckling and Sherfey, 2007; 
Miyashita et al, 2004; Westman et al, 2002; Willi et al, 1998).
However, an increase in resting energy expenditure (REE) which may have resulted from 
this greater lean body mass was not detected by Brehm et al, (2005). In this study 50 
healthy obese women were randomised to a low carbohydrate or hypocaloric low fat diet 
for 4 months and REE, the thermic effect of food (TEE) and physical activity were 
measured. Results from these outcome measures revealed no increase in REE, TEF or
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physical activity in those subjects following a LCD. Despite this a significantly greater 
weight loss (P<0.05) was seen in subjects following this diet compared to the more 
conventional low fat diet. The authors explained this as being due to, ‘a difference in 
energy intake that was not apparent in their self-reported 3-d food records’ (pl481).
Similarly an increase in REE was not detected when subjects followed an energy restricted 
LCD, (Volek et al, 2004“^) and no significant differences in REE were seen between these 
subjects and those following an isocaloric low fat diet. A possible explanation given for this 
is that the metabolic advantage of a LCD may be at a level lower than can be detected by 
measurements taken (Volek et al .,2004^ )^.
Possible explanations for the increased losses of body fat (assessed by BIA) in subjects 
following a high protein diet (protein to carbohydrate ratio of 1:1), with or without 
exercise, as compared to those following a control diet, (protein to carbohydrate ratio of 
1:3) were explored by Meckling and Sherfey, (2007). No effect of diet or exercise were 
seen in resting metabolic rate (RMR) therefore suggesting RMR could not explain the 
increased loss of body fat induced by a LCD in this study. An increased metabolism of fat 
at rest was suggested by a decrease in respiratory exchange ratio (RER) in those on the high 
protein diet with exercise. It was also postulated that TEF may be greater in subjects on a 
high protein diet, contributing to these increased fat losses.
Diet induced thermogenesis (DIT) as well as sleeping metabolic rate (SMR) were 
significantly higher in lean women on a high protein diet compared to those consuming an 
adequate protein diet (Lejeune et al, 2006). The authors proposed the increased DIT may 
be due to; the small storage capacity of the body for protein which requires its immediate 
metabolism, the high ATP cost of peptide bond synthesis and the high cost of 
gluconeogensis and urea production. Although this evidence implies a higher TEF and 
increased SMR may contribute to the increases losses of body weight seen with LCDs the 
study was short term (4 days) and the diet used differed from most LCDs as it was 
isocaloric and carbohydrate provided 40% of the energy.
5.1.3.6 Fat mobilising substance
Dr Robert Atkins in his weight loss book (Atkins, 2003) raised the profile of the existence 
of a ‘fat-mobilizing substance’ (FMS) which was said to contribute to LCD induced weight 
loss but this is highly controversial. The work of Kekwick and Pawan is credited with the
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discovery of this substance. Their earlier work (1956) suggested diets with a higher 
percentage energy from protein or fat resulted in greater weight loss than a diet with high 
percentage energy from carbohydrates, an effect the authors attributed to different rates of 
fat loss (Kekwick and Pawan, 1964). However this has been disputed due to the very short 
study durations (subjects were on each diet for 5-9 days). In order to investigate this further 
Kekwick and Pawan injected mice with a substance they extracted from the urine of 
individuals following a LCD. Dr Atkins New Diet Revolution, (2003) reports this 
substance (FMS) to have increased the excretion of unused calories via faeces and urine by 
26% (unreferenced).
Dr Atkins acknowledges that these results have not been investigated in other studies, 
(Atkins, 2003) therefore confirming that there is no further evidence of this FMS, (which 
remains the case at present) and therefore it cannot be identified as the metabolic basis of 
weight loss induced by LCDs.
5.1.3.7 Summary of the mechanisms contrihuting to low carbohydrate diet induced 
weight loss
Many explanations have been offered for the greater initial weight loss observed when 
LCDs are followed. This can often be attributed to reduced energy intake or an increase in 
energy expenditure. If energy intake and expenditure are fully controlled for any 
differences seen may be due to the combined effect of several factors: the thermogenic 
effect of protein, ketone excretion, a more complete loss of the glycogen pool and increased 
energy expenditure due to superior preservation of lean muscle mass.
Regardless of which mechanisms are involved in LCD induced weight losses the ‘short­
term changes in weight on any diet have little meaning unless the composition of the 
weight loss is known’ (Council on Foods and Nutrition, 1973, pl415).
5.1.4 The effect of low carbohydrate diets on body composition
There are a limited number of studies investigating LCDs which have measured alterations 
in body composition. However those which measured this outcome observed low 
carbohydrate induced weight loss to be comprised mainly of body fat (Table 5.1). Although 
figures were not provided by Miyashita et al, (2004) they report that weight loss was 
comprised entirely of fat mass when a LCD was followed for 4 weeks. It has been 
demonstrated through the use of regression analysis, (Garrow and Summerbell, 1995) that
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the expected loss of fat mass through dieting alone would be 71% in men and 78% in 
women which is comparable to the longer term studies, (Brehm et al, 2003; Truby et al, 
2006; Westman et al .,2002; Yancy et al, 2004).
Table 5.1 Body composition changes reported in low carbohydrate diet weight 
reducing diets
Study Sample Intervention Change in Body Composition 
(kg unless otherwise stated)
Fat Fat free Mass
Boden 
et al, 
(2005)
10 obese subjects 
with type 2 
diabetes
14 day ad libitum 
LCD
B
-2.45 + 0.43
Brehm
et al, 
(2003)
53 obese females 6 month ad libitum 
LCD
Baseline = 37.3 [4.8] 
3 months= 33.0 [4.8]
Baseline = 50.4 [6.0] 
3 months = 47.6 [5.9]
D
6 months = 32.6 [5.2] 6 months = 48.4 [5.9]
Meckling 
et a l., 
(2004)
40 overweight 
healthy subjects
10 week hypocaloric 
LCD
B
Baseline =33.3 [3.1] 
10 wks= 29.2 [13.2]
Baseline = 57.5 [3.0] 
10 weeks= 55.6 [2.9]
Miyashita 
et al, 
(2004)
22 obese subjects 
with type 2 DM
4 week low CHO 
energy restricted diet
B
Decreased No change
Truby et al, 
(2006)
57 overweight and 
obese subjects
6 months ad libitum 
LCD D
-4.6 [4.8] Not reported
Volek 
et al, 
(2004)
28 healthy 
overweight or 
obese men and 
women
30-50g/day 
hypocaloric LCD
D
Decreased Decreased
Westman 
et al, 
(2002)
51 overweight or 
obese men and 
women
6 month ad libitum 
very LCD
S
Baseline = 36.9 [6.2] 
6 months = 30.6 [5.7]
Baseline = 50.2 [7.2] 
6 months = 47.0 [7.6]
Willi
et al, 
(1998)
6 morbidly obese 
adolescents
8 week ketogenic diet.
D
Baseline = 51.1% [2.1] 
8 wks = 44.2% [2.9]
Baseline =67.2 [6.9] 
8 wks= 68.6 [6.9]
Yancy 
et al, 
(2004“)
120 overweight 
hyperlipidémie 
men and women
24 week ad libitum 
LCD
B
-9.4 -3.3
CHO -carbohydrate
Body composition methodology used;
D-D XA
B-BIA
S - Skinfold thickness
Several of these studies were randomised controlled 
LCD or a calorie restricted, low fat diet thereby 
approach on body composition to be compared.
trials with subjects following either a 
allowing the effect of each dietary
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Brehm et al, (2003) found fat and lean body mass were significantly reduced in both diet 
groups over the 6 month study. However the change in fat and lean mass was significantly 
greater in those subjects following the LCD (P<0.01) compared to the low fat group. The 
amount of weight loss which constituted fat mass was similar in both groups.
Significant decreases in fat mass were also seen in subjects who followed both a LCD and 
low fat diet for 10 weeks (Meckling et al, 2004). Although the low fat group preserved 
their lean body mass more effectively, when body weight changes were controlled for, 
similar body composition improvements were seen, (percentage body fat and lean mass) in 
both groups.
Similarly studies by Miyashita et al, (2004) and Yancy et al, (2004) showed no significant 
differences between subjects following a LCD or low fat diet in fat mass or lean body mass 
changes.
However some differences in body composition between the two diet groups were evident 
elsewhere. Significantly greater losses of body water were seen in subjects following a 
LCD during the first two weeks of the study by Yancy et al, (2004) whilst Volek et al, 
(2004^) reported a LCD to have an advantage over an isocaloric, low fat diet in terms of 
total fat loss and trunk fat loss in men.
A randomised study of four commercially available weight loss programmes (Truby et al, 
2006) allows the comparison of a LCD (Atkins) to 3 other commercially available diets, 
(Weight Watchers, Rosemary Conley or Slimfast). Overweight or obese men and women 
(n=300) followed one of 4 weight loss diets, (or were in a non dieting control group) for 6 
months. Although body fat loss did not differ significantly between diet groups between 
baseline and 6 months the greatest losses of body fat in the first 2 months of the study were 
seen in the LCD (Atkins) compared to the other 3 diets, however this difference was only 
significant between Atkins and Slimfast groups.
Two further studies measuring body composition changes when a reduced carbohydrate 
diet was followed were not included within Table 5.1 as the carbohydrate intakes were 
higher than those of a typical LCD, (Layman et al, 2005; Meckling and Sherfey, 2007). 
However these studies did illustrate that even with slightly higher absolute intakes of 
carbohydrate, (134g and 119g respectively) a reduced carbohydrate, high protein diet is
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associated with greater losses of body fat. This difference was significant (P<0.05) in 
Layman et al, (2005) only.
Miyashita et al, (2004) determined the distribution of body fat losses via visceral and 
subcutaneous fat mass measurements taken using computerised axial tomography in 
diabetic subjects following either a low carbohydrate or low fat diet for 4 weeks. The 
amount of visceral fat and the visceral fat to subcutaneous fat ratio decreased significantly 
(P<0.05) in the low carbohydrate group only.
5.1.5 The mechanism by which low carbohydrate diets effect body composition
Two possible mechanisms for the positive effect of a LCD on body fat distribution were put 
forward by Miyashita et al, (2004). Firstly, an increase in growth hormone secretion may 
be induced by the LCD causing greater lipolytic activity in visceral fat compared to 
subcutaneous fat. Although Boden et al, (2005) found no difference in human growth 
hormone between baseline and day 14 of a LCD this study had a small sample size (n=10) 
and short duration. Alternatively Miyashita et al, (2004) proposed the reduction in insulin 
secretion caused by the lower carbohydrate intake may have had an effect on reducing 
visceral fat.
Volek et al, (2004^) reported a greater loss of fat from the trunk region of the body when a 
LCD was followed compared to a low fat diet, an effect which was significant in men but 
not women. Changes in hormones insulin, leptin or cortisol due to the altered macronutrient 
balance were considered as possible mechanisms regulating the composition and 
distribution of LCD induced weight loss, although this study did not measure these 
variables.
5.1.6 The impact of body composition on health risk
Although body composition varies depending on diet, activity levels and hydration, the 
body of an average 70kg man contains 17% protein, 17% fat, 60% water with the 
remaining 6% from bone minerals and glycogen (Table 5.2). Values differ in women with a 
female of similar build having approximately 24kg of body fat, (Rowett Research Institute).
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Table 5.2 Mean body composition values in a normal weight male (70kg)
Average weight (kg)
Fat 12
Protein 12
Water 42
Bone mineral 3.5
Glycogen 0.5
Rowett Research Institute
Obesity is defined as an excess of adipose tissue (Arterbum, 2004) and it is the surplus fat 
mass which imposes on health. CVD, type 2 diabetes, hypertension, dyslipidaemia, 
osteoarthritis and gallstones are all co-morbidities associated with obesity (Freedman et al, 
2001).
Obesity has increased health risks due to the metabolically active adipose tissue. 
Adipocytes produce a multitude of products including proinflammatory cytokines, and 
components of the coagulation/fibrinolytic cascade which may mediate the health problems 
outlined above (Ahima and Flier, 2000). The distribution of body fat is also important with 
the development of insulin resistance and CHD being associated with visceral fat 
(Miyashita et al, 2004).
Therefore the optimum weight loss programme would reduce body fat mass, to reduce the 
health risks associated with excess adiposity, whilst maintaining lean body mass in order 
that resting metabolic rate is not reduced.
Identifying the body composition changes induced by LCDs is crucial in understanding 
their consequences to health.
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5.1.7 Gaps in knowledge
There are several gaps in the literature regarding the rate and composition of weight loss 
induced by LCDs.
Most studies have taken regular measurements when LCDs are initiated, (Boden et al, 
2005) but are of a very short duration and are often conducted in an in-patient setting. 
Alternatively, studies are of longer duration but measurements are not taken at sufficiently 
frequent intervals in the early stages of the diet to allow elucidation of the early rate and 
composition of these changes.
In addition, data has been presented in a graphical manner in some cases with specific 
measurements of body composition not shown, (Miyashita et al, 2004; Volek et al, 2004^) 
which does not allow direct comparison of results between studies.
Many previous studies investigating LCDs have a sample consisting of both men and 
women. The gender differences in body composition and the varying responses of men and 
women to dietary interventions, (Volek et al, 2004 ^ ) make it more difficult to interpret the 
results if the sample is analysed as a whole or reduce the power of the study if each gender 
is analysed individually.
Few studies investigating LCDs have measured body composition change at weekly 
intervals and only some of these have also measured dietary intake thus allowing the 
contribution of diet on measured outcomes to be assessed.
Therefore this pilot study was designed to begin exploring the initial, LCD induced changes 
in weight and body composition whilst measuring the changes to dietary intake to assist in 
elucidating the mechanism of weight loss induced by LCDs.
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5.1.8 Aims
The aims of this study were;
• To investigate the rate of the initial weight loss induced by a LCD.
• To investigate the composition of this weight loss.
• To assess changes in dietary intake when a LCD is commenced.
5.1.9 Hypothesis
It was hypothesised that:
• A LCD would lead to rapid initial weight loss which would be composed substantially 
of loss of body fat.
• The weight loss induced by the LCD can be explained by the observed energy deficit.
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5.2 Method
5.2.1 Study design
Twenty women were recruited for this body composition study with all subjects following a 
LCD for 8 weeks. An outline of the study design in show in Figure 5.2.
Baseline testing
Advertising
C om m ence LCD
M easurem ents taken  
w eekly for 8 w eeks
Com pleted consent 
forms returned
Subject and G .P  consent 
forms sent to subjects  
m eeting inclusion & 
exclusion criteria
Figure 5.2 Flow diagram of study design
5.2.2 Ethics
Ethical approval was requested and granted from the University of Surrey Advisory 
Committee on Ethics and South East Multi-Centre Research Ethics Committee (MREC) 
(See Appendix P).
Participation in this study required informed consent from both subjects and their general 
practioners.
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5.2.3 Sample size
This study was intended to be a pilot study collecting data which could be used in further 
research therefore a target of recruiting 20 subjects was set.
5.2.4. Sample
5.2.4.1 Subjects
Subjects were selected for the study if they met inclusion and exclusion criteria (see Table 
5.3). General Practioners were asked to provide a certified medical consent form prior to 
subjects undergoing baseline tests.
Table 5.3 Inclusion and exclusion criteria for a study of LCD induced body 
composition changes.
Inclusion criteria Exclusion criteria
Male or female Current or prior history of coronary heart 
disease or have a pace-maker in situ
21-65 years of age Known type 1 or type 2 diabetes
BM I27-40 kg/m^ Current or prior history of renal failure
Not currently losing weight Current or prior history of gout
Able to travel to Guildford weekly for 
study duration
Current of prior history of liver failure
History of, or are currently being treated 
for clinical depression, use of 
antidepressant medication and other 
psychological disorders
History of eating disorders including 
anorexia and bulimia nervosa
History of obesity of known cause e.g. 
Cushings disease
Currently using any weight loss 
drug/preparation or use of such within the 
30 days prior to enrolment
Previous gastric/obesity surgery
History of drug or alcohol abuse within the 
last 2 years
Uncontrolled thyroid disease or an
abnormal TSH based on G.P opinion
Treatment with lipid lowering or anti­
hypertensive medication
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S.2.4.2 Recruitment
Recruitment utilised media advertising. As local advertising for another LCD intervention 
(Chapter 3) had recently been conducted adverts were placed in newspapers within the 
London area as well as the immediate vicinity of the university.
Subjects responding to the advert were contacted by the researcher. If they met the age and 
BMI entry criteria (self reported height and weight were used to allow BMI to be 
estimated) and were able to travel to the University of Surrey on 9 consecutive weeks they 
were then sent further information regarding the study and a letter for their G.P to 
complete. When subjects returned both their completed consent form and the G.P consent 
form confirming they met the entry criteria, they were considered eligible for the study and 
an appointment was made for their baseline visit.
5.2.5 Intervention
All subjects were asked to come into the University of Surrey at baseline and weekly 
thereafter as shown in Figure 5.3.
A 7-day food diary was kept by all subjects for the week preceding their baseline visit. 
Subjects came in for all their appointments first thing in the morning, having fasted 
overnight for 12 hours. They were asked to refrain from having caffeinated drinks and from 
taking strenuous exercise on the previous day.
During baseline appointments weight and height were checked to ensure subjects met 
inclusion criteria and fasting blood glucose was measured to screen for undiagnosed 
diabetes. Subjects were counselled to follow a LCD by the researcher, a registered dietitian, 
with carbohydrate intake initially reduced to 20g per day. The diet used is described in 
Chapter 3 and identical diet sheets and resources were provided.
Subjects were asked to maintain baseline levels of activity throughout and to commence the 
diet 2 days after their baseline appointment. Subsequent appointments were scheduled at 
the same time on the same day of the week where ever possible. At each visit all subjects 
met with a registered dietitian to discuss their progress and advice and support was given to 
assist subjects in complying with the LCD. Long term weight management advice was 
provided at the final visit (Appendix F).
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5.2.6 Measures
Measurements were taken at each appointment as shown in Figure 5.3.
5.2.6.1 Weight
Subjects were weighed in light clothing, (without shoes) to the nearest 0.1kg using stand on 
scales. The same scales were used throughout the study (SEGA 770 high capacity floor 
scales).
5.2.6.2 Height
Height was measured, (without shoes) to the nearest 0.5 cm using a wall mounted 
stadiometer. BMI was calculated from the above measured (weight/height^).
5.2.6.3 Waist and hip circumference
Both waist and hip circumference were measured to the nearest 0.5 cm using a Holtain tape 
measure. Waist circumference was taken at 1cm above navel. Hip circumference was taken 
as the widest point around the buttocks.
5.2.6.4 Body composition
Body fat mass was estimated using bioelectrical impedance which measures total body 
water. The Bodystat 1500 MDD was used, a four-point BIA. Subjects were asked to lie in a 
supine position whilst measurements were taken. Electrodes were placed on the right hand 
and foot and percentage and absolute body fat and lean tissue were estimated by the BIA 
using inbuilt algorithms. The validity and re-test reliability of this method has been 
previously examined in obese subjects (Barratt, 2005).
5.2.6.5. Blood pressure
An electronic sphygmomanometer was used to measure blood pressure, (Omron M4). The 
mean of 3 blood pressure readings, taken with the subject sitting at rest, was calculated.
5.2.6.6. Dietary intake
Subjects were asked to complete a 7-day quantified dietary diary at baseline and during the 
last week of the study (week 8). A previously validated 7-day food diary was used 
(Appendix K). Dietary intake was recorded and analysed using identical methodology to
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that used in a previous investigation (Section 3.2.7.1) to assess total energy intake and 
macronutrient composition.
In addition a 24-hour dietary recall was taken each week to assess intake at these time- 
points and this was analysed in the same manner.
5.2.6.7 Ketone excretion
Ketone reagent sticks (Bayer) were provided and subjects were asked to test their urine for 
presence of ketones each morning for the first week of the study and once a week on the 
day of their appointment thereafter.
5.2.7 Statistical analysis
To characterise the study population descriptive statistics were performed. Independent t- 
tests were used to compare baseline characteristics of completers compared to those who 
withdrew from the study. Normality of the data distribution was assessed using 
Kolmogorov-Smimov Z samples test.
Analysis of anthropometric and blood pressure data was conducted using two sets of data, 
the first being a completers analysis including the data from all subjects who completed the 
8 week study. An ITT analysis was then carried out which allowed for variation caused by 
drop-outs. This analysis used baseline values carried forward to account for missing data.
Paired t-tests were used to compare changes in anthropometric and blood pressure 
measurements from baseline to the end of the study.
Repeated measures ANOVA was used to describe changes in weight and body composition 
over time. If data was found to be non-spherical, (Mauchly’s test of sphericity) the 
Greenhouse-Geisser epsilon was used. Estimated marginal means, using the Bonferroni 
correction was used to make pair wise comparisons to investigate significant effects.
All available data was used in the nutrient analysis with paired t-tests determining where 
significant changes in macronutrient intake occurred.
Correlation analysis was performed, using Pearson correlation, to investigate the 
relationship between continuous variables, e.g. energy intake and weight loss.
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A P value of 0.05 was considered statistically significant. Analyses were performed using 
SPSS, version 12 for Windows.
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5.3 Results
5.3.1 Recruitment
Twenty individuals met inclusion and exclusion criteria and returned consent forms within 
the timeframe of the study and were therefore invited to the University of Surrey for 
baseline measurements to be taken. Two subjects did not attend this appointment and were 
non-contactable thereafter; consequently 18 subjects commenced the study. Recruitment 
and the study progress can be seen in Figure 5.4.
U nable to obtain body 
composition d ata  from one  
subject
(n=1)
W ithdrew  before  
baseline  
m easurem ents  
taken  (n=2)
Intention to treat analysis
(n=17)
C om pleter’s analysis
(n=14)
Inclusion and  exclusion  
criteria m et
(n=20)
Baseline m easurem ents  
taken
Subjects enter study 
(n=18)
Inability to tolerate diet 
(n=2)
M edical reason  
unconnected to diet 
(n=1)
W ithdrew  (n=3)
Figure 5.4 Flow chart of subjects through the study
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5.3.2 Baseline characteristics
Although male gender was not an exclusion criterion all subjects who completed consent 
forms and attended baseline appointments were female. Baseline characteristics are 
summarised in Table 5.4. There was no significant difference in any characteristic between 
those subjects who completed the study and those who withdrew.
Table 5.4 Comparison of baseline characteristics between subjects who completed the 
study and those who withdrew
Characteristic Completers (n=14) Withdrawals (n=3)
Mean [SD]
Age 42 [10] 37 [8]
Weight 88.5 [9.0] 87.1 [7.7]
BMI 32.4 [2.8] 32.6 [1.5]
Body fat percentage 40.8 [3.4] 42 [3.1]
5.3.3 Withdrawal rate
The attrition rate from the study was 18% with reasons for withdrawal shown in Figure 5.4.
5.3.4 Weight
The total change in absolute weight of all subjects who completed the 8 week study is 
shown in Table 5.5 with results of paired t-tests comparing the two time points. An ITT 
analysis of the same parameters is shown in Table 5.6.
Those outcome measures which changed significantly over the study period with a 
completers analysis also did when an ITT analysis was used. In order to allow for the 
potential effect of drop-outs the more conservative ITT analysis is used from this point 
forward (except for nutrient data).
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Table 5.5 Weight, anthropometric and blood pressure changes from baseline to 8 
weeks (completers analysis) (n=14)
Baseline 8 weeks Change 95% Cl Paired T-test
Mean [SD] Lower
Cl
Upper
Cl
T P
Absolute weight (kg) 88.5 [9.0] 83.8 [9.5] -4.7 [2.8] 3.1 6.3 6.3 <0.001
BMI (kg/m2) 32.4 [2.8] 30.7 [3.1] -1.7 [1.0] 1.1 2.3 6.3 <0.001
Waist circumference 
(cm)
97.4 [9.5] 92.1 [8.8] -5.4 [4.3] 2.9 7.8 4.7 <0.001
Hip circumference 
(cm)
119.4
[6.3]
114.8 [7.4] -4.6 [3.3] 2.8 6.5 5.3 <0.001
Body fat (kg) 36.2 [5.8] 32.9 [5.9] -3.3 [2.2] 2.0 4.6 5.7 <0.001
Body fat (%) 40.8 [3.4] 39.1 [3.7] -1.7 [1.8] 0.7 2.7 3.6 0.003
Lean mass (kg) 52.3 [4.4] 50.9 [4.9] -1.4 [1.8] 0.4 2.5 3.0 0.011
Water (kg) 38.3 [3.2] 37.1 [3.3] -1.2 [1.4] 0.4 1.9 3.2 0.007
Systolic blood 
pressure (mm/Hg)
128.7
[15.5]
126.8 [14.9] -1.9 [10.4] -4.1 7.9 0.7 0.500
Diastolic blood 
pressure (mm/Hg)
81.4
[12.6]
79.4 [10.3] -2.0 [12.2] -5.0 9.0 0.6 0.549
Table 5.6 Weight, anthropometric and blood pressure changes from baseline to 8 
weeks (ITT analysis) (n=17)
Baseline 8 weeks Change 95% Cl Paired T-test
Mean [SD] Lower
Cl
Upper
Cl
T P
Absolute weight (kg) 88.3 [8.6] 84.4 [9.1] -3.9 [3.1] 2.3 5.5 5.1 <0.001
BMI (kg/m2) 32.4 [2.6] 31.0 [3.0] -1.4 [1.1] 0.8 2.0 5.1 <0.001
Waist circumference 
(cm)
97.8 [8.9] 93.4 [8.8] -4.4 [4.4] 2.2 6.7 4.1 0.001
Hip circumference 
(cm)
118.4
[6.3]
114.5 [6.8] -3.8 [3.5] 2.0 5.6 4.5 <0.001
Body fat (kg) 36.3 [5.3] 33.5 [5.6] -2.7 [2.4] 1.5 3.9 4.8 <0.001
Body fat (%) 41.0 [3.3] 39.6 [3.7] -1.4 [1.7] 0.5 2.3 3.4 0.004
Lean mass (kg) 52.0 [4.7] 50.8 [5.0] -1.2 [1.7] 0.3 2.1 2.8 0.012
Water (kg) 37.9 [3.4] 37.0 [3.3] -0.9 [1.3] 0.3 1.6 3.0 0.008
Systolic blood 
pressure (mm/Hg)
127 [15.2] 125.4 [14.5] -1.6 [9.4] -3.2 6.4 0.7 0.496
Diastolic blood 
pressure (mm/Hg)
80.1
[11.6]
79.2 [9.5] -1.6 [11.0] -4.0 7.3 0.6 0.545
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The mean absolute weight loss was 3.9 kg [3.1]. Weight loss was most rapid in week 1 (-
1.2 kg [1.15]) and week 2 (-1.2kg [1.04]), slowing to -0.3 kg [SD 0.42] per week thereafter 
(Table 5.7).
Eight subjects achieved a 5% weight loss over the course of the study as illustrated in 
Figure 5.5. The mean percentage change in weight from baseline was -4.5 % [3.8].
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Figure 5.5 Individual changes in percentage weight change from baseline to 8 weeks 
for women enrolled on a LCD study
------------ Clinically significant weight loss (-5%)
Repeated measures ANOVA showed absolute weight changed significantly with time, (f 
(17.38) =1.9, P<0.001) indicating that subjects lost a significant amount of weight while 
following the LCD. This significant effect was investigated further and the change in 
weight in week 1 (P=0.025) and week 2 (F=0.008) were seen to be significant, (Table 5.7) 
but this was not so in any individual week thereafter.
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Table 5.7 Mean [SD] weekly weight change in women (n=17) enrolled in a low 
carbohydrate diet study and results of Bonferroni correction investigating where 
significant changes in weight occurred.
Change in weight (kg) 
Mean [SD]
P Value
Week 1 -1.2 [1.1] 0.025
Week 2 -1.2 [1.0] 0.008
Week 3 0.1 [1.2] 1.0
Week 4 -0.5 [1.0] 1.0
Week 5 -0.3 [0.8] 1.0
Week 6 -0.0 [0.9] 1.0
Week 7 -0.4 [0.7] 1.0
Week 8 -0.4 [0.7] 1.0
5.3.5 BMI
BMI changed significantly ( f  <0.001) over the course of the study (Table 5.6). At baseline 
15 of the 17 subjects (88%) commencing the study were obese (BMI >30kg/m^) and 2 
subjects were overweight (BMI 25-30kg/m^) while at the end of the study 59% of subjects 
were obese (n=IO) with 6 having a BMI of between BMI >25<30kg/m^ and one subject 
having a BMI within the normal range (<25kg/m^).
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5.3.6 Waist and hip circumference
Both waist and hip circumference decreased significantly over the study duration as shown 
in Figure 5.6. The change in waist-hip ratio from 0.83 [0.6] at baseline to 0.82 [0.6] at 8 
weeks was non significant (P=0.128).
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Figure 5.6 Baseline and 8 week waist and hip circumferences in women (n=17) 
enrolled in a low carbohydrate diet study.
Error bars indicate standard error of the mean (SEM)
Bars with superscript symbols are significantly different from baseline; *P=0.001, '= f  <0.001
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5.3.7 Body composition
Fat mass was reduced by -2.7 kg [2.24] over the 8 week study and lean mass was reduced 
by -1.2 kg [1.72]. A total of -0.95 kg [1.3] of this was due to a reduction in body water. 
Figure 5.7 summarizes the changes seen in body composition.
Repeated measures ANOVA showed absolute fat mass changed significantly with time, (f 
(9.1) =2.5, P<0.001) indicating that subjects lost a significant amount of fat mass whist 
following the LCD. This significant effect was investigated further and the change in fat 
mass in any individual week was significant in week 6 only, (Table 5.8). ANOVA showed 
that neither the change in lean mass nor water was significant over the study duration 
(Figure 5.7) or in any individual week (Table 5.8). After the first week of the study loss of 
fat mass surpassed than of lean mass.
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Figure 5.7 Change in total, fat & lean mass and body water over the study period for 
women (n= 17) enrolled in an 8 week low carbohydrate diet study
Repeated measures ANOVA showed total body weight and body fat mass changed significantly with time; 
*(P<0.001)
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Table 5.8 Mean [SD] weekly body composition changes in women (n=17 ) enrolled in 
an 8 week low carbohydrate diet study, with results of Bonferroni correction 
investigating where significant changes in fat mass, lean mass and water occurred.
Change in 
fat (kg) 
Mean [SD]
P Value Change in 
lean (kg) 
Mean [SD]
P Value Change in 
water (kg) 
Mean [SD]
P Value
Week 1 -0.5 [1.3] 1.000 -0.7 [1.0] 0.622 -0.6 [0.9] 0.773
Week 2 -0.9 [1.3] 0.556 -0.3 [0.8] 1.000 -0.3 [0.7] 1.000
Week 3 -0.1 [1.2] 1.000 0.2 [1.0] 1.000 0.2 [0.8] 1.000
Week 4 -0.0 [1.2] 1.000 -0.3 [1.8] 1.000 -0.6 [1.8] 1.000
Week 5 -0.1 [1.3] 1.000 -0.1 [1.6] 1.000 0.2 [1.8] 1.000
Week 6 -0.6 [0.6] 0.010 0.2 [1.3] 1.000 0.2 [1.1] 1.000
Week 7 -0.1 [0.7] 1.000 -0.3 [0.8] 1.000 -0.0 [0.6] 1.000
Week 8 -0.4 [1.1] 1.000 0.1 [1.7] 1.000 -0.1 [0.9] 1.000
5.3.8 Ketone levels
Ninety-four percent of subjects had a urinary ketone level classified as trace or greater at 
week 1. This had reduced to 76% by week 2 and 57% by week 8.
5.3.9 Blood pressure
Systolic blood pressure fell from 127 mmHg [15.2] at baseline to 125mmHg [14.5] at 8 
weeks while diastolic blood pressure was reduced from 80.1 mmHg [11.6] to 79.2 [9.5] 
over this same time frame. These changes were non-significant (Table 5.6).
5.3.10 Dietary intake
In order to assess the validity of the diet diaries to provide accurate nutrient intake 
information the total energy expenditure (TEE) of each subject was predicted and compared 
to their reported energy intake at baseline. The rEI to pTEE ratio (rELpTEE) was calculated 
for each subject at baseline using the same methodology as described in section 3.2.7.1.
Identification of those subjects who were likely to be reporting their energy intake 
accurately was determined using the method described by McCrory et al, (2002).
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The within subject errors associated with each parameter are taken into account in this 
method which is based on the principals of the agreements between PAL and rEI and BMR 
(Black, 2000). They include a value of 8.2% being the coefficient of variation of the 
technical error for measuring TEE using doubly labelled water (CV tmTEE) and 17.7% for 
measurement errors in predicted TEE ( C V wptee) .
ISD = V  (CV2 w E l/ d) + CV2 wTEE + CV2 tmTEE
CVwEi = within subject coefficient of variation in energy intake
d= number of days of food records
ISD =V (23% / 7) + 313.3 + 67.2
=19.6
Therefore those reporters with a rEI of <80% difference from pTEE were identified as 
under-reporters as their rEI is physiologically implausible. Those subjects with a difference 
of >120% between rEI and pTEE would also normally be deemed as ‘over-reporters’. 
However because this was a group of overweight individuals who were recruited on the 
basis they were not to be currently losing weight and asked to maintain their normal diet at 
the time baseline diaries were recorded, it is possible their energy intake exceeded ‘usual 
parameters’. Three of 13 subjects (23%) had an ELTEE ratio of <0.8 which was not 
physiologically plausible suggesting under-reporting. In addition 3 subjects had a ELTEE 
ratio above the cut-off value (1.2). The data from all available diaries (n=l 1 where nutrition 
information was available throughout the study) was used as excluding data from 
implausible reporters can introduce further bias.
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5.3.10.1 Energy intake
Mean daily energy intake of subjects when following the LCD was 6443 kJ [2016]. This 
was significantly reduced (P=0.002) from baseline (10361 kJ [2626]) (Figure 5.8).
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Figure 5.8 Mean energy intake of subjects at baseline and during the low 
carbohydrate diet study
Error bars indicate standard error of the mean (SEM).
* Values significantly different (P=0.002) (Paired t test)
 Mean TEE
5.3.10.2 Macronutrient intake
The contribution of macronutrients to energy intake changed substantially when subjects 
commenced the LCD (Figures 5.9 and 5.10). Carbohydrate constituted 40% of energy at 
baseline, reducing to 14% on the LCD, with a subsequent increase in the contribution of fat 
and protein to energy (+26 % and +10% respectively). However, in absolute terms the 
reduction in carbohydrate intake was not replaced by either protein or fat (Table 5.9), hence 
the energy deficit observed.
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Figure 5.9 Contribution of macronutrients to energy intake at baseline for women 
enrolled on a low carbohydrate diet study
CHO-carbohydrate
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Figure 5.10 Contribution of macronutrients to energy intake for women during the 
low carbohydrate diet study
CHO-carbohydrate
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Table 5.9 Mean absolute intake of macronutrients at baseline and when following a 
LCD
Baseline 
(n=ll) 
Mean [SD]
Low CHO Diet 
(n=ll) 
Mean [SD]
CHO(g) 256.1 [143]* 54.1 [26.7]*
Fat (g) 113.8 [34.5] 97.7 [37.1]
Protein (g) 101.4 [34.5] 100.7 [33.0]
Alcohol (g) 10.3 [12.5] 4.4 [9.0]
CHO-carbohydrate
* Values with identical symbols are significantly different (P=0.001) (Paired t test)
5.3.11 Relationships between measured outcomes
To investigate relationships between measured outcomes Pearsons correlations were 
calculated (Table 5.10). Weight correlated with anthropometric and body composition data 
as would be expected.
Table 5.10 Relationships between weight and anthropometric and body composition 
measurements for 17 women enrolled on an 8 week LCD study
Factor Measure n Correlation
(r)
P
Absolute weight Change in BMI 17 0.991 <0.001
change Change in body fat (kg) 17 0.833 0.006
Change in waist circumference 17 0.700 0.002
Change in lean mass (kg) 17 0.687 0.002
Change in body water (kg) 17 0.657 0.004
Correlation analysis suggested there was no association between weight change and mean 
energy, fat, protein or carbohydrate intake whilst following a LCD. No correlation was seen 
between weight change and ketone excretion.
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One subject (a completer) gained weight over the course of the 8 week study (+ 1kg). The 
reported energy intake of this subject was 4363kJ and TEE was calculated to be 9841kJ. 
Therefore Pearsons correlations investigating associations between energy/macronutrient 
intake and weight change were repeated with this subject removed from the database (Table 
5.11).
Table 5.11 Relationship between weight and energy and macronutrient intake for 
women enrolled on an 8 week LCD study (1 subject excluded)
Factor Measure n Correlation
(r)
P
Absolute weight Average energy intake on LCD 10 0.626 0.053
change Average CHO intake on LCD 10 0.591 0.072
Average fat intake on LCD 10 0.509 0.133
CHO-carbohydrate
A trend towards an association between average energy intake while on a LCD and 
absolute weight loss can be seen ( f =0.053).
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5.4 Discussion
This study was designed to test the hypotheses that a structured and dietitian counselled 
LCD would lead to rapid initial weight loss substantially composed of body fat, and that 
this weight loss would be explained by the energy deficit induced by the restrictive diet. 
The data collected from the 17 women who followed a LCD for 8 weeks support these 
hypotheses.
The aim of this study was to investigate the rate and composition of weight loss when a 
LCD was initiated in healthy, but overweight men and women. However the final sample 
consisted entirely of women due to the lack of response from male volunteers. Therefore no 
further information is available on the initial effects of a LCD on men from this study, 
although the exclusion of possible gender differences may strengthen the power of the 
findings from this pilot study. The weekly visits required to the university may have been a 
reason for the lack of male volunteers to this study. A greater percentage of women work 
part time, (Bower, 2001) and therefore more women may have had the time to commit to 
the demands of a study such as this. In addition recruiting women to a LCD study allowed a 
new pool of potential subjects to be drawn on. As men have been recruited from the area 
for a previous study (Chapter 3) interested males may already have participated in a study 
investigating LCD.
Considering the study design that required multiple and frequent early morning visits to the 
University, the relatively low attrition rate achieved in this pilot study suggests that most of 
the participants were able to follow the dietary advice provided and that the dietary 
approach taken was both practical and acceptable to women.
5.4.1 Weight
Forty-seven percent of subjects reduced their weight by 5% or more over the course of the 
study. This degree of weight loss can reduce the risk of degenerative diseases such as CHD, 
hypertension, type II diabetes and hyperlipidaemia (Pasanisi et al, 2001).
The mean weight loss seen in this study was lower than that seen in some previous studies 
where a LCD has been followed. Brehm et al, (2003) reported a mean weight loss of 7.6kg 
[0.7] in women who had followed a LCD for 3 months. A similar degree of weight loss 
(7kg) was seen when overweight men and women followed a LCD for 10 weeks (Meckling
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et al, 2004). Although these studies are of longer duration than the current study this is 
unlikely to explain all of the additional weight loss.
A possible explanation for the lower weight loss observed in this study could be due to one 
subject gaining weight thereby affecting the mean result. The methodology used may also 
have affected the amount of weight loss seen; e.g. daily food diaries and exercise logs were 
used in the study by Meckling et al, (2004) and this may have led to the increased weight 
loss of subjects in this study as regular monitoring increases compliance to diet (O’Neil, 
1996) and exercise (Fletcher and Banasik, 2001) interventions.
One of the aims of this study was to investigate the rate of initial weight loss induced by a 
LCD. A significant weight loss was observed in week 1 and 2 only indicating a rapid initial 
weight loss as was hypothesised and has been previously well documented. Worthington 
and Taylor, (1974) observed a weight loss of 3.7 kg in women (n=20) in the first week of a 
LCD (mean intake = 17g / day). This rate of weight loss fell to 1.7kg in the second week. 
This large weight loss would be expected as subjects were institutionalized and all meals 
prepared by the investigators. Larosa et al, (1980) saw a mean weight loss of 3.6kg in free- 
living obese men and women during their first two weeks of following a LCD. However, 
most recent studies have not taken measurements during the early stages of subjects 
following a LCD to allow comparison.
The rapid initial weight loss seen can be partially explained by the depletion of liver and 
muscle glycogen stores due to the low carbohydrate intake (Anderson et al, 2000). 
Enhanced diuresis has also been suggested to contribute to rapid weight loss when a LCD is 
followed (Anderson et a l 2000). This is due to the reduction in insulin levels observed 
when a LCD is followed (Baba et al, 1999; Stem et al, 2004). As insulin has an 
antidiuresis effect, (Defronzo et al, 1975) lower levels would lead to greater diuresis. 
However the body composition results show water losses contribute to 50% of the weight 
lost in week 1 and 25% in week 2. Therefore reductions in fat and lean body mass are 
responsible for some of the weight loss even during these early weeks.
5.4.2 Waist and hip circumference
Although a significant reduction in both waist and hip circumference was seen the change 
in WHR was not significant.
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Health benefits would be expected to be derived from the lower waist circumferences 
achieved as it has been demonstrated that waist circumference is associated with all cause 
mortality (Biggard et al, 2005).
Waist circumference is a marker of visceral fat stores, (Janssen et al, 2002) therefore the 
reduced waist circumference observed would suggest visceral fat has been decreased after 
subjects followed a LCD. This finding has been reported elsewhere in a sample of patients 
with type 2 diabetes following a LCD for 4 weeks, (Miyashita et al, 2004) with a 
significant reduction in visceral fat as measured by computed tomography.
A beneficial effect of LCDs as compared to an isocaloric, low fat, high carbohydrate diet 
on body fat distribution has been reported by Volek at al, (2004^) and Miyashita et al, 
(2004) where significantly greater losses of trunk fat, (Volek et al, 2004 )^ and visceral fat 
(Miyashita et al, 2004) were seen. The distribution of the weight loss observed is important 
as visceral fat is associated with insulin resistance and development of CHD, (Miyashita et 
al, 2004).
5.4.3 Body composition
This study aimed to investigate the composition of the weight loss seen and it is evident 
weight loss was predominantly fat mass. Fat mass, but not lean mass or body water, 
changed significantly with time over the 8 weeks of the study.
Similarly Miyashita et al, (2004) found weight loss was entirely due to fat in a four week 
study investigating a LCD. In the current study 69% of weight loss was due to loss of fat 
mass. This is close to the expected 78% predicted in women through dieting alone, (Garrow 
and Summerbell, 1995) and comparable to other LCD studies measuring body composition 
changes (Brehm et al, 2003; Westman et al, 2002; Yancy et al, 2004).
Although studies measuring body composition changes when a LCD is followed are 
available, very few of these have taken serial measurements at one week intervals from 
commencement of the LCD as was undertaken in this study.
Results from the bioelectrical impendence measurements show fat mass was reduced from 
the first week of the study and continued to fall thereafter. As the early changes in weight 
when a LCD is followed are often attributed to loss of glycogen and water the degree of
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change in fat mass (-1.4kg in the first 2 weeks) starting on commencement of this diet is 
perhaps unexpected.
In a study by Yancy et al, (2004) overweight, hyperlipidémie subjects (n=120) were 
randomised to follow a LCD or low fat diet for 6 months and those in the LCD group lost 
more body water (1.1kg) than those in the low fat group (0.5kg) in the first two weeks. This 
loss of body water is similar to that seen in the current study (0.9kg) two weeks after 
commencing the LCD. The difference in the amount of body water lost in each group was 
explained by the authors on the basis of the diuretic effect of the LCD.
Glycogen stores in adults are estimated to be ~500g (Denke, 2001) with each gram stored 
with 4 g of water, equating to a total weight of -2.5 kg. Therefore water losses of 0.95kg, 
as seen in this study, can be entirely accounted for by an incomplete loss of glycogen 
associated water suggesting that enhanced diuresis due to the low carbohydrate content of 
the diet may not be a contributing factor.
The rate at which body water changed would appear to support these changes being due to 
a loss of glycogen associated water losses. Ninety-five percent of the total change in body 
water over the study period occurs in weeks 1 and 2, which is when carbohydrate intake is 
first restricted and glycogen stores are utilised. After the initial two weeks subjects were 
encouraged to increase their carbohydrate intake slightly in order to increase dietary 
variety. This is matched by a slight increase in body water as some of the lost glycogen 
stores are restored.
In week 4 body water again decreased substantially, (mean change -0.6kg). This is 
unexpected as it would be assumed body water would stabilise after the initial loss of 
glycogen stores. However a large standard deviation is seen at this time point so it may be 
explained by several subjects having body water levels higher or lower than expected due 
to variation in hydration status.
During one week of the study the BIA analyser was not functioning due to a broken lead. 
Although a stand-on BIA machine was used during this week to ensure a measurement was 
taken it was decided these results would not be used in the analysis due to the high degree 
of variation possible between difference apparatus. Therefore an imputation technique was 
applied to account for missing data. This occurred in weeks 4, 5 or 6 for different subjects
211
depending on the stage of the study they had reached. Therefore the increase in body water 
seen in week 4 could be explained by this.
From week 5 onwards body water changed only marginally. At this stage carbohydrate 
intake was maintained at a constant level therefore no substantial change in glycogen stores 
would be expected.
5.4.4 Ketone excretion
All subjects, with the exception of one, were ketotic at their first appointment after 
commencing the LCD. Subjects were instructed to commence the diet two days after 
baseline measurements were taken so had been following a LCD for 5 days by this stage. 
Glycogen stores would be depleted by this time and the body would therefore have begun 
utilising adipose stores for energy meaning ketone production would have commenced.
The subject who was not ketotic at week 1 gained weight in week 1 therefore the lack of 
ketones in her urine is expected and probably due to non-compliance with the dietary 
advice. This subject withdrew from the study after 5 weeks.
After the first week the number of subjects who continued to be in ketosis gradually 
reduced. A reduction in the proportion of subjects following a LCD excreting ketones has 
been reported elsewhere (Yancy et al, 2004). Although there is currently ‘no consensus as 
to what is the absolute cut-off limit for maximal amount of carbohydrate intake necessary 
to induce ketosis’, (Bilsborough and Crowe, 2003, p398) a carbohydrate intake of <20g/day 
would be expected to induce ketosis (Brehm et al, 2003). As carbohydrate intake increased 
above this level after the first two weeks ketosis would be expected to cease in some 
individuals.
No correlation between weight loss and ketone excretion was evident. It might be expected 
that those subjects who were complying most rigidly with the diet would have the greatest 
weight losses and would be ketotic as a result of their low carbohydrate intake. However, as 
it has been shown that energy intake and not carbohydrate intake is associated with weight 
loss, (Bravata et al, 2003) those subjects most successful in weight loss may not 
necessarily have had the lowest carbohydrate intakes.
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5.4.5 Blood pressure
No significant changes in blood pressure were seen over the 8 week study. Current research 
indicates LCD have no detrimental effect on blood pressure, (Bravata et al, 2003) and 
although some studies have shown LCD may reduce this parameter, (Nobels et al, 1989; 
Westman et al, 2002; Foster et al, 2003) other studies, (Brehm et al, 2003; Samaha et al, 
2003) have reported no significant effects. These women were normotensive at baseline so 
it would not be anticipated that huge changes in systolic or diastolic pressure would be 
measurable over a relatively short intervention period.
5.4.6. Energy intake
Reported daily energy intake was reduced by 3918kJ when a LCD was commenced. An 
energy deficit of 32.2 MJ is needed for each kg of body weight loss, (Hall, 2007) therefore 
this energy deficit would be expected to produce a weight loss of 0.90 kg per week or 7 kg 
over the 8 week period. The actual weight loss seen, 3.9kg (equating to 0.49kg per week) is 
considerably lower than this. The likely reason for this discrepancy is an under-reporting of 
energy intake while following the LCD.
In order to assess the extent of under-reporting total energy expenditure (TEE) at baseline 
was predicted for each subject in this study. In 23 % of subjects reported energy intake at 
baseline was less than is physiologically plausible. This suggests a degree of under 
reporting at baseline and it could therefore be anticipated under reporting was increased 
further when a LCD was initiated and subjects knew their expected energy intake would be 
lower. The high incidence of under reporting has been widely published with a review of 
studies which have reported energy intake and measured energy expenditure concluding 
that underestimation of energy intake is a widespread problem (Livingstone and Black, 
2003).
Nevertheless it is evident from the successful weight loss achieved in most subjects that an 
energy deficit was achieved. This energy deficit, along with glycogen associated water 
losses can fully explain the weight loss seen. Although other potential weight loss 
mechanisms such as changes in metabolic rate were not measured in this study it would 
appear that any effects of such mechanisms were small.
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5.4.7 Macronutrient intake
The percentage contribution of carbohydrate to energy decreased significantly when a LCD 
was commenced as would be anticipated with compliance to dietary advice provided in a 
supported setting. Consequently the percentage energy derived from protein and fat 
increased. However when the absolute intakes are considered is can be seen the reduction 
in carbohydrate was not compensated for by an increase in either fat or protein. Although 
concerns have previously been raised regarding the high intake of these macronutrients, (St 
Jeor et al, 2001; Council on Foods and Nutrition, 1973) and the potential implications this 
could have on health these results show fat and protein intake may actually be lower when 
a LCD is followed compared to usual intakes.
An association between average energy intake while on a LCD and absolute weight loss 
was seen (r=0.626, P=0.053). There was no correlation between carbohydrate intake and 
weight loss indicating that energy intake per se and not dietary composition affects weight 
loss.
Nevertheless dietary analysis indicates weight loss in subjects following this LCD was 
achieved primarily through the non-compensated reduction in carbohydrate intake.
Protein intake was not reduced when the LCD was initiated. Maintaining baseline levels of 
protein, which is the most satiating macronutrient, (Stubbs, 1995), may have enabled 
subjects to keep their energy intake to a minimum due to lower hunger levels.
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5.4.8 Limitations
The main limitation of this study is the small sample size. The study was set up as a pilot 
study to investigate early changes in body composition. Therefore although the results 
cannot be generalised to the larger population they do add to our understanding of the area 
and will be useful in the planning of a larger study.
As the sample in this study were all women who have a higher percentage fat mass than 
men, (Bouchard, 1991) the results from this study may not be applicable to men. Weight 
fluctuations are evident in women throughout the menstrual cycle, however Mckee and 
Cameron (1997) concluded these changes in body weight were not sufficient to affect lean 
body mass and total body water measurements using BIA.
Due to an unforeseeable problem with the BIA machine it was not possible to collect body 
composition measurements during one week of the study. This problem was overcome by 
using interpolation to correct for missing data but to ensure this did not occur in future 
studies it would be necessary to have a second BIA machine of the exact specifications 
available.
No reasonable body composition measurements could be taken from one subject which led 
to the other measured parameters being unusable.
The validity and reliability of using tetrapolar impedance to determine body composition 
has been reported previously, (Lukaski et al, 1986) and the advantages of this method, (low 
cost, non invasive, reproducibility, safety, speed, ease of use) are numerous. However its 
major limitation is that is reliant on regression models which are derived from a limited 
sample (Lukaski, 1999). Measurement of body composition using bioelectrical impedance 
is affected by numerous factors; body position, hydration status, food and drink 
consumption, temperature, recent physical activity and conductance of the examining table 
(National Institute of Health, 1994). However these variables were standardised wherever 
possible in the current study to ensure measurements taken were reliable.
Underreporting is a limitation of all studies assessing dietary intake. It is not possible to 
determine if this bias in recording food intake is selective to certain foods thereby affecting 
the nutrient information collected as well as the energy intake data. In a community based
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study such as this measurement of actual energy intake is not possible therefore 
acknowledging the limitations of dietary assessment is vital.
The majority of individuals following a LCD do so without support or monitoring from 
health professionals. Therefore the results of this study which provided individual dietary 
counselling by a registered dietitian may not translate to a free-living, unsupported 
population.
5.4.9 Future work
The findings of this study are interesting and demand further attention to explore the body 
composition changes induced by LCDs in a larger sample and other population groups.
A randomised controlled trial with a second group following a higher carbohydrate, low fat 
diet, would allow comparison of the body composition changes during the initial stages of 
each diet.
5.4.10 Conclusion
It is evident that positive changes to body composition can be achieved relatively quickly 
with LCDs. This may benefit people who follow this type of diet for short time periods 
only. In addition, if dieters are aware their weight loss largely comprises of a reduction in 
fat mass this may motivate them to remain on the diet for longer periods. However, 
individual dietary counseling was likely to be an important contributor to the compliance 
and success seen in this study which may not be generalisable to an unsupported setting.
The data collected from this study suggest the initial weight loss seen when a LCD was 
followed could be attributed to the loss of glycogen and its associated water as well as the 
energy deficit induced by the dietary restrictions which led to body fat losses from the 
outset.
This study adds to our understanding of the rate and composition of the initial weight loss 
achieved via a LCD, enabling the lay population and health professionals alike to make 
more informed decisions regarding the efficacy of this approach.
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6. The efficacy of reduced carbohydrate diets with exercise as a weight loss 
intervention in overweight and obese patients and the implications of this approach on 
cardiovascular risk factors
6.1 Introduction
6.1.1 Background
As we continue the battle with obesity and its inevitable impact on increasing CVD risk, 
health professionals need to arm themselves with a broad knowledge of weight loss 
approaches and different dietary patterns in order to best advise and support their patients 
in a weight management regime that they can adhere to in the long term.
Low carbohydrate diets (LCDs) are one such strategy and offer an alternative to the 
accepted standard low fat approach that has gathered a large evidence base over many 
years. The efficacy of LCDs in producing weight loss has been clearly demonstrated with a 
growing body of research to suggest in healthy overweight adults even reducing 
carbohydrate in the diet to levels that induce ketosis does not produce any measurable 
harmful effects, at least in the short term (Crowe et al, 2005; Truby et al, 2006).
Interest in using alternative dietary patterns such as reducing the carbohydrate proportion of 
the diet has led to recent studies examining reduced carbohydrate diets in controlled weight 
loss programmes. The systematic review process enables the results of several studies to be 
compared by combining the power of different group’s results. In 2003, the first systematic 
review investigating the efficacy and safety of LCDs was published (Bravata et al). 
Bravata concluded that there was insufficient evidence to make recommendations for or 
against the use of LCDs though it was stated they may be an effective short term weight 
loss approach in healthy individuals with no significant detrimental effects on lipids, 
glycaemic control or blood pressure. Due to the lack of published studies at that time 
Bravata et al, (2003) were unable to compare the effects of LCDs with and without 
exercise. This review fills that gap by examining whether it is now possible to assess the 
added effects, if any, of an exercise programme combined with a LCD to assist in weight 
loss in the obese population.
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The importance of regular exercise alongside any weight loss diet to assist in creating an 
energy deficit, increase the likelihood of successful weight maintenance (Wing and Hill, 
2001) and to reduce CVD risk has been well documented (Fentem, 1994).
Therefore this review will provide important information to the lay population and health 
professionals alike as to the efficacy of incorporating exercise alongside a LCD into a 
whole lifestyle approach to weight management and disease risk reduction.
6.1.2 Aims;
The aims of this review were:
• To evaluate the changes in weight among overweight and obese adults using LCDs 
combined with exercise as an intervention for weight loss.
• To assess the effects of LCDs with exercise on changes in body composition, lipids 
and insulin in overweight and obese adults.
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6.2 Methodology
A search was conducted using PubMed (via Ovid) from 1950 to January 16^  ^ 2008 
following the search strategy outlined in Figure 6.1. There is no clear definition of a LCD 
(Crowe, 2005) therefore the keywords used in this search were selected to be as inclusive as 
possible. Thus any study defined as ‘low carbohydrate’, ‘ketogenic’, ‘carbohydrate 
restricted or ‘high protein’ was eligible for inclusion potentially allowing any study 
comparing a reduced carbohydrate diet with a higher carbohydrate diet to be included. With 
limits set, (Humans, Adults, English language and RCT) the keyword search identified 23 
studies. The full papers of these studies were then sourced and using pre-determined 
exclusion criteria (see Figure 6.1) the studies suitable for inclusion in the review were 
identified (n=3) and are shown in Table 6.1.
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Keywords (as specified below) were used;
1. Diet
2. Weight
3. Low carbohydrate
4. Ketogenic
5. Carbohydrate restricted
6. High protein
7. Exercise
8. Activity ,
Keywords were combined;
1 and 2 and (3 or 4 or 5 or 6) and (7 or 8)
Limits set; humans, adults (19 plus years), 
English language and ROT
23 studies were identified
Copies of the full paper were obtained for 
all studies and compared to exclusion 
criteria as shown below;
Exclusion criteria Studies excluded (n=20)
Subjects had a BMI <25kg/m2 at baseline 2
Not an exercise intervention with a comparable exercise vs. 
non-exercise group
17
Not a weight loss intervention 1
Diets provided <500 kcals a day 0
Pregnancy 0
Interventions were <7 days in duration 0
Study was carried out in children 0
Article not in English 0
Not a RCT 0
Animal study 0
Previously excluded via limits set
Papers to be included in 
review (n=3)
Figure 6.1 Search strategy for identification of studies to be included in review
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The three studies meeting selection criteria to be included in the review of the efficacy of 
reduced carbohydrate diets, with and without exercise, and the implications of this 
approach on cardiovascular risk factors are summarized in Table 6.1.
Table 6.1 Studies meeting selection criteria to be included in the review of the efficacy 
of reduced carbohydrate diets, with and without exercise, and the implications of this 
approach on cardiovascular risk factors
Author Year Title
Layman et al 2005 Dietary protein and exercise have additive effects on body 
composition during weight loss in adult women
Meckling 
and Sherfey
2007 A randomized trial of a hypocaloric high-protein diet, with 
and without exercise, on weight loss, fitness, and markers 
of the Metabolic Syndrome in overweight and obese 
women
Racette et al. 1995 Effects of aerobic exercise and dietary carbohydrate on 
energy expenditure and body composition during weight 
reduction in obese women
Information regarding the participants, (BMI, health status, age, gender) and the 
intervention used, (duration, method, energy and macronutrient balance of diet, type, 
intensity, frequency and duration of exercise and any monitoring or support given) was 
then extracted from each of the 3 studies. The characteristics of each study can be seen in 
Table 6.2.
Outcome measures were weight, BMI, body fat mass, lean body mass, fasting insulin, total 
cholesterol, HDL-cholesterol, LDL-cholesterol and TAG and baseline and post test 
measurements of these (mean and SD) were abstracted from each study. This information 
was only available in graphs for weight, body fat mass and lean body mass in the study by 
Racette et al, (1995). As it was not possible to obtain accurate readings from these graphs 
the corresponding author was contacted to request the information required but they were 
no longer at the contact address. In addition the measurements provided in this study, 
(Racette et al, 1995) were not taken before and after the intervention in all subjects but 
within a 2 week time period around each point and very small sample size was available for 
some data. Therefore the decision was made to not include the results from this study from 
the analysis.
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The 2 remaining studies, (Layman et al, 2005; Meckling and Sherfey, 2007) had a 2 x 2 
factorial design with subjects following either a reduced carbohydrate, high protein diet or a 
higher carbohydrate diet and were in either an exercise intervention group or an exercise 
control group. To achieve the aims of this analysis, the results from the groups of subjects 
following the reduced carbohydrate diet only were used. Thus allowing the comparison of 
individuals following a reduced carbohydrate diet with and without exercise.
Baseline and post intervention results for each outcome measure were identified to enable 
comparison of the changes in parameters in subjects who were in an exercise intervention 
group or a control intervention group. In order to combine the results of the 2 studies, a 
meta-analysis was conducted using Review Manager (version 4.2). The change in outcome 
measures was not available from published papers therefore end data was utilized. Weight 
and body fat mass data was suitable for analysis using end data as the difference at baseline 
between the exercise intervention and control groups was small in both studies. Therefore 
meta-analysis was conducted on weight and body fat mass only. Weighted mean 
differences (WMD) and 95% confidence intervals were calculated for weight and body fat 
mass.
The results from the new but currently unpublished study reported in Chapter 3 and 4, ‘A 
randomised trial investigating the effects of a low carbohydrate weight loss regimen, with 
and without the additive effects of exercise, on cardiovascular risk factors in overweight 
and obese men’ were also analyzed alongside the studies included in this review. Therefore 
allowing the results from this latest investigation of LCD and exercise, (Hiscutt et al), to be 
viewed along with existing research to give an overall picture of the efficacy of a reduced 
carbohydrate diet with exercise as a weight loss intervention in overweight and obese 
patients and the implications of this on CVD risk. The meta-analysis was then repeated to 
include the results from Hiscutt et a l thus demonstrating how the results from this study 
will contribute to the evidence base.
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6.3 Results
6.3.1 Characteristics of included studies
The characteristics of included studies are shown in Table 6.2. Many methodological 
similarities were apparent in the studies by Layman et al, (2005) and Meckling and 
Sherfey, (2007). Both used a 2 x 2 factorial design with subjects randomized to a lower or a 
higher carbohydrate diet and either an exercise intervention or control group. In addition, 
these studies had a similar subject profile; all female, non-smokers, and a similar BMI and 
age at baseline, (33 and 30 kg/m^ and 46 and 43 years in Layman et al, (2005) and 
Meckling and Sherfey, (2007) respectively. Although the mean age was similar in each 
study the age range was not, with pre-menopausal status being an inclusion criteria in 
Meckling and Sherfey, (2007) (20-62 years) but not Layman et al, (2005) (40-56 years).
6.3.2 Compliance to diet and exercise interventions
The composition of the reduced carbohydrate diets subjects were instructed to follow are 
shown in Table 6.2. The reduced carbohydrate diets used were both hypocaloric with the 
same energy level (7100 KJ /day) used for all subjects in Layman et al, (2005) and energy 
intake being reduced by 2092 KJ/day from the habitual intake of each subject in Meckling 
and Sherfey, (2007). The diet used by Layman et al, (2005) was designed to be higher in 
carbohydrate (carbohydrate: protein ratio of <1.5) than that used by Meckling and Sherfey, 
(2007) (carbohydrate: protein ratio of 1). The diets in both studies aimed to provide -30% 
of energy as fat.
Layman et al, (2005) concluded that subjects following the reduced carbohydrate diet were
successful in reducing their energy intake (mean daily intake of 5801 KJ/day) and
achieving the macronutrient goals set, (carbohydrate: protein ratio of 1.24 with fat
providing 32% of total energy intake). The mean daily energy intake when following a
reduced carbohydrate diet was similar (5441 KJ) in the study by Meckling and Sherfey,
(2007). All subjects (including those following the higher carbohydrate diet) were reported
to reduce their energy intake by 1900 KJ therefore were very close to meeting the energy
deficit prescribed. The carbohydrate: protein ratio achieved across both groups (exercise
intervention and control) was 1.19 with those in the exercise intervention group but not the
exercise control group meeting the 1:1 ratio set (Meckling and Sherfey, 2007). Fat intake
provided 32% of total energy intake. Mean absolute intakes of carbohydrate for subjects on
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the reduced carbohydrate diets were 134g and 119g per day respectively (Layman et al, 
2005; Meckling and Sherfey, 2007).
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eristics ot included studies and those ot Hiscutt et at., (see Chapter 3)
Study Method Participants Intervention Monitoring &  
Support
Layman 
et al 
2005
16 week study 
with a 2 X 2 
factorial design
Women
n=48
40-56 years 
Inclusion criteria;
• BMI >26 kg/m^
• Weight < 140kg
• Non-smokers
• No existing medical conditions requiring 
medications that would affect study 
outcomes,
• No use of oral steroids or antidepressants
Protein diet -Protein at 1.6g/kg/d (-30% energy). 
CHO:protein ratio of <1.5. Lipids -30% energy 
CHO diet -Protein at 0.8 g/kg/day (-15% of energy 
intake). CHO:protein ratio >3.5 and lipids at -30% 
energy
Exercise-Minimum of walking 5d/week for 30 
minutes plus 2d/week resistance training for 30 
minutes
Exercise control-lifestyle recommendations for 
activity-voluntary recommendations of minutes 
walking 5d/week
Weekly 1 hour 
meetings specific for 
treatment group
Weekly 3 d weighed 
food record and daily 
activity log
Meckling
and
Sherfey,
2007
12 week study 
with a 2 X 2 
factorial design
Women.
n=60
Inclusion criteria;
• BMI 25-30 kg/m^
• Non-smokers
• Pre-menopausal
• No major clinical disease requiring 
treatment with drugs known to affect 
blood pressure, protein metabolism, CVD 
or diabetes risk factors
Protein dicM g protein;lg CHO and target fat <30%. 
Hypocaloric
Control diet-1 g protein:3g CHO. 0.75g protein/kg. 
Hypocaloric
Exercise-Supervised circuit-training 3 d/week for 36 
minutes (resistance and endurance) initially at 65% 
max heart rate increasing to 80%.
Exercise control-Maintained normal activity levels
Weekly 30 minute 
counseling sessions 
with each subject
Daily exercise and 
food diaries for all 12 
weeks
Hiscutt 
et a!., 
(Chapter 
3)
6 month 
randomized 
study with 2 
intervention 
groups
Men
n=57
Inclusion criteria;
• BMI 27-40 kg/m^
• 21-65years
• Not currently losing weight
(for complete list of inclusion & exclusion criteria 
see chapter 3 (section 3.2.4.2)
Low CHO Diet -  Ad libitum LCD with 20g of 
carbohydrate initially increasing to -50g/day after 2 
weeks
Exercise - 3 sessions of self-directed moderate 
intensity (50-70% maximum heart rate) endurance 
exercise per week for 30 minutes.
Exercise Control -maintain baseline activity levels
Appointments every 2 
months in addition to 
regular telephone and 
email contact
7 day food & activity 
diaries at baseline & 6 
months and daily 
exercise logs in the 
exercise group
Diet shown in italics is the reduced carbohydrate diet intervention group investigated in this review, defined in these studies as the protein group (Layman 
et ai, 2005) or high protein group, (Meckling and Sherfey, 2007).
CHO - carbohydrate
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Review: The efficacy of a reduced carbohydrate diet with exercise as a weigM loss intervention in overweight and obese patients and the implications of this approach on carcfiovascular risk factors
Comparison; 01 Exercise intervention versus no exercise
Outcome: 01 Weight
Study
or sul)-category
Exercise 
Mean (SD)
Control Exercise 
Mean(SD)
WMD (fixed) 
95% Cl
Weight
%
VM) (fixed) 
95% a
Layman2005
MecklingZ)07
12
14
76.30(13.50)
79.20(12.40)
Total (95% a) 26
Test for heterogeneity: Chi’ ■ 0.51, df ■ 1 (P « 0.47), I’ » 0%
Test for overall effect: Z ■ 0.76 (P » 0.45)
12
10
22
82.40(15.20)
79.50(14.20)
47.49 -6.10 1-17.60, 5.40]
52.51 -0.30 [-11.24, 10.641
100.00 -3.05 [-10.98, 4.87)
•10 -5 0 5 10
Favours treatment Favours control
Figure 6.3 Forest plot of WMD and 95% Cl for body fat mass
Review: The efficacy of a reduced carbohydrate diet with exercise as a weight loss intervention in overweight and obese patients and the implications of this approach on cardiovascular risk factors
Comparison: 01 Exercise intervention versus no exercise
Outcome: 02 Fat mass
Study Exercise 
or sub-category N Mean (SD) N
Control Exercise 
Mean (SD)
WMD (fixed) 
95% Cl
WeigW
%
VM) (fixed) 
95% a
Layman2005 12 32.10(10.40) 
Meckling2007 14 2 8.50(10.20)
12
10
33.10(8.30)
30.70(9.50)
52.73
47.27
-1.00
-2.20
[-8.53, 6.531 
[-10.15, 5.75]
■
m
Total (95% 0) 26
Test for heterogeneity; Chi’ - 0.05, df » 1 (P ■ 0.83), 1’ - 0%
Test for overall effect: Z ■ 0.56 (P ■ 0.57)
22 100.00 -1.57 [-7.03, 3.90]
-10 -5 0 5 10
Favours treatment Favours control
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The exercise protocol was also quite different in Hiscutt et al with the amount of exercise 
recommended per week being a minimum of 90 minutes, substantially lower than the 
amount in Layman et ai, (2005) and slightly less than that in Meckling and Sherfey (2007). 
Subjects were given the choice of the type of exercise they wished to do, and although this 
was un-supervised either gym passes or exercise bikes were provided in order to maximize 
compliance.
The exercise control group was asked to maintain baseline levels of activity. Self reported 
levels of activity in addition to a 7 day activity diary at baseline and 6 months were used to 
assess compliance to this.
Subjects in the exercise intervention group were asked to keep exercise logs throughout the 
study as well as a 7 day activity diary at baseline and 6 months. This data showed 86% of 
subjects in the exercise control group and 63% of those in the exercise intervention group 
were compliant to the exercise instruction they were given.
The intervention reported in Chapter 3 (Hiscutt et al) was designed to replicate, as much as 
possible, the way individuals follow dietary advice and exercise when not part of a 
scientific study. Therefore face to face contact was provided at appointments every 2 
months when measurements were taken. A registered dietitian provided information and 
answered questions at these points as well and offering support to maximize retention and 
compliance. Regular telephone and email contact ensured subjects were used to monitor 
subjects whilst following a diet low in carbohydrate.
6.3 5.3 Changes in outcome measures
6.3.5.3.1 Diet and diet & exercise groups
Outcome measures at baseline and post intervention for subjects in the diet and the diet & 
exercise groups in the study by Hiscutt et al are compared to those studies included within 
this review in Table 6.3. Baseline values of weight and body fat mass were very different in 
Hiscutt et al, compared to Layman et al, (2005) and Meckling and Sherfey, (2007) and this 
is likely to be partly attributable to the sample being men. However baseline differences 
between the 2 groups within this study (Hiscutt et al) were small therefore a meta-analysis 
of results from these outcome measures alongside those from Layman et al, (2005) and 
Meckling and Sherfey (2007) was conducted using end point data..
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No significant differences between the exercise intervention (diet & exercise group) and 
control (diet only) groups were reported for any of the outcome measures used in this 
review (Hiscutt et ai). The weight loss achieved in subjects in both the exercise 
intervention and control groups were higher than those reported by Meckling and Sherfey, 
(2007) and lower than those in Layman et al, (2005). The change in body fat mass seen in 
subjects in Hiscutt et al were lower in the exercise intervention group compared to studies 
from the review but comparable changes were seen in the exercise control group.
6.3.5.3.1.1 Meta-analysis of weight results
The meta-analysis of the weight results from Hiscutt et al, (diet and diet & exercise 
groups), Laymen et al, (2005) and Meckling and Sherfey, (2007) found that an exercise 
intervention did not significantly reduce body fat mass, WMD= -0.72, 95% Cl, -4.21, 5.66, 
Z=0.29, f=0.77 compared with control (Figure 6.4).
6.3.5.3.1.2 Meta-analysis of body fat mass results
The meta-analysis of the body fat mass results from Hiscutt et al, (diet and diet & exercise 
groups). Laymen et al. (2005) and Meckling and Sherfey, (2007) found that an exercise 
intervention did not significantly reduce body fat mass, WMD = 1.03, 95% Cl, -2.23, 4,29, 
Z=0.62, F=0.54 compared with control (Figure 6.5).
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Results from the intervention reported in Chapter 3 (Hiscutt et al.) suggest a LCD 
combined with exercise as a weight loss intervention in overweight and obese men does not 
have additive effects on weight loss or CVD risk factors when compared with a LCD 
without exercise.
After combining the results from Hiscutt et al, (using diet and diet & exercise groups) with 
studies in this review, (Layman et ai, 2005; Meckling and Sherfey, 2007) it is apparent 
from current research, that while exercise combined with a reduced carbohydrate diet has 
been seen to increase weight loss and improve body composition compared to a reduced 
carbohydrate diet alone in individual studies the combined results from the limited research 
currently available shows no significant additive effects of exercise.
6.3.5.3 2 Movers and non-movers
Further analysis was conducted using results from the LCD and exercise intervention 
(Hiscutt et al.) as described in Chapter 4. Subjects were re-grouped based on their reported 
exercise levels therefore those who increased exercise levels from baseline became 
‘movers’ and those who did not increase exercise became ‘non-movers’ (as described in 
Section 4.2.2). This analysis was thus based on reported rather than assumed exercise 
levels. As this review aimed to investigate the effects of a LCD with exercise the meta­
analysis was repeated using results following re-allocation of subjects by Hiscutt et ai 
alongside those from Layman et al, (2005) and Meckling and Sherfey, (2007).
6.3.5.3.2.1 Meta-analysis of weight results
The meta-analysis of the weight results from Hiscutt et al, (movers and non-movers), 
Laymen et al, (2005) and Meckling and Sherfey, (2007) found that an exercise intervention 
did not significantly reduce weight, WMD= -0.79, 95% Cl, 6.21, 4.63, Z=0.29, P=0.78 
compared with control (Figure 6.6).
6.3.4.5 2.2 Meta-analysis of body fat mass results
The meta-analysis of the body fat mass results from Hiscutt et al, (movers and non­
movers), Laymen et al, (2005) and Meckling and Sherfey, (2007) found that an exercise 
intervention did not significantly reduce body fat mass, WMD = -1.23, 95% Cl, -4.69, 2.22, 
Z=0.70, P=0.48 compared with control (Figure 6.7).
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Using the analysis based on reported exercise levels (movers and non-movers) from Hiscutt 
et al. alters the meta-analysis for both weight and body fat mass towards an effect for 
exercise as compared to no exercise. However this effect remains non significant.
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6.4 Discussion
This review was designed to evaluate the changes in weight among adults using 
reduced carbohydrate diets combined with exercise as an intervention for weight loss 
and to assess the effects of this weight loss approach on CVD risk factors. The 
combined results from studies in this review show following a reduced carbohydrate 
diet whilst exercising is an effective method of reducing body weight with a mean 
weight loss of 8.75kg across both studies. However analysis conducted from research 
available to date suggests there is no significant added effect of a reduced 
carbohydrate diet with exercise on weight loss, compared to a reduced carbohydrate 
diet without added exercise.
Although exercise with a reduced carbohydrate diet significantly reduced body fat 
losses and reduced losses of lean body mass in one study (Layman et al, 2005) when 
results were combined in a meta-analysis exercise did not have an added effect on 
body composition. No significant additive effects of exercise were seen on changes in 
insulin or lipids. Therefore the evidence available for this review suggests exercise 
with a reduced carbohydrate diet does not appear to have added effects on the CVD 
risk factors investigated as compared to a reduced carbohydrate diet alone.
Although the selection criteria were chosen to be as inclusive as possible only 2 
studies were eligible for the review. These studies both had a sample of women with a 
mean age in the 40’s therefore the data currently available in this area is not 
representative of a diverse population. It is apparent there is still a shortage of 
research investigating the effects of a LCD with exercise. However these recent 
studies, (Layman et al, 2005; Meckling and Sherfey, 2007), do provide us with 
information on the effects of reduced carbohydrate with and without exercise, an area 
which could not be assessed due to insufficient information in the review by Bravata 
et a l., (2003)
As data for the change in outcome measures was not available from the information 
published by authors, (Layman et al, 2005; Meckling and Sherfey, 2007) the meta­
analyses conducted used results from the end of the intervention. Although this 
allowed results from these studies to be summarised it is possible this review may 
have seen different results had change in outcome data been available for use. In 
addition meta-analysis could also have been conducted for other outcome measures
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(lean body mass, insulin and lipids) to further our knowledge about the additive 
effects of LCD and exercise on a broader range of CVD risk factors.
The diets in these studies (Layman et al, 2005; Meckling and Sherfey, 2007) were 
lower in carbohydrate compared to subjects’ usual intake (carbohydrate reduced by 
50% in absolute terms and providing 14% less of total energy). However, with mean 
intakes of 134g and 199 g carbohydrate respectively they contain substantially more 
carbohydrate than many LCDs such as the renowned Atkins Diet (Atkins, 2003). 
Therefore it is apparent there is currently no published data investigating the effects of 
a LCD with exercise when carbohydrate levels are reduced to low levels.
The exercise protocol differed in Layman et al, (2005) compared to Meckling and 
Sherfey (2007) with subjects being instructed to exercise for a much longer period of 
time over the course of a week at an apparently lower intensity. Despite this a 
significantly greater weight loss (Meckling and Sherfey, 2007) and reduced body fat 
mass (Layman et al, 2005) was seen by subjects in the exercise intervention group 
compared to the exercise control group. This demonstrates a variety of approaches to 
increasing exercise levels are effective in producing significant health benefits and 
illustrates lifestyle based changes to exercise can be as useful as more intense gym 
based activity.
Intensive monitoring and supervised exercise was used by both Layman et al, (2005) 
and Meckling and Sherfey, (2007). While this is likely to have aided compliance and 
attrition of subjects, it is likely the results seen are greater than those in a non-research 
situation as most individuals following this type of diet and exercise program outside 
of a study situation do not have this increased level of motivation and support.
It has been reported that reduced carbohydrate diets can reduce the desire to exercise 
due to increased levels of fatigue during exercise (White et al, 2007). However 
subjects in the exercise intervention group (Layman et al, (2005) achieved >200 
minutes of additional activity per week whilst following a lower carbohydrate diet. A 
higher retention rate was also seen in the exercise intervention group compared to the 
exercise control group in the study by Meckling and Sherfey, (2007) as well as the 
recent intervention (Hiscutt et al). This evidence suggests exercising whilst following 
a reduced carbohydrate diet can be achieved and does not cause individuals to 
withdraw from a dietary program.
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Subjects in the exercise intervention groups and control groups were given the same 
instructions regarding diet and should therefore have been consuming the same diet. 
In reality the carbohydrate: protein ratio was considerably higher in the exercise 
control group compared to the intervention group in the study by Meckling and 
Sherfey, (2007). In addition those subjects in the exercise control group had a higher 
mean energy intake than the intervention group. It was not stated if these differences 
were significant but these between group variations in diet may have affected 
outcome measures thereby making it difficult to determine if diet or exercise was 
responsible. No significant differences in the change in energy, protein or 
carbohydrate intake from baseline to 6 months were reported between groups by 
Layman et al, (2005).
Despite subjects in each study being the same gender and a similar age and BMI 
variation in the changes in insulin and lipids were seen between studies. It is 
recognized there is a high level of variability in lipaemic responses to exercise (Leon 
and Sandez, 2001) and a LCD (Volek et al, 2005). In addition insulin and lipids may 
have been affected differently by the interventions in Layman et al, (2005) and 
Meckling and Sherfey, (2007) because all subjects in Meckling and Sherfey, (2007 
were pre-menopausal while this was not an inclusion criteria in Layman et al, (2005). 
As unfavorable effects of menopause are seen on lipid metabolism and glucose 
tolerance (Rosano et al, 2007) results from Layman et al, (2005) may have been 
affected by some women being post-menopausal.
The study by Hiscutt et al provides new information on the effects of a reduced 
carbohydrate diet with exercise on weight and CVD risk factors, specifically in a 
different sample (men) and using a lower carbohydrate diet. In addition valuable 
information on the effects of this weight loss approach on other CVD risk markers 
was collected, (see Chapter 3).
No significant between group differences in change in body weight or body fat mass 
were seen by Hiscutt et al in the initial analysis (Chapter 3). As this is the first study 
comparing the effects of a LCD with and without exercise in a sample of men it 
appears there are no significant additive effects of exercise at the level used in this 
study. However compliance to exercise instructions was low and this may have
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reduced the differences in activity between groups. The issue of compliance is 
discussed in Chapter 4 and further analysis has been conducted to address this.
This review has shown that while important health benefits are seen in some 
individuals when combining a reduced carbohydrate diet and exercise no significant 
additive effects of exercise on weight loss or CVD risk are apparent when a LCD is 
used for weight loss in women.
Results from a recent intervention, (Hiscutt et al.) add to the information from studies 
in this review and suggest there is no significant additive effect of exercise alongside 
a LCD. However due to the limited amount of published data it was not possible to 
review the effects of a reduced carbohydrate diet with exercise on many other 
important CVD risk factors such as lipid subfractions and inflammatory markers.
While individuals who exercise whilst following a reduced carbohydrate diet may not 
see significant differences in weight loss, body composition, insulin or lipids 
compared to those who follow reduced carbohydrate diet alone no detrimental effects 
of exercising whilst following this type of diet were reported by Hiscutt et ai, Layman 
et al, (2005) or Meckling and Sherfey, (2007). Therefore individuals wishing to 
follow a reduced carbohydrate diet should be given the same advice as the general 
population regarding exercise, being encouraged to include exercise within their 
lifestyle to assist with weight maintenance and to take advantage of its potential health 
benefits; reduced blood pressure, reduced risk of osteoporosis and cancer, improved 
mood, self-esteem, reduced stress (Fentem, 1994) and reduced inflammation (Pitsavos 
et al, 2005).
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6.4.1 Conclusion
The evidence summarized in this review suggests a reduced carbohydrate diet 
combined with exercise does not have significant additive effects on weight loss or 
CVD risk factors, (body composition, insulin and lipids) as compared to a reduced 
carbohydrate diet alone. Hiscutt et al, (Chapter 3) provides further evidence for this 
conclusion.
Individuals are able to participate in an exercise programme whilst following a 
reduced carbohydrate diet without any adverse effects. Therefore this lifestyle 
approach provides an alternative solution to weight loss which allows individuals to 
reduce their adiposity whilst enjoying the far reaching health benefits of increased 
activity.
Further research investigating the effects of reduced carbohydrate diets with and 
without exercise across a broader range of CVD risk factors is needed to add to the 
evidence from Hiscutt et al, (Chapter 3).
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7. Overall discussion
Obesity is a major public health issue which impacts on life expectancy, increases 
morbidity and has enormous financial implications with the potential to bankrupt the 
NHS, (Haslam, 2006). At the individual level being overweight or obese can impinge 
upon quality of life due to psychological and social problems, (Stunkard et al, 2003), 
ill health with increased risk of osteoarthritis, compromised fertility and reduced 
mobility as well as co-morbidities of type 2 diabetes, hypertension, dyslipidaemia 
and CVD (Freedman et al, 2001).
The enormity of the problem of obesity requires a combination of top down and 
bottom up action to bring about change at a national, community and individual level 
in order to have any impact on this epidemic. Research into effective lifestyle 
interventions provides information which may assist in reducing the body weight and 
improving the health of many individuals. In addition the knowledge acquired through 
robust research builds an evidence base of the strategies available and their relative 
merits, thus providing a guide for public health policy in order to optimise its 
effectiveness.
Conventional weight loss approaches have incorporated a hypocaloric, low fat diet 
with exercise, (NICE, 2006) and although there is a well established evidence base 
demonstrating this to be an effective method of reducing adiposity, this approach does 
not work for everyone. Dietary interventions comparing several weight loss diets 
(Dansinger et al, 2005; Truby et al, 2006) have shown that significant weight losses 
can be achieved via a variety of popular diets. Information on a range of weight loss 
strategies is needed to enable health professionals to best advise their patients on the 
various options available and help them select the approach best suited to them.
LCDs have continued to be a popular weight loss method with participants in the Diet 
Trials study, (Herriot et al, 2008) reporting the advantages of the Atkins diet (a 
renowned LCD) to be that it; produces quick weight loss, allows unlimited amounts of 
food, is easy to follow and is a novel approach. The evidence for the efficacy and 
safety of LCDs has been strengthened in recent years (Crowe et al, 2005). However 
gaps in the literature remain which has led to caution in the recommendation of LCDs 
for weight loss and this potentially effective weight loss strategy being dismissed by 
many health professionals.
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This thesis aimed to investigate LCDs further in order to expand the data available on 
their efficacy and health implications. More specifically this work set out to gain 
information on; the rate and composition of the rapid initial weight loss achieved with 
LCDs; the effects of a LCD on novel CVD risk factors and the additive effect of 
exercise.
The evidence presented here suggests LCDs are a safe and effective method of weight 
loss with no adverse effects across body composition or CVD risk factors seen in 
healthy overweight and obese women following a LCD for 8 weeks, (Chapter 5) or 
healthy overweight and obese men following a LCD for 6 months (Chapter 3). In 
addition no detrimental changes in renal function were observed in the 6 month LCD 
intervention in men.
As with all weight loss interventions variations in weight loss achieved were apparent 
although clinically significant weight losses were still achieved by the majority of 
subjects. Moreover, significant positive changes in men who followed a LCD for 6 
months were seen in weight, BMI, WHR, body fat mass, systolic blood pressure and 
TAG as well as significant reductions in weight, waist and hip circumference and fat 
mass in women over a shorter duration (8 weeks). It is apparent from these studies 
that a reduction in some CVD risk markers is seen in subjects following a LCD. This 
adds to the current literature illustrating the safety of LCDs and provides further 
evidence that health professionals should consider this dietary approach as a potential 
weight loss strategy for their patients.
Investigation of the rate and composition of the rapid initial weight loss induced by a 
LCD revealed that positive changes in body composition occur from the outset, with 
losses of fat mass exceeding those of lean mass after the first week. It is clear that the 
early weight loss seen with a LCD is not solely due to glycogen associated water 
losses. As the health risks associated with obesity are linked to excess body fat, 
reducing adiposity from the first week of commencing a LCD can result in immediate 
benefits to health. A rapid initial weight loss was also seen in this study. This has been 
cited as an advantage of LCDs (Herriot et ai, 2008) and this motivating effect may 
increase the likelihood of an individual achieving their weight loss goals.
The analysis conducted based on reported exercise levels, (movers and non-movers) 
suggests that even modest exercise combined with a LCD has additive effects on
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weight loss, body fat, blood pressure, CRP, insulin sensitivity and fasting insulin. This 
indicates exercise combined with a LCD leads to increased efficacy and reduced CVD 
risk, as compared to a LCD alone. Conversely when analysis was conducted using the 
groups to which subjects had been originally been allocated (LCD and LCD & 
exercise) no added effect of exercise combined with a LCD on CVD risk was seen as 
compared to a LCD alone.
The differences seen when results are based on actual (reported) exercise levels rather 
than assumed (instructed) exercise levels demonstrate how non-compliance can 
drastically affect outcomes in an intervention. Not all subjects who were asked to 
increase their exercise levels followed these instructions fully, while increased 
amounts of exercise were seen in some subjects who were asked to maintain baseline 
activity levels. Therefore the differences between the amounts of exercise undertaken 
by subjects in the LCD & exercise group and the LCD group were smaller than 
anticipated. Re-grouping subjects according to their reported exercise levels removes 
the confounding factor of non-compliance. It would appear that insufficient between 
group differences in exercise levels led to no effect of exercise being seen in the 
original analysis (Chapter 3).
It is difficult to draw conclusions on the additive effect of exercise with a LCD 
because the analysis of ‘movers’ and ‘non-movers’ was not part of the original study 
design and the sample size calculations were not based on these new groups. 
Nevertheless this further analysis allowed those subjects who increased their exercise 
levels to be compared to those who did not and therefore provided useful data in 
addition to the main analysis.
The difficulties faced by researchers when designing an intervention in which free 
living subjects are required to make positive lifestyle changes are demonstrated by the 
low levels of compliance to exercise instructions. Achieving 100% compliance to diet 
and exercise instructions is unrealistic in free living subjects as making lifestyle based 
changes for any significant period of time is problematic and perhaps partially 
explains why obesity is such a difficult issue to overcome. However this type of 
research, when interpreted with caution, allows lifestyle strategies to be assessed and, 
when levels of compliance are reported, allow us to compare strategies to see which
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have the highest levels of adherence and therefore have the greatest potential to be 
translated successfully into the non-research setting
The results from the LCD and exercise intervention have shown that beneficial effects 
on CVD risk markers, in addition to those associated with a LCD, can be achieved by 
individuals who adhere to a modest level of exercise over 6 months. This is in contrast 
to the conclusions reached the review of the current published literature investigating 
the effects of reduced carbohydrate diets with exercise. As described in Chapter 6 no 
significant additive effect of exercise, combined with a LCD, was evident from 
available research to date.
Additive effects of exercise were seen in weight and body composition within the 
individual studies in this review (Chapter 6) therefore the lack of a significant effect 
when studies were combined may be due to the small amount of data available. Levels 
of compliance to exercise instructions were not reported by either study (Layman et 
al, 2005; Meckling and Sherfey, 2007) included in this review. It is therefore not 
possible to determine if the anticipated differences in exercise between groups were 
achieved and these results are thus interpreted with caution.
The reduced carbohydrate diets used in the studies included in this review. Layman et 
ai, (2005) and Meckling and Sherfey, (2007) had carbohydrate intakes which were 
substantially higher than many LCDs therefore the LCD and exercise intervention 
developed and reported within this thesis is the first study to investigate the effects of 
a low carbohydrate weight loss diet with and without exercise.
One of the potential limitations of LCDs as a weight loss approach is the possible 
impairment to exercise (Bilsborough and Crowe, 2003). Therefore it is important to 
establish if it is feasible and realistic for individuals to follow an exercise programme 
whilst following a LCD, particularly given the emphasis on multicomponent 
interventions to effectively tackle obesity (NICE, 2006) . Evidence to support the 
combined use of exercise with a LCD is provided by the intervention described in 
Chapter 3 and the reduced carbohydrate diet and exercise studies included within the 
review, (Layman et al, 2005; Meckling and Sherfey, 2007) in which subjects 
followed an exercise programme whilst on a LCD with no adverse effects. This 
knowledge enables health professionals to encourage patients following a reduced 
carbohydrate weight loss approach to incorporate exercise into their daily lives.
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Incorporating exercise with a LCD in a whole lifestyle approach to weight loss allows 
individuals to enjoy the diverse health benefits of exercise and increases the 
likelihood of maintaining their weight loss.
The dietary information collected at baseline and whilst following the LCD during 
both interventions (Chapters 3 and 5) demonstrated a significant energy deficit was 
achieved when carbohydrate intake was reduced. The weight losses achieved by 
subjects in these studies can be fully explained by the energy deficit observed. A 
correlation between carbohydrate intake and weight change was seen in the LCD 
group in the LCD and exercise intervention, but not in the LCD and exercise group in 
this study or women in the body composition intervention. Therefore it appears 
weight loss is not due to the low carbohydrate intake per se but the energy deficit 
which can be achieved by a non-compensated reduction in carbohydrate. This 
supports the finding of Bravata et al, (2003) that restricted energy intake is associated 
with weight loss. There is also no evidence of a ‘metabolic advantage’ that Atkins 
postulated as the reason for the efficacy of the LCD.
As the LCD used in both interventions was ad libitum, with participants encouraged 
to eat sufficient to satisfy their appetite, it might be expected intakes of protein and fat 
would be increased. This was not the case and restricted food choices as well as 
increased satiety (via appetite regulating hormones) may have enabled individuals to 
maintain protein and fat intakes while limiting carbohydrate foods.
Glycogen associated water losses, ketone excretion, the thermogenic effect of protein 
or an increased metabolic rate, (due to a greater percentage lean body mass) may have 
had a role in the weight loss seen when LCDs were followed but a greater weight loss 
would be expected if any of these factors had a substantial impact on energy balance. 
No correlation between change in fitness and weight was seen in the LCD and 
exercise intervention suggesting energy expenditure through increased activity was 
not sufficient to significantly affect weight. The weight loss in these studies is 
therefore likely to have been achieved primarily by the energy deficit reported in diet 
records.
Concerns have been raised over the nutritional quality of LCDs (Council on Foods 
and Nutrition, 1973; Freedman et al., 2001; Crowe, 2005). As no significant increase 
in absolute intakes of protein and fat were observed in subjects following a LCD in
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these studies (Chapters 3 and 5) we suggest that there is no increased risk of 
conditions such as renal impairment and dyslipaemia due to high intakes of these 
macronutrients as has been previously suggested. However, the subjects in these 
studies were healthy and the impact of a LCD on those with diabetes and potential 
renal impairment needs further confirmation in appropriately designed trials.
The micronutrient analysis conducted from subjects food records at baseline and 6 
months (Section 3.3.6) confirm earlier reports which suggest that LCDs may be 
nutritionally inadequate (Freedman and Kennedy, 2001). The mean NSP intake of 
subjects who had been following a LCD for 6 months was less than 50% of the 
recommended amount of an adult in the UK. In addition folate, calcium, magnesium, 
iron, zinc and copper were significantly reduced from baseline and intakes at 6 
months were below RNIs. Although health promoting compounds such as 
antioxidants and flavonoids were not measured it is likely the intake of these 
substances is low in a LCD which restricts fruit and vegetable intake. As a 
nutritionally balanced diet is of utmost importance for optimum health a weight 
reducing diet which does not encourage this may compromise long term health. 
However as indicated by the baseline diet of subjects in this study, where intakes of 
fibre and several micronutrients are seen to below recommended amounts, the 
‘normal’ diet of many individuals is far from ideal. Therefore the nutritional quality of 
a LCD may not be deleterious as compared to the previous diet for many individuals 
and if followed for a limited period may allow them to reduce their body weight and 
CVD risk.
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7.1 Future work
While conducting this research several avenues for future work became apparent. 
Compliance has been highlighted as an issue and this will affect any future work 
involving lifestyle interventions. Forthcoming diet and exercise interventions should 
include robust measures of compliance to not only aid interpretation of the results but 
also to demonstrate those strategies with the highest levels of compliance. This 
information can then be incorporated into public health policy for maximum effects 
on obesity.
The pilot study investigating the rate and composition of the rapid initial weight loss 
induced by a LCD provided important information on the health implications of 
commencing a LCD. This work could be developed further by conducting a 
randomised trial with an additional group following a higher carbohydrate, low fat 
diet thus allowing the early body composition changes to be compared between diets 
of varying macronutrient composition.
The beneficial body composition effects which can be achieved when a LCD is 
followed have been made apparent by the interventions reported in this thesis. The 
distribution of body fat is known to be crucial in determining health risk therefore 
intervention studies which measure the changes in body fat distribution in the initial 
stages of a LCD and in the longer term would add to the limited data available.
The review of the efficacy of a reduced carbohydrate diet and exercise and the 
implications of this weight loss approach on CVD risk factors illustrated the lack of 
published studies in this area. The LCD and exercise intervention described in this 
thesis is the first study to investigate this combined approach with a /ow carbohydrate 
diet. Therefore further research is required in different population groups. Increasing 
the intensity of the exercise programme used may help to ensure a difference in 
activity levels was achieved between the exercisers and non exercisers even accepting 
a degree of non-compliance.
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7.2 Conclusion
The safety and efficacy of LCDs has been repeatedly demonstrated with evidence 
from this thesis adding to previous research. With concerns regarding CVD risk, renal 
function and ability to exercise unsubstantiated by the evidence in these studies this 
useful weight loss approach should be accepted by health professionals as one 
potential strategy which may assist their patients in losing weight. In order to 
maximise the potential benefits of this approach, whilst minimising the possible 
deleterious effects, individuals following a LCD should be advised to do so for a 
limited amount of time to achieve their weight loss goals after which intake of 
nutrient dense foods such as fruit, vegetables, pulses and wholegrains should be 
increased. Low carbohydrate diets may therefore represent one component of the 
whole lifestyle approach recommended for weight loss and can be encouraged 
alongside exercise in order to achieve and sustain a negative energy balance.
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Appendix A: Ethical Approval from South East Multi-centre Research Ethics 
Committee for the Low Carbohydrate Diet & Exercise Study
NHS
South East Multhcentre Research Ethics Committee
Chairm an o f the South  East MREC -  D r J M Lam berty FR C A  Room 76, b Block
40 Eastbourne Terrace
Dr Helen Truby London W2 3QR
Senior Lecturer In Nutrition and Dietetics
School of Biomedical and Life Sciences J®’;
UniversityofSurrey E m all:jane.m artIr,0% recA net.co .uk
Guildford
Surrey GU2 7XH
9*  ^December 2003
Dear Dr Truby
M REC 03/01/122 A  random ised trial investigating the effects o f a low
carbohydrate w eigh t loss regim e on card iovascular risk ■ 
factors in men
Application form dated 2 0 1 0  03
Protocol version 2  dated 20 11 03
G P  Information sheet version 1 1 5 /1 0 /0 3
Curriculum vitae D r Helen Truby
Participant letter version 2  dated 20/11/03
Consent form version 1 dated 15 10 03
W ebsite advertisement for research subjects version 2  20  11 03
Advert for se in D r Atkins Diet Revolution book version 2  20  11 03
Participant information for body composition sub-group version 1 1 5 1 0  03
The Chairman of the South East M REC has considered the amendments 
submitted in response to the Committee’s earlier review of your application on 
12^ November 2003 as set out in our letter dated 19’*' November 2003.
The Chairman, acting under delegated authority, is satisfied that these accord 
with the decision of the Committee and has agreed that there is no objection on 
ethical grounds to the proposed study. I am, therefore, happy to give you our 
approval on th§ undorstanding that you win follow the conditions of approvaj set 
down below. A record of the review undertaken by the M REC is contained în (lie 
attached M REC Response Form. The project must be started within three years 
of the date on which M REC approval is given.
While undertaking the review of your application the MREC noted the research 
involves the use of an existing database collected for previous research or other 
purposes with limited patient contact through the central research team. For this  
reason you are not required to  notify any LRECs w hen undertaking this  
research.
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MREC Conditions of Approval
•  T h e  protocol approved by the M R E C  is followed and any changes to the  
protocol are  undertaken only a fte r M R E C  approval.
•  If projects are  approved before funding is received, th e  M R E C  m ust see , and  
approve, any m ajor changes m a d e  by the funding body. T h e  M R E C  would  
expect to see  a  copy o f the final questionnaire before it is used.
•  Y ou  m ust com plete and return to  th e  M R E C  the annua) review form th at will 
be sent to you once a  year, and  the final report form  when your research is 
com pleted.
Legal and Regulatory Requirements
It rem ains your responsibility to  ensure in the subsequent collection, storage or 
use of data o r research sam ple you are  not contravening the legal or regulatory  
requirem ents o f an y  part o f the UK  in which th e  research m aterial is collected, 
stored or used. If data is transferred outside the U K  you should be aw are o f the  
requirem ents o f the D ata  Protection A ct 1998 .
ICH GOP Compliance
T h e  M R E C s  are  fully com pliant w ith the International C onference on 
Harm onisation/G ood Clinical Practice (IC H  G C P ) G uidelines for the Conduct of 
Trials Involving the Participation o f Hum an Subjects as they relate to the  
responsibilities, composition, function, operations and records of an Independent 
Ethics C om m ittee/Independent R eview  Board. T o  this end it undertakes to 
adh ere  as fa r as is consistent with its Constitution, to the relevant clauses o f the  
IC H  Harm onised Tripartite G uideline for G ood Clinical Practice, adopted by the  
Com m ission o f the European Union on 17 January 1997 . T h e  Standing O rders  
and a  S tatem ent o f Com pliance w ere  included on the com puter disk containing  
the guidelines and application form and are  availab le on request or on the  
Internet at w w w .corec.org.uk
Y ours sincerely
^ D R U M  LAMBERTY 
CHAIRMAN, SOUTH EAST MREC
Enclosures MREC Response Form dated 09 12 03
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Appendix B: Low Carbohydrate Diet Sheet-Potassium
Potassium
As many foods are eliminated or drastically reduced when following a low 
carbohydrate diet intakes of some vitamins and minerals may be below 
recommendations.
A multivitamin and multimineral supplement is therefore being provided for the 
duration of study. However few supplements provide sufficient potassium and prior 
research has shown potassium intakes to be low when a low carbohydrate diet is 
followed. Therefore to ensure you obtain sufficient potassium we recommend you try 
to include some of the following foods within your diet.
Banana 23^ 400
(1 medium)
Blackcurrants 10.6 266
(140g, canned in juice)
Grapefruit 5.4 160
(1/2)
Mushrooms 0.13 150
(44g, fried in butter)
Tomatoes 2.6 213
(1 medium)
Watercress 0.08 46
(20g bunch)
□ Foods in yellow suitable during the induction period.
These foods are all good sources of potassium; their carbohydrate content is also 
shown. During the induction period try to include the foods highlighted in yellow. 
After induction small amounts of any of these foods can be included without 
increasing your carbohydrate intake dramatically
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Appendix C Low Carbohydrate Diet Sheet -Induction Period Sheet
Low Carbohydrate 
Diet Study
Induction 
Period
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Low Carbohydrate Diet
induction
Introduction
The diet is normally comprised of carbohydrate, protein and fat with carbohydrate
providing -50% of the total energy. When carbohydrate is eaten it is converted into
glucose to fuel the body.
If carbohydrate intake is low an alternative fuel is needed for the body to function.
Body fat is broken down and used as energy thus fat stores are reduced and weight
loss occurs. This is what happens when a low carbohydrate diet is followed.
What will I eat?
• Protein and fat foods will be the main staples of your diet.
• Pure protein foods -  fresh meat, fish, eggs and poultry may be eaten in unlimited 
amounts (see free foods)
• Oils (sunflower, olive, vegetable) and butter is allowed in unlimited quantities.
• A small amount of carbohydrate may be eaten. During the first two weeks 
(induction) this is limited to 20g of carbohydrate a day.
• This allows approximately 9oz / 250g of salad or 6oz / 170g salad plus 80g oz / 
3oz cooked vegetables from the below 10% carbohydrate list.
• All foods except pure protein and pure fats should be carbohydrate counted to 
ensure the daily intake does not exceed the 20g allowed (see carbohydrate 
counter)
• To ensure your diet contains as many nutrients as possible use your 20g 
carbohydrate on vegetables and salad.
• Choose vegetables with less than 10% carbohydrate as this will allow you to have 
a greater quantity.
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What will I need to avoid?
• Bread, pasta, rice, grains, noodles and pasta and potatoes are not allowed on this 
diet.
• Any foods containing sugar or flour must be avoided (cakes, biscuits, chocolate, 
sweets, desserts)
• Fruit is too high in carbohydrate to be included whilst on the induction diet
• Protein foods which are processed (sausages, burgers, etc) should not be eaten 
unless the carbohydrate content is checked and included within carbohydrate 
allowance
• Dairy foods are not allowed except for cheese, cream and butter.
• Nuts and seeds need to be avoided for the first two weeks.
• Foods such as beans which contain both carbohydrate and protein should be 
avoided during the induction phase.
• Cough sweets and syrups, chewing gum, etc should be avoided due to their sugar 
content.
• Tea, coffee and soft drinks containing caffeine should be avoided.
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Free Foods
The following foods may be eaten liberally:
Meat Fish Fowl
Beef Cod Turkey
Pork Haddock Chicken
Lamb Tuna Goose
Bacon** Sole Duck
Ham** Salmon Pheasant
Venison Sardines Quail
Veal Trout
Gammon Mackerel
Shellfish Eggs
Prawns Scrambled
Mussels* Fried
Lobster Poached
Crabmeat Boiled
Squid
Oysters*
Omelettes
Exceptions:
• Canned fish in tomato sauce
^Oysters and mussels are higher in carbohydrate than other shellfish so limit to 4 oz a 
day
** Processed meats such as bacon, ham, luncheon meat, salami, hot dogs, etc may 
have added sugar so check labels to check suitability
Other Induction Foods
The following foods are suitable in measured amounts during the induction period
Cheese
Cheddar 
Mozzarella 
Roquefort 
Stilton 
Goats cheese 
Cream cheese 
Gouda 
Swiss
• As all cheeses have some carbohydrate content intake needs to be limited to 90- 
1 lOg (3-4oz) / day (use carbohydrate counter for content of individual cheeses)
Herbs & Spices
All spices to taste 
Fats & Oils
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All vegetable oils (sunflower, safflower, olive, canola, walnut, soybean, sesame)
Butter
Beverages
Water
Decaffeinated tea or coffee (with cream, not milk)
Most diet, caffeine free fizzy drinks 
Herb tea
Cream (whipping or single) -  use carbohydrate counter
Vegetables & Salad
Salad
230-340g (8-12oz) per day
Lettuce Peppers Chicory
Celery Mushrooms Rocket
Cucumber Alfalfa sprouts
Radishes Bok Choy
Vegetables
140-200g (5-7oz) per day if salad consumption is less than 230g (8oz)
Asparagus Leeks Artichoke
Runner beans Spinach Aubergine
Cabbage Courgettes Bamboo shoots
Cauliflower Tomato Bean sprouts
Aubergine Broccoli French Beans
Brussel sprouts Courgettes Kale
Mange-tout Onion Pumpkin
Check carbohydrate content and choose lowest carbohydrate vegetables to enable you 
to have more!
Ideas to garnish salads
Grated cheese
Mushrooms sauteed in butter or olive oil 
Sour cream 
Crispy bacon
Hard boiled egg- roughly chopped 
Sweeteners
• Sucralose, saccharine, aspartame, acesulfame-K are allowed 
Also....
If you feel you need to add variety to your diet you may have 10-20 olives, half a 
small avocado, loz of sour cream or 3oz whipping cream and two-three tablespoons 
lemon/lime juice -  Beware that these foods are higher in carbohydrate.
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Menu Examples 
This is how your daily food intake may look.
Breakfast: Scrambled eggs & Bacon
Lunch: Roast chicken 
Salad 
Dressing
Dinner: Pork chops
Broccoli & green beans 
Cheese sauce
Sugar-free jelly & cream
Breakfast: Ham & Poached eggs
Lunch: Tin of tuna 
Mayonnaise
Lettuce, cucumber, celery
Dinner: Grilled salmon
Kale cooked with garlic & onion
Sugar-free jelly & cream
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Meal Ideas 
Breakfasts:
Bacon & fried eggs 
Omelette (plain, cheese or ham)
Kippers & scrambled eggs 
Gammon & poached eggs 
Ham & Scrambled eggs 
Sausage (low carbohydrate), bacon, eggs and mushrooms
Lunches:
Serve with salad or vegetables and dressing if desired (use carbohydrate counter)
Roast chicken 
Ham with or without cheese 
Can of corned beef 
Crispy bacon and/or cheese, grated or cubed 
Can of tuna with mayonnaise 
Can of salmon 
Mackerel fillets in oil or chilli dressing 
Omelette 
Boiled egg (s) and crispy bacon 
Lamb-burger or cheese burger (see recipe)
Eggs benedict (see recipe for hollandaise sauce)
Dinners:
Serve with salad or vegetables and dressing if desired (use carbohydrate counter)
Meat loaf (see recipe)
Pork chops with cheese sauce (see recipe)
Roast chicken, lamb, pork or beef 
Marinated lamb chops (see recipe)
Chicken in white wine sauce (see recipe)
Omelette (cheese, ham, prawn)
Smoked salmon frittata (see recipe)
Whole trout, baked or steamed 
Poached salmon
Mixed grill (steak, lamb chops, gammon, bacon, pork chop, eggs)
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Helpful Hints
Do not miss meals
Eat nothing unless you KNOW its allowed (check the carbohydrate counter or 
with your dietitian)
Eat to your appetite. When hungry eat until satisfied 
Watch out for gravies, sauces which may have cornflour added 
Drink plenty of water (at least 8 glasses a day)
Plan meals in advance
Keep your store cupboard stocked with canned sardines, pilchards, tuna, corned 
beef, etc
Certain brands of hot dogs are carbohydrate free -  keep handy for a quick meal or 
snack
Use frozen vegetables for ease
Make batches of lamb-burgers and cheeseburgers and freeze 
Weigh out salad and vegetables for the day and keep in the fridge 
Make up small pots of sugar-free jelly to have on hand 
Keep cubes of ham or cheese handy for snacking between meals 
Cook a pack of chicken drumsticks then refrigerate for snacks
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Carbohydrate Counter
Foods Portion
Size
Grams of 
carbohydrate
Grams of 
digestible 
carbohydrate
Vegetables
Artichoke 1 13.4 6.9
Asparagus 6 3.8 2.4
Aubergine 135g 3.3 2.0
Bean, French 60g 4.9 2.9
Broccoli llOg 3.9 1.7
Brussel Spouts 6 10.9 7.6
Cabbage,green 60g 1.9 1.1
Carrot 1 7.3 5.1
Cauliflower 6 4.4 1.5
Celery 1 1.5 0.8
Courgette 1 5.7 3.3
Chilli Pepper 1 0.0 0.0
Cucumber, small 1/2 2.5 1.8
Endive 55g 1.8 0.4
Fennel 55g 3.2 1.8
Greens, mixed 60g 1.6 0.4
Kale 55g 3.7 2.4
Leek 1 12.6 11.0
Lettuce, cos 75g 1.3 0.4
Lettuce round 75g 1.3 0.7
Mushrooms 55g 1.4 1.0
Okra llOg 7.5 5.0
Onion 1 9.5 7.5
Onions, spring 30g 1.8 1.2
Peas, green 75g 9.9 6.5
Peppers, green lOOg 4.8 3.4
Peppers, red lOOg 4.8 3.3
Potato, sweet 1 22.4 19.2
Potato, white lOOg 15.4 13.9
Pumpkin 55g 9.9 6.3
Radishes 6 1.0 0.5
Spinach llOg 1.1 0.2
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Foods Portion
Size
Grams of 
carbohydrate
Grams of 
digestible 
carbohydrate
Vegetables
Squash, butternut 90g 10.8 7.9
Sweetcorn 70g 16g 14.1
Tomatoes, tinned llOg 5.2 4.0
Turnips 90g 3.8 2.3
Watercress 20g 0.2 0.0
Fruit
Apple, medium 1 21.0 17.3
Applesauce 60g 6.9 6.2
Apricot, fresh 1 3.9 3.1
Apricots, dried 45g 24.9 21.3
Avocado 1 14.9 4.8
Banana, small 1 23.7 21.2
Blackberries 35g 4.6 2.7
Cantaloupe 60g 3.3 3.0
Cherries 60g 4.8 4.2
Cranberries, raw 30g 3.0 2.0
Fiq 1 9.6 7.9
Grapes 40g 7.1 6.7
Honeydew Melon 60g 3.9 3.6
Juice, apple 115ml 14.5 14.4
Juice, grapefruit 115ml 11.1 10.9
Juice, lemon 1 tbsp 1.3 1.3
Juice, orange 115ml 13.4 13.2
Juice, tomato 115ml 5.1 4.7
Kiwi 1 11.3 8.7
Mango 60g 7.0 6.3
Nectarine 1 16.0 13.8
Orange 1 16.3 12.9
Papaya 60g 3.4 2.8
Peach, medium 1 10.9 8.9
Pear, medium 1 25.1 21.1
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Foods Portion
Size
Grams of 
carbohydrate
Grams of 
digestible 
carbohydrate
Fruit
Pineapple 70g 4.8 4.3
Plum 1 8.6 7.6
Raspberries 35g 3.6 1.5
Strawberries 35g 2.7 1.8
Tangerine 1 7.8 6.2
Watermelon 60g 2.8 2.6
Meat
Unless listed Og Og
Calf liver 170g 10.4 10.4
Beef salami 90g 2.4 2.4
Bacon,back 3 rashes 0.9 0.9
Garlic sausage 60g 0.8 0.8
Fish /  Shellfish
Unless listed Og Og
Mussels 170g 8.4 8.4
Oysters 170g 12.5 12.5
Scallops 170g 3.9 3.9
Squid 170g 7.0 7.0
Lobster 170g 2.2 2.2
M ilk & Dairy
Butter 6g 0.0 0.0
Milk chocolate 30g 16.8 15.8
Milk, semi-skimmed 230mls 11.5 11.5
Milk, full cream 230mls 11.4 11.4
Cream, whipping 2 tbsp 0.8 0.8
Cream, soured 2 tbsp 1.2 1.2
Yoghurt, whole, plain 230ml 11.4 11.4
Cheese
Blue cheese, crumbled 2 tbsp 0.4 0.4
Cheddar, grated 2 tbsp 0.2 0.2
Cream cheese 2 tbsp 0.8 0.8
Feta, crumbled 2 tbsp 0.8 0.8
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Foods Portion
Size
Grams of 
carbohydrate
Grams of 
digestible 
carbohydrate
Cheese
Goats cheese 2tbsp 0.3 0.3
Mascarpone cheese 30g 0.6 0.6
Mozzarella, grated 2tbsp 0.3 0.3
Parmesan, grated 2 tbsp 0.3 0.3
Ricotta 55g 1.9 1.9
Swiss (emmenthal), grated 2 tbsp 0.5 0.5
Fats /  Oils
Olive, vegetable, butter 0 0
Beans
Haricot llOg 23.9 18.1
Black-eyed llOg 20.4 12.9
Soya Beans llOg 9.9 6.2
Chickpeas llOg 22.5 16.2
Hummus 2tbsp 6.2 4.6
Lentils llOg 19.9 14.2
Red kidney beans llOg 19.8 11.6
Nuts & Seeds
Almonds 2tbsp 3.6 1.4
Hazelnuts 2tbsp 2.8 1.2
Macadamia Nuts 2tbsp 2.3 0.9
Peanut Butter, no added sugar 2tbsp 6.9 4.8
Peanuts 2tbsp 3.4 1.8
Pecans 2tbsp 2.1 0.6
Pine nuts 2tbsp 2.4 1.7
Pistachio nuts 2tbsp 4.7 3.1
Pumpkin Seeds 2tbsp 3.1 2.4
Sunflower seeds 2tbsp 3.4 1.5
C^^^o\s
Cornflakes 1 cup 24.2 23.4
Porridge Oats 50g 12.6 10.6
Puffed Wheat 15g 11.1 10.5
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Foods Portion Size
Grams of 
carbohydrat 
e
Grams of 
digestible 
carbohydrate
Cereals
Rice krispies 30g 22.8 22.5
Sultana Bran 80g 47.1 38.9
Breads
Bagel 70g 38g 36.3
Breadstick, sesame Small 2.2 2.1
White bread 1 slice 14.9 14.2
Wholemeal bread 1 slice 11.8 10.7
Grains
Couscous,cooked 2 tbsp 18.2 17.1
Rice, brown, cooked 30g 22.4 20.6
Rice, white, cooked 30g 22.3 21.9
Pasta
Noodles, egg, cooked 20g 19.9 19.0
Pasta, cooked 30g 19.8 18.6
Condiments
Balsamic vinegar 1 tbsp 2.3 2.3
Chilli powder Itbsp 1.4 0.5
Garlic 1 clove 1.0 0.9
Honey 1 tsp 5.8 5.8
Horseradish 1 tsp 0.6 0.4
Jam 1 tsp 4.6 4.5
Ketchup Itbsp 4.2 4.0
Olives, black 5 1.4 0.7
Olives, green 5 2.5 2.5
Pesto sauce 1 tbsp 1.0 0.6
Salsa, red 1 tbsp 0.8 0.7
Worcestershire sauce 1 tsp 0.9 0.9
Eggs
Whole 1 0.6 0.6
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Foods Portion
Size
Grams of 
carbohydrate
Grams of 
digestible 
carbohydrate
Sauces
Barbecue sauce 2 tbsp 4.0 3.6
Gravy ôOmIs 3.2 3.0
Hollandaise sauce 2 tbsp 0.3 0.3
Sweet & Sour 80g 15.1 15.1
Snacks
Tortilla chips 10 11.3 10.2
Crisps 10 0.6 9.7
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Recipes
Omelette
2 eggs
2 tbsps water 
sa lt and pepper 
15g (1 /2  oz) butter
Fillings
• Cheese
• Prawns
• Ham
W^nated Tamh Chop^
2 tbsps olive oil
1 tbsp W orcestershire sauce
2 tbsp lime juice 
2 tbsp soy sauce
2 tbsp dry white wine
3 cloves garlic, crushed 
salt and pepper
1 lb lamb chops
1. Mix all th e  ingredients in a bowl
2. Add th e  lamb chops and allow to marinade forl5m ins-l hour (in fridge)
3. Remove from marinade and grill until cooked
Serves 2.
1.4g carbohydrate per serving
2 tbsp butter  
T cup dry white wine 
juice o f i  lime
1/3 cup o f chicken stock  
2 chicken quarters /  breasts  
salt and pepper
1. Heat th e butter in a pan and brown th e  chicken on both sides
2. Add th e  wine, lime juice, chicken stock, salt and pepper
3. Bring to  th e boil, cover and simmer until chicken is cooked
Serves 2 
Ig per serving
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Kleat Loaf
1.4kg (3 lb) mince (lamb, b eef or 
pork)
2 tbsp chilli powder
3 eggs
3 cloves garlic
3 tbsps fresh coriander or 
parsley
170g (6oz) Cheddar cheese, 
grated
salt and pepper
1. Preheat oven to 190 °C (375 F / gas mark 5)
2. Mix all th e  ingredients thoroughly
3. Place in an oiled loaf tin and bake for  45  mins to 1 hour
Serves 6
2.5g carbohydrate per serving
^ a m b
1 garlic clove, crushed 
15g ( l/2 o z )  butter 
450g  (lib) minced lamb
15ml (Itbsp) chopped parsley 
1 egg, beaten  
4  rashes streaky bacon
1. Place lamb, garlic and parsley 
in a bowl
2. Add egg and mix well
3. Cut rashes in half
4. Divide lamb mixture into 8 equal pieces
5. Shape into burgers, using dampened hands
6. Wrap a piece of bacon around th e  sides of burger
7. Grill until brown on both sides and cooked through
Makes 8
Total carbohydrate: 2g
0.25g per burger
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Cheese Burger^
450g (lib) minced beef 
1 garlic clove, crushed 
5ml (1 tsp) dry mixed herbs 
lOOg (4oz) Cheddar cheese, grated 
1 egg, beaten
1. Put all the ingredients in a bowl and mix well
2. Use dampened hands to shape mixture into 4 burgers
3. Chill for 30 minutes
4. Grill or fry for about 8-10 on each side until golden brown and cooked 
through
Makes 4
Total carbohydrate: 2g 
0.5g carbohydrate per burger
Sauces and Dressing^
Cheese Sauce
170ml (6f I oz) single cream 
75ml (21/2 fl oz) water 
340g (12oz) cheddar cheese, diced 
1 teaspoon prepared mustard 
1 teaspoon salt 
i  teaspoon paprika
Add all ingredients to a pan and heat over a low heat until the cheese has 
melted and sauce is smooth.
Makes 18 tablespoons 
Total carbohydrate: 10.8g
0.6g carbohydrate per serving
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French Dressing
3 tablespoons vinegar 
1 tablespoon lemon juice
1 teaspoon salt 
pepper
6 tablespoons olive oil
2 tablespoons vegetable oil
1 teaspoon Dijon mustard 
T teaspoon dry mustard
Beat all ingredients together until well blended
Makes 120ml (4 fl oz)
Total carbohydrate: 2.5g
Hollandaise Sauce
1/3 cup butter
2 egg yolks
1 tablespoon fresh lemon juice 
salt to taste 
cayenne pepper to taste 
nutmeg (optional)
1. Heat butter in a saucepan over a low heat until gently bubbling
2. Meanwhile, place egg yolks in a blender or food processor and blend for a 
few seconds
3. Add the lemon juice, salt, pepper and nutmeg
4. Slowly add melted butter and blend for 10 seconds or until think and 
smooth
Makes ~l/2 cup
Total carbohydrate = 1.3g
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endix D: Low Carbohydrate Diet Sheet - On-Going Weight Loss Period
Low Carbohydrate Diet 
On-Going Weight Loss
Main principles
The on-going weight loss diet is a continuation of the 14-day 
induction diet but allows more carbohydrate
The diet continues to be low in carbohydrate to ensure your own 
body fa t stores continue to be used for energy
Meals should be based on 'free foods', (as induction diet) with a small 
amount of low carbohydrate vegetables and salad. However small 
amounts of foods with a slightly higher carbohydrate content can be 
slowly introduced, (avocado, tomato juice, etc)
You will now be able to introduce; more salad and vegetables, nuts 
and seeds, berries. Also some wine and low carbohydrate spirits can 
be incorporated
Aim to have between 20-40g of carbohydrate a day. This may be 
increased to 60g per day depending on your weight loss.
The on-going weight loss stage continues until you near your ideal 
weight
Weight loss is likely to slow down as the rapid initial weight loss is 
partially water, however weight loss each week should be expected if 
you carbohydrate intake remains low.
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Carbohydrate content of foods which can now be included
Each of the following contains ~5g of carbohydrate
Food Quantity
Almonds 24
Pecans 31
Cashews 9
Walnuts 14 halves
Macadamia nuts 10-12
Peanuts 26
Sunflower seeds 3 tibsps
Asparagus 8 spears
Red peppers llOg /4  oz
Cauliflower 75g /  2 i  oz
Broccoli 75g /  2 i  oz
Tomato 1 medium
Spinach 340g /12 oz
Avocaco 12
Onion 40g /  i  oz
Cottage cheese llOg /4  oz
Ricotta cheese 160g /5  i  oz
Lemon juice 60 mis /  2 f 1 oz
Lime juice 60 mis /2  fl oz
Tomato juice lOOmIs /4  fl oz
Raspberries 23g /3 /4  oz
Blueberries 37g /  1 i  oz
Strawberries 60g /2  oz
Cantaloupe/honeydew melon 60g /2  oz
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Meal Ideas for On-Going Weight Loss'
Continue to use the meal ideas from induction but include a wider variety of foods within your 
meals. Here are a few more meal ideas to add;
Breakfast
• Ham, avocado & tomato /cheese &. tomato omelette
• Sausage with bacon and eggs, mushrooms and tomato
• Kippers or smoked mackerel with scrambled eggs
• Scrambled eggs with smoked salmon and dill 
With
85mls of tomato juice
Lunch
Salad with ham, chicken or egg 
Steak and salad
Tuna mayonnaise with avocado and salad leaves 
Hot dog sausages with cheese and tomato slices 
Salmon salad (see recipe)
Broccoli Frittata (see recipe)
Eggs Florentine (see recipe)
Y avocado filled with blue cheese, mayonnaise and chopped celery 
Greek salad with olives, feta cheese., red onion, tomato, cucumber and olive oil 
Prawn cocktail made with mayonnaise and a little lemon juice 
Tinned fish, (mackerel, sardines, pilchards) with salad
Dinner
Serve all of the following with vegetables or salad of your choice
Salmon with béarnaise sauce (see recipe)
Chicken salad (see recipe)
Coq au vin (see recipe)
Chicken curry (see recipe)
Stuffed peppers (see recipe)
Mince or chicken strips cooked with garlic, chilli powder. Serve with guacamole, salsa, 
sour cream, lettuce and grated cheese
• Gammon steak with mustard or cheese sauce
To follow
• No added sugar jelly with whipping cream
• 80g strawberries with single cream
• Small slice of melon
Snacks
In addition to the snacks from induction keep some nuts or seeds handy.
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Recipes
Chicken Salad
2 large chicken breasts (cooked)
2 large gherkins, chopped
3 hard-boiled eggs, chopped 
3 spring onions, chopped
70 mis mayonnaise 
70 mis soured cream 
23 tbisp dill 
60g pecan halves
Cut meat into strips and combine with other ingredients 
Salmon Salad
1 X 213g tin of salmon
2 chopped spring onions
1 stick of celery
3 tbIsp Roquefort dressing (see below)
Remove bone and skin from salmon. Break into chunks in a bowl and mix with onions and 
celery. Pour over dressing and serve with watercress, rocket and endive
Roquefort Dressing
60mls (2 fl oz) tarragon vinegar 
6 tbisp olive oil
2 tbsps whipping cream 
Y tsp lemon juice
30g crumbed Roquefort cheese 
Seasoning
Beat liquid ingredients together and stir in the cheese 
Guacamole
1 ripe avocado, cubed
2 medium tomatoes, cubed 
1 medium onion, mined
2-3 tbisp chopped coriander 
1 tsp salt 
1 tsp lemon juice
Mix all chopped ingredients together and chill
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Salmon with béarnaise sauce
4 salmon steaks 
230 mis /  8 f  I oz chicken stock 
230 mis /8  f I oz white wine 
1 bay leaf
Put the salmon in a frying pan with remaining ingredients and simmer gently for 10-15
minutes
Sauce:
3 egg yolks
230 mis /8  f  I oz warm butter 
1 tbisp chopped tarragon 
3 tbIsp white wine vinegar 
Seasoning
1 shallot, chopped
1. Place tarragon, vinegar, shallot and seasoning in a pan and simmer until 1 tbisp on 
liquid remains. Strain
2. Put the egg yolks in a bowl and drained liquid and beat them gently over a gently 
heat (bain-marie) until they acquire a ribbon texture.
3. Add the melted butter slowly. Keep beating the mixture until all the butter has been 
incorporated
4. Removed the pan from the heat and mix in chopped tarragon 
Beef Strogonoff
2 tbisp chopped parsley
2 large onions, finely chopped 
450g /  1 lbs mushrooms, sliced 
900g /  21b sirloin, cut into strips 
1 i  tbisp dry mustard
120mls /  4 f I oz soured cream
3 tbisp tomato ketchup 
3 tbisp oil 
Seasoning
1. Combine mustard, ketchup and enough hot water to form a thick paste.
2. Saute onions and mushrooms in 2 tbisp of oil until golden and soft. Remove with
slotted spoon and transfer to a large casserole
3. Add remaining oil to the pan and sauté meat strips in batches. Transfer meat to 
casserole
4. Put mustard paste and soured cream in a frying pan with remaining juice. Stir gently 
until all ingredients are smoothly mixed
5. Put over meat and onions and mix well. Gently simmer until hot
6. Sprinkle with parsley and season.
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Coq au vin
1.8 kg /  41b chicken
110g /  4 oz bacon, diced
60g/ 2 oz butter
230 mis /  8 f  I oz red wine
230 mis /  8 f  I oz chicken stock
3 cloves of garlic
1 bay leaf
2 large onions
450g mushrooms, sliced 
Seasoning
1. Saute diced bacon in butter until golden. Removed form the pan
2. Brown chicken in bacon fat and remove
3. Saute onions and mushrooms
4. Return chicken and bacon to the pan. Add stock, garlic, wine and bay leaf.
5. Simmer gently for 40 mins to 1 hour in uncovered frying pan
6. Season
Chicken Curry
4 chicken breasts, chopped
2 onions, finely chopped
3 cloves of garlic, crushed 
1 tbisp turmeric
1 tbisp ground cumin
1 tbisp ground ginger
1 tbisp chilli powder
55g /  2 oz butter
230 mis /  8 f  I oz whipping cream
230 mis /  2 f  I oz hot water
Seasoning
1. sauté chicken pieces in butter until golden, remove
2. Gently sauté onions, garlic and all remaining condiments for 2-3 minutes, stirring 
constantly
3. Place chicken into sauce. Add hot water and cream
4. Simmer until chicken is tender and sauce is reduced
Stuffed Peppers
8 medium peppers 
2 large onions, finely chopped
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900g /  2 lb meat loaf mixture (see induction recipe)
1 tsp dried dill
2 tbisp vegetable oil
1 large carrot, grated 
120 mis /4  fl oz chicken stock 
230 mis /8  fl oz soured cream 
Seasoning
1. Saute onions in frying pan until golden. Add mea tmixture, seasoning and dill. Brown 
for 15 minutes. Allow to cool
2. Wash and core peppers. Fill with meat mixture and place open side up in a large 
casserole
3. Combine chicken stock and tomato puree and pour over peppers. Sprinkle grated 
carrot on tip of peppers
4. Cover and cook at 190 °C /375 °F /gas mark 5 until peppers are cooked
5. Add soured cream to serve
Broccoli Frlttcta
4 eggs
llOg /4  oz cooked broccoli florets 
1 large onion,. Thinly sliced 
230g /1 /2  lb mushrooms, thinly sliced 
55g /2  oz butter
30g /I  oz grated parmesan cheese 
1 tsp bicarbonate of soda 
Parsley
1. Saute onions and mushrooms in 2/3 rds of the butter. Remove from the hob
2. Put eggs, bicarbonate of soda and seasoning in a bowl and beat well. Add onions, 
mushrooms and broccoli and mix well
3. Add remaining butter to the pan and pour in egg mixture. Tilt pan to cover bottom 
with mixture
4. Fry eggs until they begin to set. Sprinkle with parmesan cheese and place under 
medium-hot frill until golden
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Eggs Florentine
430g /15 oz cooked spinach 
6 eggs
1 recipe cheese sauce (see induction recipe)
Seasoning
1. Preheat oven to 180°C /350°F /gas mark 4
2.Drain cooked spinach well and chop finely. Place in a shallow baking dish with seasoning
3.Make a hole for each egg in spinach. Break eggs into hole
4.Prepare cheese sauce and pour over eggs and spinach
5. Bake for 25 minutes
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idix E: Low Carbohydrate Diet Sheet -  Pre-Maintenance Period
Low Carbohydrate Diet 
Pre - Maintenance 
Main Principles
• The pre-maintenance stage of the low-carbohydrate diet should be 
commenced once you have 5-lOlbs left before you reach your goal 
weight.
• This stage will allow you to add new foods into you diet and moved 
towards the maintenance stage of the diet.
• Aim to lose less than lib a week, it may take you 1-3 months your 
reach your goal weight. This may seem slow but by adjusting your 
eating slowly, lifetime maintenance of your weight will be easier.
• Increase your carbohydrate intake by lOg /week for as long as you to 
continue to lose weight.
• Introduce new foods slowly, if you begin to gain weight, drop 
carbohydrate intake by 10kg.
• Once you reach your goal weight-hurrayl -keep your carbohydrate at 
that level for a month before increasing by another lOg per week (see 
long term weight maintenance diet sheet for further advice).
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Or... an Alternative Approach.
• Continue with your daily eating habits as in the on-going weight loss 
stage.
• Have a 20g 'treat' 2-3 times per week. This should be something you 
do not include as part of your daily eating patter and could be a piece 
of fruit, some starchy vegetables (sweet potatoes), rice or a glass of 
wine/beer.
**Continue to take your multivitamin and multimineral supplements
Hints and Tips
• Don't be afraid to let you weight loss slow down- remember this 
indicates you are more likely to be successful at maintaining your 
weight loss in the future
• Don't relax too much once you reach your goal weight-try not to let 
your weight go more than 2 kg above your goal-then you can easily 
bring it back down without needing to work as hard again!
Included on the following pages are some lOg carbohydrate increments. Add 
an extra lOg of carbohydrate to your daily diet each week. Don't add too 
many foods at once but gradually add more variety back into your diet.
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Carbohydrate Increments
Each of the following food items contain '^ lOg of carbohydrate
Food Quantity
Almonds 60g (2 oz)
Pecans 90g (3 oz)
Cashews 30g (1 oz)
Walnuts 80g (2 i  oz)
Macadamia Nuts 60g (2 oz)
Peanuts 60g (2 oz)
Pistachios 35g (1 i  oz)
Pine Nuts 50g (1 i  oz)
Sunflower Seeds 60g (2 oz)
Sesame Seeds 55g (1 $ oz)
Carrots 75g (2 i  oz)
Sweet potatoes 60g (2 oz)
Beetroot 240g (8 i  oz)
Parsnips 90g (3 oz)
Potatoes 60g (2 oz)
Lentils 23g (3/4 oz)
Kidney Beans 60g (2 oz)
Haricot Beans 60g (2 oz)
Chickpeas 55g (1 $ oz)
Broad beans 60g (2oz)
Apple i
Cherries 12
Peach 1
Grapes 12
Grapefruit 12
Strawberries llOg (4 oz)
Cantaloupe /  honeydew melon 180g (6 i  oz)
Kiwi Fruit 1
Watermelon 230g (8oz)
Plum 1
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Food Quantity
Banana 1/3
Mango 1/3
Long grain brown rice 40g (1 i  oz)
Porridge (made with water) 80g (2 i  oz)
Sweetcorn lOOg (3 i  oz)
Wholemeal bread 1 slice
Barley (cooked) 40g (1 j  oz)
Milk (semi-skimmed) 200 mis
Yoghurt-natural bio 200g
Ideas for Pre-Maintenance
Continue to use the meal ideas from on-going weight loss but gradually add in 
more foods (see table above). Here are suggestions on ways to include them;
• Add seeds to salads - pine nuts to a brie and bacon salad on a bed of 
mixed leaves with spinach and tomato
• Walnuts to a coleslaw made with shredded cabbage, onion and carrot 
with mayonnaise
• Add nuts to stir-frys-cashews work well
• Have a small amount of parsnips or based sweet potato with your
chosen meat or fish
• Add chickpeas to a curry or kidney beans to a soup
• Have fruit as a dessert or grapefruit for breakfast
• Serve your meals with brown rice
• Milk could be used to make sauces or to make a milk jelly
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Appendix F: Low Carbohydrate Diet Sheet -Maintenance Period
Long Term Weight Loss /  Maintenance Diet 
Main Principles
> This diet is intended for when you reach your goal weight or to help 
you to continue working towards this.
> This diet aims to provide you with a nutritionally complete diet with 
enough calories for you continue to lose weight. I f  you are now trying 
to maintain your weight increase the portion sizes slightly, especially 
of wholegrains.
> This stage will allow you to have a varied nutrient dense diet. Although 
refined, processed carbohydrates such as sugar will not become a 
regular part of your diet, some starches can now be included.
> You should aim to maintain your weight on 100g+ of carbohydrate per 
day. Good food choices will make sure your diet is nutritionally 
balanced.
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What should I eat to maintain my weight on a low carbohydrate diet?
Base your meals upon fresh meat and fish, vegetables, salad, nuts, seeds, 
fruits and foods containing starch such as rice and pasta
can be eaten in small amounts
Processed, refined carbohydrates contain few 
nutrients and are energy dense so try to avoid these where-ever possible
Instead choose some nutrient dense starchy vegetables (carrots, 
parsnips), fruit, legumes and wholegrains such as wild rice, cous-cous, 
oats and barley
This will ensure your diet provides sufficient micronutrients and fibre 
whilst enabling you to maintain your new healthy weight
Have a variety of foods each day - choose different coloured vegetables 
and salad as they each provide a different mix of nutrients
Keep sweet foods to an occasional trea t (a piece of birthday cake)
Have alcohol in moderation -a s  a trea t rather than a habit
Exercise regularly - ideally 5 times a week, this does not need to be 
strenuous and can be broken down into small chunks (15 minute walk twice 
a day)
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What if things go wrong?
■ I f  you eat something high in refined carbohydrate or have a few days 
when your intake is higher than normal don't panic! Just cut back a little for 
the next few days and your weight won't be affected. Learning to do this is 
essential to be able to maintain your weight in the long term.
■ Try to keep your weight within ~2kg of you goal weight - allowing your 
weight to yo-yo isn't healthy.
285
What will my daily food intake look like?
Example Daily Intake
Breakfast
Branflakes with semi skimmed milk and 1 dessertspoon of sultanas /  4 chopped strawberries
Cup of tea /  coffee with semi-skimmed milk
Snack
A piece of fruit such as a Peach 
Lunch
Chicken & avocado salad with 60g mixed green leaves (try watercress, rocket and cos), 1 
chopped tomato, 1/2 chopped raw pepper and balsamic vinegar and 1 tsp low fat mayonnaise
1 low fat plain yoghurt or diet fruit yoghurt
Snack
A small handful of mixed nuts
Cup of tea /  coffee with semi-skimmed milk
Dinner
Chargrilled tuna steak with asparagus, green beans and 1 tablespoon of cous-cous 
A slice of galia melon
Glass of red wine or 1/2 pint lager (weekends!)
Drinks - water/tea/coffee/no added sugar squash
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Hints <& Tips
■ Try not to think of these dietary changes as a ’diet', this sets you up for 
failure as these changes are seen as short term. Instead you need to 
continue the changes already made to your diet, which can be maintained 
in the long-term.
■ Many of the changes you made when following a low carbohydrate diet 
were healthy and could now be continued. Try to keep up the positive 
changes you've already made such as reducing your intake of sugary foods 
(cakes, biscuits, chocolate, sweets, desserts, fizzy drinks). Many of the 
snack options you ate on a low carbohydrate diet were healthier than 
common snacks:
Continue to choose:
Nuts and seeds 
Vegetable crudites Pastries 
Sugar free jelly
Instead of
Crisps
Chocolate /  sweets
Weight can be maintained by ensuring energy intake = energy out or 
weight loss achieved by making sure energy intake < energy out. Exercise 
can be a very effective way of increasing energy requirements 
sufficiently to lose or maintain weight. Successful weight maintainers 
very often state exercise to be the reason for their sustained lower 
weight. I t  is often easier to stick to an exercise routine if you have a 
goal, why not enter a sponsored walk, 5km run or 10 mile cycle ride -this 
will give you the continued motivation to keep exercising.
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Remember back to before you lost weight - why did you put on weight 
originally? Large portion sizes, unhealthy snacks, alcohol or habits such as 
having biscuits with each cup of tea? I t  may have been a combination of 
these things and /or an inactive lifestyle. By thinking back to old habits 
you can try to avoid slipping back into them.
Best wishes for your lighter, healthier future !
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Appendix G: Low Carbohydrate Diet Shopping List
Low Carbohydrate Diet Shopping List
DAIRY
□ __  Eggs
Q  Butter
□□□□□
Sour Cream 
Whipping Cream 
Single Cream 
Cheddar Cheese 
Blue Cheese
3  Other Cheese
MEAT & FISH POULTRY
 □__  Bacon
 □___ Sausage
 □ Cold Meat
 □__  Hot Dogs
 □ Chicken
 □ Turkey
 □ Beef
G   Pork
 □ Ham
G  Salmon
G Tuna Steaks
G Shellfish
G Tofu
EEVERAGE5
G  Decaff Tea
G Decaff Coffee
G  Herb Tea
G  Mineral water
VEGETABLES CANNED GOODS
□ Asparagus □ Tuna
□ Broccoli □ Salmon
□ Cabbage □ Pilchards
□ Cauliflower □ Mackerelo Celery □ Sardines
□ Cucumber □ Crabmeat
□ Garlic □ Corned meat□ Lettuce □ Tinned hamn Mushrooms □ Hot dogs
□ Peppers □ Beef consommé
□ Radishesn Spinach
□ Tomatoes FROZEN FOODS
□ Courgettes □ Tuna steaks
□ Rocket □ Other fish
□ Watercress □ Cauliflower
□ Spring onions □ Broccoli□ Pepper□ Radishes
CONDIMENTS COOKING GOODS
□ Olive oil □ Stock cubesa Sesame oil □ Salta Vinegar □ Peppera Mayonnaise □ Dried Herbs
□ Mustard □ Chilli powder
□ Olives □ Cayenne Pepper
□ Low sugar jelly □ Paprika
□ Worcestershire Sauce
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Appendix H: Supermarket Foods Suitable for a Low Carbohydrate Diet 
Supermarket Foods Suitable for a Low Carbohydrate Diet
Product Carbohydrate Content
Per100g Per
serving
Canned Fish
Sainsburys sardines in olive oil <0.1g
Sainsburys sardines in tomato sauce 2.2g
Sainsburys sardines in sunflower oil 
with whole chilli pepper
<0.1g
John West sardines in sunflower oil Trace
Tesco sardines in sunflower oil og
Tesco sardines in tomato sauce 0.5g
Sainsburys mackerel in mustard 
sauce
5.1g
Sainsburys mackerel in olive oil 2.0g
John West mackerel in Curry sauce 4g
John West mackerel pepper fillets in 
sunflower oil
0.5g
Princes mackerel in tangy mustard 
sauce
6g
Princes mackerel in hot chilli dressing Trace
Tesco mackerel in sunflower oil Og
Tesco mackerel in tomato sauce 3.4g
John West white crab meat in brine 0.7g
Glenryck pilchards in tomato sauce 2.8g
Princes Slimming World Tuna in 
Tikka Dressing
4.0g
Princes Slimming World Tuna in Lime 
& Black Pepper Dressing
3.5g
Canned Meat
Sainsburys premium lean ham 0.2g
Sainsburys lean ham 0.2g
Ye Olde Oak Ham 2g
Tesco premium ham 0.2g
Sainsburys corned beef 1.00
Princes corned beef I.Og
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Product Carbohydrate Content
PerlOOg Per
serving
Canned Meat (cont)
Fray Bentons corned beef 0.8g
Tesco corned beef I.Og
Tesco cured chicken breast 1.3g
Sainsburys hot dogs 0.5g 0.1 g per 
sausage
Meica german frankfurters 0.5g
Tesco hot dog sausages 3.5g 2.4g per 
sausage
Sausages
Sainsburys pork sausages 12.4g 7g per 
sausage
Sainsburys butchers choice 6.9g 3.9g per 
sausage
Sainsburys taste the difference pork 
chipolatas
0.4g 0.16g per 
sausage
Sainsburys Cumberland sausages 11 lg 6.3g per 
sausage
Tesco butchers choice pork sausages 6.3g 3.6g per 
sausage
Tesco Finest 10 traditional pork 
chipolatas
2.5g 0.9g per 
sausage
Burgers
Sainsburys 6 beef grill steaks 1.6g 0.4g per 
grillsteak
Sainsburys 100% beefburgers 0.8g 0.4g per 
burger
1 Ross beef grill steaks
:
3.7g 3.3g per 
grillsteak
Birds Eye 100% beef quarter 
pounders
Og
Tesco quarter pounders (fresh) 4g 4.64 per 
QP
Tesco black pepper grill steaks 8.6g 7.5g per 
grillsteak
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Product Carbohydrate Content
PerlOOg Per
serving
Packaged Meat
Sainsburys Blue Parrott frankfurters 0.8g 0.3g per 
frankfurter
Sainsburys frankfurters 1.5g 0.53g per 
frankfurter
Tesco kids mini hot dogs 3.5g 0.35g per 
hot dog
Tesco hot dog sausages 3.5g 2.4g per 
sausage
Sainsburys roast chicken breasts 0.2g
Sainsburys cooked ham 0.9g 0.16g per 
slice
Sainsburys roast chicken breast 0.1g 0.0175 per 
slice
Sainsburys pork luncheon meat 2.8g
Sainsburys taste the difference roast 
ham
1.3g 0.35g per 
slice
Tesco german sausage 0.3g
Milano salami 0.1g
Bernard Matthews wafer thin turkey 
ham
3.5g
Bernard Matthews chicken breast 3.0g 0.6g per 
slice
Bernard Matthews wafer thin turkey 5.5g
Sainsburys Blue Parrott dry cured 
wafer thin ham
O.Gg
Tesco smoked ham 0.8g 0.2g per 
slice
Tesco ham 0.4 0.05g per 
slice
Tesco sliced beef Trace
Tesco mustard sausage 0.7g
Tesco chunky tikka chicken 0.5g
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Product Carbohydrate Content
PerlOOg Per
serving
Fish (frozen)
Tesco thai style tuna steaks Og
Tesco sweet chilli & soy tilapia fillets 1.2g 125g =1.5g
Cheese
Philadelphia 3.2g
Cheesestrings Trace
Sainsbutys singles 5.4g
Boursin 2g
Mascarpone 4.8g
Dressings / sauces
Green pesto 9.5g
Black olive pesto 2.7g
Sainsburys reduced sugar & salt 
ketchup
20.3g
Heilmans mayonaise 1.3g
Loyd Grossman Caesar dressing 7g
Newmans oil Italian dressing ig
Pizza express olive oil dressing 3.4g
Sainsburys blue cheese dressing 8.6g
Nandos Portuguese vinegrette 
dressing
1.9g
Also..
Pepperami 17g 0.4g per 
25g
S’moret appetisers ‘herbes de 
province (cheese section)
3g Packet-3g
Tofu 2.4g
Cauldren tofu 1.2g
Quorn mince 4.5g
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Product Carbohydrate Content
PerlOOg Per
serving
Tesco
Sainsbury Smoked mackerel pate 0.8g
Tesco mackerel pate ig
Tesco healthy eating smoked salmon 
pate
26g
Tesco egg mayonnaise sandwich 
filler
0.5g 0.3g per 2 
oz serve
Cauldren spinach, cheese & crunchy 
almond pate
6.3g Per pack 
7:2g
Cauldren mushroom pate 4.3g
Campbells consommé -  a clear beef 
soup
0.5g
Tesco snack salami crisps 0.7g
Tesco finest green olive with lemon & 
garlic tapenade
5g
Sainsburys chunky salsa dip 7.8g
Sanisburys spicy red pepper salsa 3.8g
Sainsburys guacamole 3.2g
Rowntrees orange low sugar jelly pot 1 Ig 1.3g per 
pot
Rowntrees strawberry low sugar jelly 
pot
O.Sg 0.4g per 
pot
Michelob Ultra lager 0.91g (per 
lOOmIs)
2.5g per 
bottle
294
Appendix I: Low Carbohydrate Diet Sheet -Constipation
Low Carbohydrate Diet Study 
Dietary Advice for Constipation
This information sheet is designed to help maintain normal bowel movements. 
I f  your bowel moments become less frequent and you pass hard stools this is 
termed as constipation. To help prevent this try to;
1. Drink plenty of fluids
Water Is ideal. Aim for 1/5 -2 litres per day, (more if the weather is hot 
or you exercise). Fill a 1 i  litre bottle in the morning and sip it 
throughout the day-this will allow you to know your drinking enough.
Other drinks will provide additional fluid.
2. Ensure fibre intake is maintained.
Dietary fibre in the indigestible part of plant foods adds bulk to the 
stool. Many vegetables and salad, as well as some fruits, are suitable 
sources of fibre whilst following a low carbohydrate diet. During 
induction ensure you use the vast majority of your 20g carbohydrate 
allowance on vegetables and salad. Choose some of the following higher 
fibre (low carbohydrate) vegetables regularly;
- Spinach
- Aubergine
- Broccoli
- Asparagus
- Spring greens
- Green beans
- Celery and chopped pepper 
added to salads
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After the first two weeks of induction add some strawberries or 
raspberries to you diet
3. Keep moving!
Activity helps prevent constipation so make sure you include some walking 
in you everyday life.
I f  this advice does not prevent/alleviate constipation discuss with your 
pharmacist a suitable bulk-forming laxative and please inform Rebecca, 
your dietitian.
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Appendix J: Front cover and page 1 of the Exercise Log used in the LCD and 
exercise Intervention (Chapter 3)
Exercise Log
Month 1
Subject -
Week
1 Date
Type of 
Exercise
Length of 
Exercise Average HR
1
2
3
4
5
6
7
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Appendix K: Diet and Activity Diary
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What did you do?
Date Day of the Week,
Time pedometer put on at beginning of day:__________ Pedometer reading   steps
Time started Time stopped Activity
- i- ........ ..............
Time pedometer taken off at end of day; Pedometer reading _ _ _ _ _ _ _  steps
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Appendix L: Fitness Test Protocol
Fitness testing using the Aerobic Adaptation Test
focus
Detect changes in sub-maximal workload capacity and minimize participant discomfort 
Outcomo
Work output over a 3 min period 
Protocol
Resources
-  art rate monitor
Cvcle ergometer (which allows ramped workload increments of 5-20 W/min)
?AR
Jackson non-exercise test regression equations:
To predict max watts
Max Watts=([(Pred V02max. WT)-(lMEr.WT)]/2y6.1l8kg.m.min
AT= weight in Kg 
* -  regression constant for mlAg/min to kg/Wmin 
: 118 kg/m/min =1W
result divided by 0.75 to derive 75% max workload equivalent to 70%Max HR
Pedalling speed 60 rpm
Workload
Constant ramp rate as per prediction until 70% MHR (age predicted) achieved 
Workload clamped at this level for 3 minute plateau
Warm down @30 watts for 3 minutes 
D u ra tio n
Preferred ramp duration 8-12 minutes
Primary outcome measures average workload (W) during steady state 3 min plateau period 
Stao bv step guide
I. Using the “Watts calculator” spreadsheet input participant’s details in the white boxes
a. PAR (physical activity rating) score - this derived from the PAlR questionnaire (sec 
below) (Boverts.RM & Jackson,AS; 1990 : Exercise Concepts, Calculations, and 
Computer Applications, pi 09) of the participant should be asked to read though the 
options PAR score that is used in the spreadsheet.
FAR Questionnaire
Code for physical activity rating PAR (numbers describe general activity level for the previous month)
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DO NOT PARTICIPATE REGULARLY IN PROGRANÎKÆD RECRIATION SPORT OR
0-Avoid walking or exertion, e.g„ always use elevator, drive whenever possible instead of
walking.
1-Walk for pleasure, routinely use stairs; occasionally exercise sufficiently to cause heavy 
breath ing or perspiration.
f  ACnF/TT GOIF, CÆUSTÏ/EATCS:
GKWhWSnCS: J:4giEIEm7S, ROm/WG, TKE/GZfrZJFnVG, K4RDIFG/ÜA:
2-10 min to 60 min per week.
3- over one hour per week
fXRHOfXTE RFGGURLF W EEd WCA" AS EUmZNG OR
JGGG/WGSlf7mi7WG, CTCL/WG, EGM7M?, SQ?f/WGEGfE, EUAMM/WfZACE 
GE EWGAG/Mj W  PYGGEGaSAEmB/CACnK/TY TKPEEAEEOSESGŒ AS
TENNIS, BASKETBALL OR HANDBALL.
4- Run less than one mile per week or spend less than 30 minutes per week in comparable 
physical activity.
5- Run ho 5 miles per week or spend 30 to 60 minutes per week in comparable physical 
activity.
6- run 5 to 10 miles per week to spend I to 3 hours per week in comparable physical 
activity.
7- Run over 10 miles per week or spend over 3 hours per week in comparable physical 
activity
b. Gender score (Female=0, Male=l)
c. Age
d. Weight
e. Height
2. The spreadsheet will now show:
a. Predicted V02 max (‘Tred. V02 Max”)
b. Predicted maximum workload (“Max Watts”)
c. 75% of maximum workload (“75%max”)
d  Rate at which workload should be increased in the test = 10% of 75% Wmax (“Ramp 
rate (W)”). The tester will use their discretion to select a work rate to the nearest 5 'watts 
(e.g. for ramp rate of 12 watts, 10 watt ramp steps might be selected)
e. Target pulse (“70% HR max”) 70% of age predicted maximum, which is the point at 
which the workload is clamped.
f. Ramp steps for the subject (actual) and options for ramp steps selection (5,10,15,20 
watt increments)
3. After adjusting the cycle ergometer position to suit the participant and equipping the participant 
with the HR monitor the first workload may be selected and the participant set cycling @ 60 
rpm for the first minute
4. At the end of the minute note the heart rate and increase workload in accordance with the ramp 
step schedule.
5. Repeat the increases in workload until the 70% HR max level is achieved by the participant at 
this point the no further increases in workload should be made but the participant should 
continue cycling until 3 minutes have been maintained at this level. The final workload should 
be noted and the pulse though out each minute of the test.
6. Once the 3 minute “plateau” is completed the workload should be reduced to 30 watts and the 
participant should continue to cycle at this workload for a further 3 minutes by way of warm 
down.
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7. The outcome (or result) o f the test is thé final workload (the last 3 minutes workload before 
warm down) e.g, 130 watts. This figure may be represented as a watts/kg figure for comparison 
between individuals.
Please do check this through to make sure you are comfortable with the test and the spreadsheet 
attached has arrived without errors.
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Appendix M: Nutritional composition of multivitamin and mineral supplement 
provided to subjects
Micronutrient Per daily dose %RDA
Vitamin A SOOug 100
Vitamin D 5ug 100
Vitamin E lOmg 100
Vitamin C 60mg 100
Thiamin ( vitamin 81) 1,4mg 100
Riboflavin (vitamin 82) I.Bmg 100
Niacin (vitamin 83) 18mg 100
Vitamin 86 2mg 100 '
Folic Acid ZOOpg 100
Vitamin 812 ip g 100
Biotin 0.15mg 100
Pantothenic Acid 6mg 100
Vitamin K 30pg
Calcium 220mg 27.5
Phosphorous 40mg 5
Iron 14mg 100
Magnesium 60mg 20
Zinc 15mg 100
Iodine ISOpg 100
Copper Img
Chloride 36mg
Chromium 25ug
Manganese 2.5mg
Molybdenum 25pg
Potassium 40mg
Selenium 25fjg
RDA = Recommended Daily Allowance 
To be taken once per day
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Appendix N: Scattergraph showing Plots of Residuals for change in Insulin, CRP & NEFA
from baseline to 6 months within the Diet & Exercise Group (Chapter 3)
Scatterplot
Dependent Variable: Change in insulin from bl to 6 months
1----------- r
-120.00 -90.00 -60.00 -30.00 0.00 30.00
Change in Insulin from bl to 6 months
60.00
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Scatterplot
Dependent Variable: Change in erp from baseline to 6 months
-1.00 -0.50 0.00
Change in crp from baseline to 6 months
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Scatterplot
Dependent Variable: Change in NEFA from baseline to 6
months
1-
0 -
■o
-1 —
0.00 0.20 0.40- 0.20-0.40
Change in NEFA from baseline to 6 months
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Appendix O: Scattergraph showing Plots of Residuals for change in Triglycerides and
LDL3 from baseline to 6 months within the Diet Group (Chapter 3)
Scatterplot
Dependent Variable: Change in TAG from baseline to 6 months
- 2.00 - 1.00 0.00 
Change In TAG from baseline to 6 months
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Scatterplot
Dependent Variable: Change in LDL3 from baseline to 6
months
-40.00 -30.00 -20.00 -10.00 0.00 10.00
Change In LDL3 from baseline to 6 months
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Appendix P: Ethical Approval from South East Multi-centre Research Ethics 
Committee for the Body Composition Study
(Chapters)
3
SL32 Favcurabt» ophton of amendmont 
V«r9fon2,0ctot»r2004
South East MuKI-Centre Research Ethics Commtnee
Kent and Medway Strategfc HeaKh Autfiorify 
Preston H# 
Aytesford 
Kent 
ME207NJ
Tel: 01227831 662/01622713106 
Fax 01227 831 662/01622885966 
Email: ’igne-mgrtgi@stmrec.fsnet.cQ.ufc 
jg. hi jdef@virqin. net
1 February 2005
Dr H Truby  
SBMS
The University of Surrey
Guildford
Surrey GU2 7XH
D earD rT ru by
Full title  o f study: A  randomised trial investigating the effects of a
low carbohydrate weight loss regimen on 
cardiovascular risk factors in men 
REC reference num ber: MREC 03/01/122
Protocol n u m b e r Version 3 27/08/04
Am endm ent n u m b e r 4  
Am endm ent date: 26/01/05
The above amendment was reviewed at the meeting of the Sub-Committee of the Research 
Ethics Committee held on 9‘” February 2005.
Ethical opinion
The members of the Committee present gave a  favourable ethical opinion of the amendment 
on the basis described in the notice of amendment form and supporting documentation.
Approved docum ents
The documents reviewed and approved at the meeting were:
Notice o f substantial am endm ent form  dated 25 01 2005
Gut peptide supplem entary pilot study protocol version 1 24 01 05
Volunteer inform ation sheet version 3 24 01 05
OP information sheet version 2 24 01 05
V olunteer consent form  version 1 1 5 1 0  03
GP consent form  version 1 1 5 1 0  03
Mem bership o f the Comm ittee
The members of the Ethics Committee who were present at the meeting are listed on the 
attached sheet.
M anagem ent approval
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SL32 Favourable opâiion of amendmor#
Vwslor» 2, October 2004
All Investigators and research collaborators in the NHS should notify the R&D Department for 
the relevant NHS care organisation of this amendment and check whether it affects local 
management approval of the research.
Statement of compliance
This Committee is recognised by the United Kingdom Ethics Committee Authority under the 
Medicines for Human Use (Clinical Trials) Regulations 2004, and is authorised to carry out 
the ethical review of clinical trials of investigational medicinal products.
The Committee is fully compliant with the Regulations as they relate to ethics committees 
and the conditions and principles of good clinical practice.
The Committee Is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK.
MREC 03/01/122 Please quote this number on all correspondence
Yours sincerely,
*
bane Martin
Committee Administrator
' E-mail: iane-martin@stmrec.fsnet.co.uk 
Copy to:
Enclosures List of names and professions of members who were present at the meeting
and those who submitted written comments
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